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Abstract  
 
Voice tremor is associated with Parkinson’s disease (PD), however little is 
known about the precise characteristics of PD voice tremor, optimum methods 
of evaluation or possible relationships with other speech, voice, and disease 
variables. The question of possible differences between voice tremor in people 
with PD (pwPD) and neurologically healthy ageing people has not been 
addressed. 
 
Thirty pwPD ‘off-medication’ and twenty eight age-sex matched neurologically 
healthy controls were evaluated for voice tremor features using acoustic 
measurement, auditory perceptual voice rating, and nasendoscopic vocal tract 
examination. Speech intelligibility, severity of voice impairment, voice disability 
and disease variables (duration, disability, motor symptom severity, phenotype) 
were measured and examined for relationship with acoustic voice tremor 
measures. 
 
Results showed that pwPD were more likely to show greater auditory perceived 
voice instability and a greater magnitude of frequency and amplitude tremor in 
comparison to controls, however without statistical significance. PwPD had a 
higher rate of amplitude tremor than controls (p<0.05). Judged from ‘silent’ 
video recordings of nasendoscopic examination, pwPD had a greater amount of 
tremor in the palate, tongue, and global  larynx (vertical dimension) than 
controls during rest breathing, sustained /s/, /a/ and /i/ (p<0.05). Acoustic voice 
tremor did not relate significantly to other speech and voice variables. PwPD 
had a significantly higher voice disability than controls (p<0.05), though this was 
independent of voice tremor. The magnitude of frequency tremor was positively 
associated with disease duration (p<0.05). A lower rate of amplitude tremor was 
associated with an increase in motor symptoms severity (p<0.05). Acoustic 
voice tremor did not relate in any significant way to PD disability or phenotype.  
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PD voice tremor is characterised by auditory perceived instability and tremor, a 
mean amplitude tremor of 4.94 Hz, and tremor in vocal tract structures. Acoustic 
analysis and nasendoscopy proved valuable adjunctive tools for characterising 
voice tremor. Voice tremor is not present in all people with PD, but does appear 
to increase with disease duration. However pwPD examined here represent a 
relatively mild group with relatively short disease duration. Further work will look 
at people with more severe disease symptomatology and longer duration.  
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Introduction   
There are four salient aspects to this thesis, Parkinson’s disease (PD), tremor, 
speech and voice changes in PD and voice tremor. Chapters 1 and 2 cover the 
disease and speech and voice changes associated with PD, chapters 3 and 4 
address the tremor and voice tremor aspects.Chapter 4 leads into the research 
questions and study aims. 
Chapter 5 describes the methods used in the study. Chapter 6 delineates the 
main research question results and the supplementary results. Chapter 7 
discusses general points emerging from the study, the findings from the four 
research questions, some additional findings, clinical implications and pointers 
for further research. The appendices, glossary and references follow chapter 7.  
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Chapter 1. Understanding Parkinson’s disease (PD) 
Chapter 1 begins with a definition of idiopathic Parkinson’s disease or PD as it 
is commonly referred, with further information given on its prevalence and 
incidence. This is necessary in order to place the current PhD study in context. 
The neuropathology underlying the cardinal motor symptoms is described, 
leading to a delineation of myriad of motor and non-motor symptoms associated 
with PD. In order to complete the background knowledge, the chapter also 
includes a description of the clinical diagnosis and evaluation of PD, different 
phenotypes, and medical management of PD. Underlined words in chapter 1 
and subsequent chapters are explained in the glossary section. 
 
1.1. Definition 
Idiopathic Parkinson’s disease (PD), the most common parkinsonian disorder is 
a progressive neuro-degenerative, multi-system disorder with both motor and 
non motor symptoms1 2.  PD differs from parkinsonism, a condition which refers 
to any symptom profile similar to that of PD, but with a known aetiology 
including vascular Parkinson’s, Wilson’s disease, iatrogenic Parkinson’s, 
exposure to dopaminergic neurotoxins as in 1-methyl- 4 phenyl-1,2,3,6-
tetrahydropyridine (MPTP)3 or encephalitis4.  
Traditionally, PD has been described in relation to the four cardinal motor signs 
of rigidity, bradykinesia, postural instability, and rest tremor 5. Rigidity is 
detected as a resistance to passive movement of the limbs. It is often 
characterised as uniform in directions of flexion and extension resulting in ‘‘lead 
pipe rigidity’’, and there may also be a superimposed ratcheting most likely 
associated with accompanying tremor referred to as ‘‘cogwheel rigidity’’ 6. 
Bradykinesia defined as slowing of motion and a decrease in automatic 
movements is considered the most characteristic finding of PD and is 
manifested by the loss of facial expression, and loss of other associated 
movements such as arm swinging when walking6.  Postural Instability relates to 
the loss of postural reflexes and is associated with advanced PD, occurring 
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after the onset of other clinical symptoms6. Tremor, in particular a 4 Hz “pill 
rolling” rest tremor is considered the hallmark symptom of PD6. Tremor, with 
particular reference to tremor in PD will be elaborated on in chapter 3. In 
addition to the classical motor symptoms, the disease process is associated 
with involvement of the limbic, autonomic and non-motor symptoms7-9. The non-
motor symptoms will be outlined in section 1.4. PD is associated with a reduced 
life span10, increased disability11, reduced quality of life12, and ageing13.  
1.2. Prevalence and incidence 
PD, the second most common degenerative disease of the ageing brain after 
the dementia of Alzheimer’s disease1, is twice as frequent in men as it is in age-
matched women14.  Prevalence varies worldwide from 7 to 450 per 100,000 with 
lower rates associated with the developing world15, possibly reflecting the 
association of PD with age and its nonappearance in countries with low life 
expectancy. The estimated incidence is 13/100,000 population, with incidence 
increasing with age14. PD is associated with the loss of the chemical 
neurotransmitter dopamine in the substantia nigra pars compacta (SNpc) of the 
basal ganglia, and ageing is closely linked with progressive decline in dopamine 
levels16. Although there are close links between PD and the ageing process16, 
PD is not due to ageing alone17. The exact cause of PD is unknown however 
several mechanisms are thought to be involved with interaction between toxic 
environmental factors, genetic susceptibility, and ageing4,1. 
1.3. Neuropathology  
There is consensus that the neuropathophysiology resulting in the motor 
symptoms of PD relates to the progressive loss of melanin-containing 
dopaminergic neurons in the substantia nigra pars compacta (SNPc) of the 
basal ganglia and the resultant depletion of dopamine in the striatum18. This 
depletion in turn leads to changes in thalamic and cortical activity19. The basal 
ganglia (BG) are large subcortical interconnecting nuclei  involved in the 
regulation and control of movement, through a complex circuitry, which also 
involves the cerebral cortex and the thalamus20 21. The primary role of the BG is 
to synergistically effect and coordinate the initiation and direction of volitional 
movement. Disorders of the BG result in paucity of movement, or ‘hypokinesia’ 
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as well as some degree of involuntary movement, including tremor22.The 
standard account of this basal ganglia-thalamic-cortical (BG-TH-CTX) circuitry 
is that the striatum (the primary input structure in the BG) receives messages 
primarily from the motor cortex and then through direct and indirect activation 
output pathway sends messages to the globus pallidus internal segment (GPi) 
(output structure) which in turn feeds back to the cortex21. The neurotransmitter 
dopamine which is produced in the substantia nigra pars compacta (SNpc) has 
a differential effect on the pathways. In the direct pathway it increases or has a 
facilitatory effect, whilst in the indirect pathway it has a suppressive effect on 
movement. In PD, the increased rate of the GPi neuronal discharges (GPi rate 
theory) is posited to suppress neuronal activity in the thalamus and motor 
cortex, thus suppressing movement23, and resulting in the cardinal PD symptom 
of hypokinesia (reduced movement). More recently the ‘systems oscillator 
theory’ has been put forward as an explanation for PD. The BG-TH-CTX system 
is thought to be made up of dynamically coupled polysynaptic oscillators 
representing a wide range of frequencies. Dopamine loss could affect synaptic 
efficiency within the BG-TH-CTX system changing the oscillatory dynamics and 
thus affecting behaviour23. 
It is argued that PD progresses sequentially and topographically in 6 stages 
beginning in the dorsal motor nucleus of the vagus in the brain stem, and the 
olfactory bulb24 and finishing in the cerebral cortex with the full range of PD 
symptoms including dementia 2 9. The early stages (stage 1 and 2) are 
considered pre-symptomatic in that the disease is not clinically evident. In 
advance of the clinical diagnosis being made, a significant amount (60-70%) of 
dopaminergic neuronal degeneration occurs 25. Lowered volume of voice, 
changes in rate of speech, flat facial expression, and changes in fundamental 
frequency variability (monotone voice) have been reported in patients in 
advance of the clinical diagnosis of PD26 4.  
1.4. Symptomatology 
The depletion of dopaminergic neurons results in the characteristic motor 
symptoms, described in section 1.1. In addition to the ‘cardinal’ motor 
symptoms, other clinical features termed secondary motor symptoms are also 
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associated with PD and can be equally or more disabling than the cardinal 
features6. They include: micrographia  (abnormally small handwriting)27;  
festination (increase of speed with reduced amplitude during fast repetitive 
movements, which may affect gait, tapping, and movement of  the articulators 
during speech)28; freezing of gait or FOG (sudden and transient difficulty in 
moving forward)29; dystonia6; bradyphrenia (slowness of thought)17; hypomimia 
(reduced facial expression)6; sialorrhea (poor saliva control)30; dysarthria 
(neuromuscular speech disorder)31;dysphagia (swallowing disorder)32.  Speech 
and voice symptoms, described in chapter 2 have been linked to orofacial-
laryngeal bradykinesia and rigidity33 34. 
The neuropathology underlying PD extends beyond the nigrostriatal pathways 
and into other areas not directly involved in motor control (non dopaminergic), 
including the peripheral autonomic nervous system35. These wider effects of 
change are  reflected in the non-motor symptoms which feature strongly in 
PD36. They include: cognitive impairment37 38 39 40, dementia37 41, depression42, 
43, anxiety43, sleep disorders44,visual hallucinations45, autonomic changes 
(postural hypotension, bladder dysfunction) hyposmia (loss of sense of smell)46, 
and apathy43. Cognitively, bradyphrenia, reduced attention span and alertness, 
slowness in processing information, and difficulty in switching sets may occur17. 
A substantial number of patients will develop dementia during the course of 
their PD (PD-D)40. Although dementia is associated with advanced PD47, 
cognitive executive dysfunction has been identified in the early stages of PD48.  
Depression is a frequent co-occurring symptom in PD49 50 43 51, with prevalence 
rates of 40% reported52-54. Anxiety, which has received much less attention in 
the literature  is also prevalent with rates reported from 28% to 49%54. Anxiety 
and depression impact negatively on quality of life in pwPD.  
The myriad of motor and non-motor symptoms just described create a complex 
clinical picture, resulting in wide ranging effects on the life of a pwPD including 
loss of independence, difficulty communicating, withdrawal from socialisation, 
and early retirement, leading to reduced quality of life11. 
5 
 
1.5. Diagnosis and evaluation  
There is no specific diagnostic test available to identify PD17. Diagnosis is made 
on the basis of clinical symptoms which must fulfil the UK Parkinson’s Disease 
Society (PDS) Brain Bank criteria for PD55. For a diagnosis of PD to be made, 
bradykinesia must be present and at least one of the following symptoms; 
muscular rigidity; a 4-6 Hz rest tremor; disorders of posture, balance or gait56. 
The two most widely used clinical scales for rating clinical symptoms in PD57 58 
are the Hoehn & Yahr 59 staging system and the Unified Parkinson’s Disease 
Rating Scale (UPDRS)55.  
The Hoehn & Yahr scale59 is the most commonly used instrument for evaluating 
overall severity of PD, using a simple staging approach, ranging from stage 0 
(no sign of disease) to stage 5 (wheelchair bound)6 57.  Patients are usually 
classified into ‘early’ or ‘late’ stage PD on the basis of the severity of motor 
symptoms7, with postural instability being the primary index of severity60. In this 
study, the disability resulting from PD will be measured using UPDRS section II 
(APPENDIX A), and the overall severity of motor symptoms and disease stage 
will be measured using UPDRS section III (APPENDIX B), and Hoehn & Yahr 
(APPENDIX D) staging respectively. 
Unified Parkinson’s  Disease Rating Scale (UPDRS) 
The UPDRS 55 is made up of four subsections: Part 1 (Mentation, Behaviour, 
and Mood), Part II [(activities of daily living (ADL)], Part III (motor examination), 
Part 1V (complications of treatment).  Part II and III are widely used clinically 
and include patient’s self-rating of activities of daily living and a clinician rating 
of motor signs respectively. Each item is scored from 0 (normal) to 4 (severe 
disability). There are thirteen items in the UPDRS II, which can yield an overall 
score between 0 (normal) and 52 (severe disability). In UPDRS III (motor) there 
are fourteen items with a range of scores from 0 (normal) to 108 (severely 
impaired).  
There are three tremor items for scoring in the UPDRS II and III combined. Item 
16 in part II is a self-report measure of tremor. Items 20 and 21 in part III are 
clinician ratings of tremor at rest, and action tremor respectively. Two items only 
6 
 
in the UPDRS cover speech: item 5 in part II and item 18 in part III. Item 5 
addresses how intelligible a person considers he or she is, based on the 
frequency with which he/she needs to repeat him or herself. Item 18 is rated by 
the examiner and could be described as a’ global’ measure of speech, voice 
and communication rating. It encompasses diction, volume, intelligibility and 
expression, with a score of 0 = normal and 4 = unintelligible speech. It is evident 
from the range of parameters included that item 18 is an insensitive measure of 
the speech and voice symptomatology associated with PD. Therefore, in this 
study, item 18 (UPDRS III) will not be utilised as an index of speech or voice 
symptom severity. However, UPDRS II and III will be utilised to obtain an overall 
rating of motor disability and impairment in pwPD, and to determine PD sub-
type or phenotype (section 1.6.3). 
1.6 Disease variables 
1.6.1 Onset of disease 
The mean age of onset of PD, defined as when the first PD symptom is 
reported to appear61 was 59.0 (9.6) years in a large study of 800 patients61. Age 
of onset of the disease is an important factor in terms of the rate of disease 
progression and clinical manifestations. For example, patients with early-onset, 
(defined as patients who had their first symptom at or before the age of 40)62, 
have a greater tendency to develop fluctuations of response to medication and 
abnormal involuntary movements17. Older age at onset, termed ‘late-onset’ 
(greater than 70 years old) is associated with a more rapid disease progression, 
greater cognitive decline17 and, greater likelihood of freezing than at younger 
age at onset62. The rate of deterioration of the disease process and of different 
functions affected (e.g. speech, gait, mood) is variable6. But whatever the 
relative pattern, as the disease process advances, the motor and non-motor 
symptoms become more prominent.63  
1.6.2 Disease duration 
The length of time that a person has the disease, i.e duration of disease, may 
be calculated from the time of clinical diagnosis, or based on patient reporting of 
first PD symptom. Regardless of the method used, it is accepted that  significant 
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neuronal degeneration, in the region of  60-70% has occurred in the substantia 
nigra46, at the time that a patient fulfils the clinical diagnostic criteria of PD56. 
Non-motor symptoms46 including low mood, and olfactory dysfunction, subtle 
motor impairment46 and voice changes may be apparent in this ‘pre-clinical’ 
phase64.  Efforts are being made to identify ‘markers’ of early signs of PD, to 
assist in the development of neuroprotection and thus avoid the relentless 
course of neuronal degeneration46.  
1.6.3 Phenotypes 
PD is not a single clinical entity. There is considerable heterogeneity in the 
clinical symptomatology and disease progression, to the extent that the 
existence of distinct clinical subtypes or phenotypes with different clinical 
profiles and different pathophysiological systems is recognised5 18 61 62 65.  
People with PD (pwPD) are broadly classified into tremor- dominant and non-
tremor subtypes18 61 66, for example, postural instability gait disorder (PIGD). 
Some people with PD (pwPD) do not fit neatly into tremor-dominant or PIGD 
subtypes and are described as indeterminate. The particular phenotype is 
determined from the UPDRS by calculating the ratio of the average global 
tremor score to the overall postural instability gait disturbance score61. A ratio of 
mean tremor score/mean PIGD score greater than or equal to 1.5 constitute the 
tremor-dominant phenotype, those with a ratio of less than or equal to 1.0 
constitute the PIGD group.61 The indeterminate phenotype does not fit into 
either category, with scores falling between the extremes.  
Tremor dominant PD is associated with early symptomatic tremor in the upper 
and lower limbs, and is contrasted with a different form of PD in which postural 
instability and gait problems (axial symptoms) are dominant (PIGD). Tremor 
dominant PD is also contrasted with a phenotype in which bradykinesia and 
rigidity are the dominant features18. There are different rates of progression for 
each phenotype62, with the tremor-dominant form  associated with a slower rate 
61,18 67, and PIGD associated with a more rapid disease progression68 64.  
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1.7 Treatment with dopaminergic medication 
The mainstay treatment of the cardinal motor symptoms in PD is through 
medication using dopamine replacement, levodopa (L-dopa), which is converted 
to dopamine in the brain and, dopamine agonists which directly stimulate 
dopamine receptors in the brain69. The positive effect of L-dopa on the limb 
symptoms of tremor, rigidity and limb akinesia is strongly established in the 
literature63.  The reported effect of dopaminergic medication on ‘axial’ signs, 
including neck rigidity, rising from a chair, posture, gait postural instability, and 
speech, are less positive69 70. Patients taking dopaminergic medication often 
experience cyclic fluctuations of their symptoms, with the term “on” used when 
motor symptoms are relieved and “off”, when motor symptoms are present71.  
Long-term side effects of dopaminergic medications include motor 
complications, neuropsychiatric complications, and lowered blood pressure63. 
The motor complications include fluctuations (shortening of the response to 
individual L-dopa doses) and dyskinesias or involuntary movements63 69. 
Sometimes, it can be difficult to discern which motor symptoms are disease and 
which are medication related. This issue is frequently addressed during clinical 
evaluation and/or research by evaluating pwPD when they are in a “practically 
defined off” state, which is considered to be at least twelve hours after the last 
medication dose72. This topic will be discussed further in section 2 
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Summary  
• PD is a common, multi-system, degenerative, neurological disease, 
resulting in motor and non-motor symptoms.  
• The depletion of dopamine in the substantia nigra pars compacta (SNpc) 
is considered pathognomic of the disease, but the underlying cause of 
the neuronal degeneration is unknown. 
• PD is twice as frequent in males as females. It is associated with ageing; 
however it is not caused by increasing age.  
• The clinical diagnosis of PD is made primarily on the basis of the cardinal 
motor symptoms of rest tremor, muscle rigidity, bradykinesia and 
postural instability. 
•  Clinical heterogeneity is extensive and is reflected in the emergence of 
PD sub-types or phenotypes. 
• Dopaminergic medication is the mainstay treatment for PD. 
Chapter 2 explains the terminology used in speech-voice studies, describes 
the varied PD speech and voice symptoms with special focus on voice 
symptoms, outlines evaluation approaches used to identify speech and 
voice symptomatology, gives consideration to possible influencing factors in 
speech and voice analysis, and finally describes findings from studies 
exploring relationships with disease variables.  
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Chapter 2. Speech and Voice changes in PD 
The focus of this thesis is voice tremor in PD. Chapter 2 addresses speech and 
voice changes in PD, in order to place voice tremor in the context of the wider 
changes in the speech-voice system. The relevant technical terms frequently 
used in the literature are explained in section 2.1. Sections 2.2 and 2.3 
delineate the overall speech and voice symptomatology respectively. Evaluation 
approaches and relevant studies applying these measures are discussed in 
section 2.4. Potential confounders associated with PD are explored in section 
2.5. The final section 2.6 relates PD speech and voice symptom to the 
underlying disease process which was the focus of chapter 1.  
2.1 Terminology 
Speech generally refers to the production or articulation of sounds in words and 
sentences used to communicate a message verbally and involves the tongue, 
lips, soft palate and mandible. Voice refers to the sound that is generated 
through the combined action of the expiratory breath and muscular properties of 
the vocal cords and modified by the resonating cavities above the vocal cords. 
Voice relates to the function of the larynx. The term phonation is frequently used 
interchangeably with voice.  Prosody incorporates loudness, pitch and rate of 
speech and refers to the stress, intonation and rhythmic patterns of a language. 
Fluency refers to the smooth flow of words and sentences. Dysfluency refers to 
presence of (unexpected) pauses, hesitations, false starts, repetitions of sounds 
and syllables. Intelligibility of speech refers to the degree to which a listener/s 
can understand a person’s speech. Dysarthria is a neuromuscular speech 
disorder, potentially involving the four speech sub-systems: respiratory; 
phonatory, resonatory; articulatory. Respiratory refers to the lungs and 
breathing; phonatory refers to the vocal cords and voice; resonatory refers to 
balance of sound between oral and nasal cavities which in turn relates to nasal 
and non-nasal resonance; articulatory refers to articulators used in the 
production of different sounds. Communication refers to a speaker conveying a 
message to a listener/s using either, a verbal and/or a non-verbal medium or 
both. Non-verbal communication relates to facial expression and arm gestures 
that may accompany speech.  
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2.2 Symptomatology 
Motor speech, voice and communication disorders are strongly associated with 
PD 73 31 74. Reported prevalence rates are high with varied speech and voice 
symptomatology reported across studies75 76 77 78. For example, in a study of 
178 patients with parkinsonism, [idiopathic PD and post-encephalitic etiologies 
(mixed)], 89% were reported to have impaired function of the larynx, lip and 
tongue, on perceptual voice analysis75. Logemann et al.,76 in a different study of 
200 patients (mixed etiologies) reported mis-articulations in 45 % of their 
sample. Miller et al.,77 in a study of 125 pwPD reported that 69% had reduced 
intelligibility of speech. Sapir et al.,78 found that 85% of their group of 42 pwPD 
had voice changes, some of whom had additional deficits in articulation, 
prosody, and fluency. 
In addition to the varied speech and voice symptoms just described, non-verbal 
communication is also impaired as a result of a masked-like facies, reduced 
blinking, smiling, arm gestures, and deterioration in writing79 31. PwPD are 
perceived negatively and less likeable by their listeners, as a result of reduced 
fundamental frequency variability (monopitch), increased use of pauses, and 
lack of facial expression80 81. Speech and voice problems in pwPD are 
associated with increasing disability and may be an equal or more disabling 
feature than the cardinal motor signs82 83, with poor awareness of symptoms 
reported84.  
The term ‘hypokinetic dysarthria’ coined initially by Darley et al.,85 in a seminal 
piece of work, is frequently used as a global descriptor of  the varied perceptual 
speech and voice symptoms in PD. ‘Hypokinetic’ refers to reduced movement 
extent 86 and, ‘dysarthria’ relates to the neuromuscular speech disorder (section 
2.1). However, it is clear that the term ‘hypokinetic dysarthria’ does not capture 
the clinical heterogeneity that is associated with the PD profile87 88 89. 
2.3 Voice symptomatology 
Among the heterogeneity, there is consensus that the voice-related features are 
central among the diverse symptomatology in pwPD, with voice impaired more 
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frequently than the other symptoms and featuring early in the disease process. 
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88  75 89 77 90 64 Darley et al.,31 considered that monopitch, monoloudness and 
reduced stress were the most salient features evident when they evaluated 
thirty eight speech dimensions in a group of 32 pwPD. Stewart et al.,88 in their 
study of twelve ‘early’ stage (mild disease severity) pwPD reported that changes 
in voice quality (breathiness, roughness), reduced loudness, and monopitch 
were the most common voice features on a dysarthria evaluation. Logemann et 
al.,75 reported that 89% of a group of 200 patients had abnormal vocal features 
(breathiness, hoarseness, roughness,tremulousness), in contrast to 45% with 
articulation and 20% with rate disorders.  Chenery et al.,89 in their study of 
nineteen pwPD reported that from a total of thirty - two respiratory, speech, and 
voice symptoms, the voice symptoms (hoarseness, breathiness, strained-
strangled phonation) occurred more frequently than the other symptoms.  Miller 
et al.,77 in a survey of one hundred and twenty-five patients reported that 76% of 
the group felt that their voice was not as good it used to be prior to PD. Ho et 
al.,90 found that 73.5 % of a group of two hundred PD patients showed a 
gradual deterioration of speech features, with voice quality being the first 
parameter to change. Finally, Harel et al.,64 in a retrospective speech analysis 
identified reduced fundamental frequency variability (a measure of pitch 
variability) during free speech in two pwPD prior to the clinical diagnosis of 
PD.64 The fact that voice symptoms frequently occur early in the PD clinical 
presentation and even more importantly in the ‘pre-clinical’ 46 (section 1.5) stage 
of the disease warrants their focussed attention.   
Although there is agreement regarding the salience and early presentation of 
voice problems in PD, there is less clarity regarding the presence and nature of 
voice tremor. Duffy et al.,84 consider that  ‘true voice tremor’ is uncommon in 
PD, but consider that the voice may be ‘unsteady’ or ‘tremor like’. The authors 
did not elaborate on what they meant by ‘true voice tremor and how it is 
different to ‘tremor like’ or ‘unsteady’. Darley et al.,79 state that the tremor of 
parkinsonism is not reflected in speech. However they did not state how they 
came to this conclusion. Conversely, other authors have described 
tremulousness,75 91  ‘vocal tremor’88  and shakiness in pwPD. The issue of 
varied tremor descriptors will be revisited in chapter 4.  
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2.4 Evaluation approaches 
A major goal of this thesis is to find ways to evaluate and measure PD voice 
tremor, so that methods of identification can be improved upon. The purpose of 
section 2.4 is to assist in this goal with an explanation of the terms used in the 
evaluation of speech and voice symptoms in general, to highlight some of the 
strengths and weaknesses of the different evaluation approaches, and finally to 
focus on evaluation methods and findings that have been used in PD studies.  
A review of the literature highlights that a range of evaluation approaches have 
been used in the study of PD speech and voice symptomatology, These include  
auditory perceptual, visual perceptual, instrumental, and patient self-report 
measures. Table 2.1 provides a summary of studies with respect to the 
evaluation methods used, together with key study findings.  
 
2.4.1 Auditory Perceptual evaluation  
Auditory perceptual evaluation is a central component in the measurement of 
speech and voice disorders by speech and language therapists (SLT’s)92 93. It is 
the process whereby an expert listener/s listens to a live or recorded speech 
sample, and rates intelligibility of speech and/or the overall (global) severity of 
voice quality on a rating scale94. In relation to voice, ratings are carried out 
using pre-determined features, e.g. roughness, breathiness, weakness, tremor. 
The person carrying out the rating (‘rater/s’) may be required to indicate the 
presence/absence of a feature or to rate its severity.  The voice quality can be 
rated during different tasks; for example during sustained vowels, during 
reading, and/or speaking. The rating of voice quality during a speaking task is 
more functional than that during sustained vowels. However a sustained ‘steady 
state’ vowel task95, allows the rater to focus on the target voice quality without 
the extraneous influence of different articulatory configurations.  
The key strengths of perceptual evaluation are that: it has the most functional 
significance relative to the other approaches, in that a person’s voice is judged 
to be normal or abnormal through the ear of the listener; it is convenient; does 
not require expensive instrumentation; is non-invasive; and findings are easily 
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communicable between clinicians110 94.However, perceptual evaluation is 
susceptible to a variety of sources of error and bias110 . Listeners vary widely in 
their levels of reliability and agreement sometimes failing to reach even chance 
levels in the mid-range of the rating scale96. Suggested solutions to the 
‘unreliable rater problem’ include: averaging the scores across raters to achieve 
a reliable mean (based on the assumption that rating variability within and 
across raters is mostly random),97 and training listeners to increase the extent to 
which they share common standards for different voice qualities98. In designing 
the protocol for perceptual rating in the current study, cognisance was given to 
these recommendations.  
There are a variety of formal perceptual rating tools available for rating voice 
quality features94, including the GRBAS99 scale, and the Consensus Auditory 
Perceptual Evaluation of Voice (CAPE-V)100.  There are a number of similarities 
and differences between the GRBAS and CAPE-V, which are important to 
mention in the context of the current study. Both measures are reported to have 
a similar mild level of difficulty regarding the application of the scale101. They 
use different measurement scales, GRBAS an ordinal measurement scale and 
the CAPE-V a continuous visual analogue scale (VAS). The VAS in CAPE-V is 
considered to have greater sensitivity in detecting small differences in voice 
quality than has the ordinal scale in GRBAS101. Finally, CAPE-V offers the 
possibility of including additional parameters for rating in additional to the 
standard pre-determined measures in GRBAS.  
In PD studies, perceptual rating has been the cornerstone of speech and voice 
analysis studies and has frequently been used as the sole method of evaluation 
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76 89 102 78 90 103. A striking feature of perceptual based PD studies is their 
generic focus on a wide range of different sub-systems (voice, respiration, 
articulation, prosody), in the same study. PD studies carried out by Darley et 
al.,31 Logemann et al.,75 Chenery et al.,89 Stewart et al.,88 Murdoch et al.,104  and 
Plowman-Prine103   all exemplify generic perceptual approaches (Table 
2.1).These studies reflect the extent, complexity and variability of perceptual 
changes in pwPD, and thus are valuable. However, a weakness of this 
approach in relation to PD symptomatology is that varied descriptors are used 
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extensively, with the result that there is little detailed knowledge on any one 
specific feature. This certaintly has been the case with PD voice tremor, and 
this issue will be elaborated on further in Chapter 4.  In addition, an overreliance 
on perceptual evaluation, relative to visual perceptual (section 2.4.2) and 
instrumental evaluation (2.4.3) leads to poor characterisation of the underlying 
pathophysiology. To counteract this weakness, the additional use of 
physiological and acoustic evaluation is recommended89. 
 
2.4.2 Visual Perceptual evaluation 
Another evaluation approach used in the evaluation of speech and voice 
symptoms is that of visual perceptual evaluation, which is the process whereby 
a rater or raters makes a judgment about the presence and/or severity of a pre-
determined behaviour based on what the person perceives visually.  
Appearance and/or movement of facial features55, the jaw105, tongue105, 
palate106 and larynx107 may be rated clinically using visual perceptual 
evaluation. Clearly, identifying structures in the vocal tract is an important 
component in the evaluation of speech and voice symptoms. 
However, obtaining an adequate view of internal bodily structures, for example, 
the palate, the tongue base, and the larynx for the purpose of diagnostics is 
challenging. Specialised ‘invasive’ procedures and expertise is required. 
Laryngoscopy is a broad term used to describe the procedure whereby the 
larynx and associated structures in the vocal tract are examined using a flexible 
endoscope and/or a rigid endoscope. The flexible endoscope is passed 
transnasally (‘nasendoscopic’ examination) and permits the examiner to view a 
number of different structures in the vocal tract including the soft palate, tongue 
base and larynx during speech and voicing. The term ‘nasendoscopy’ or 
‘nasendoscopic’ examination will be used by this author when referring to the 
aforementioned procedure in the remainder of the thesis.  A key strength of the 
flexible endoscope in voice evaluation is that different structures in the vocal 
tract can be visualised and imaged during a range of speech and voice tasks. In 
contrast, the rigid endoscope is introduced transorally, and affords a view of the 
larynx and vocal cords during a sustained /i/ [i] vowel [(International Phonetic 
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Alphabet (IPA)]. The vowel /i/ is pronounced ‘e’ as in the word ‘eel’. In this 
thesis, the ‘vocal tract’ is an all encompassing term referring to the vocal cords, 
the larynx and the structures above the larynx (tongue base, palate), involved in 
speech and voice production. This researcher is aware that other texts may also 
include the respiratory structures (lungs, diaphragm) in their definition of the 
vocal tract.  However, for the purpose of this thesis, the respiratory structures 
are not included in the definition of vocal tract108. The examination of the vocal 
tract for the purpose of identifying and measuring voice tremor will be 
addressed in Chapter 4. 
In addition to the inherent difficulty in visualising dynamic vocal tract structures, 
a further challenge is in quantifying the observations, since one is required to 
extract objective information from observations which are subjective,109 and 
prone to variability between individuals110.  It is important to note that visual 
perceptual rating of laryngeal examinations is plagued with the same reliability 
issues as perceptual rating. There are also issues around rater experience and 
training, quality of video recordings, and the method of rating the target 
behaviour111. Rating involuntary movement in the vocal tract from video 
recordings has been shown to have poor reliability in a study of patients with 
‘normal’ voices111. 
Despite the possibility afforded by nasendoscopy of gaining increased 
understanding of the underlying PD vocal tract physiology, few PD studies have 
adopted this approach. Those studies that have used laryngeal examination, 
report closure defects (incomplete closure of the vocal cords), bowing of the 
vocal cords, contraction of the supra-glottic (above the vocal cords) muscles, 
and tremor in the strap muscles, tongue and larynx in pwPD34 107 112 113 114. 
 
2.4.3 Instrumental evaluation  
The term instrumental evaluation encompasses a range of computer-based 
equipment methods used to measure the acoustic properties of the speech 
output signal (acoustics), the movement of structures (kinematics), and the 
physiological properties of speech and voice related structures.  Instrumental 
evaluation is considered to add objectivity to findings, since the ensuing 
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measures are quantifiable and are not subject to the same variability as is the 
case with listener ratings. The different instrumental approaches and the PD 
studies that have applied them in voice analysis are outlined in the following 
sub-sections. The studies reported in this section are also summarised in Table 
2.1. 
Acoustic measures 
Acoustic measures provide a non-invasive measure of the voice output 
pressure signal and provide indirect quantifiable information about the physical 
properties of sound115. For example, the acoustic measure fundamental 
frequency relates to the rate of vibration of the vocal cords, amplitude relates to 
the extent of vocal cord excursion. Jitter and shimmer relate to the amount of 
perturbation (instability) in the frequency and amplitude of the voice respectively 
116.Acoustic measurement of phonatory function is widespread and popular in 
voice quality measurement, aided by the proliferation of cheaper computers 
systems, the availability of automated analysis algorithms, the non-invasive 
nature of the equipment, and the quantifiable findings117 118. 
Acoustic material for the evaluation of voice is frequently drawn from maximally 
stable or ‘steady state’ vowel prolongations 94, to avoid the confounding effects 
of interaction between the vocal tract and larynx. Understandably therefore, the 
clinical utility of many acoustic measurements based on sustained vowels is 
questionable in relation to their significance for voice quality and speech. The 
relationship between the majority of acoustic measures and perceptual features 
has not been established117. The authors of the Motor Speech Profile (MSP) 
programme from the Computerised Speech Laboratory (CSL) advised that 
since many of the parameters were new it would take some time before efficacy 
was established119. 
In PD studies, acoustic measures have been applied for a range of purposes, 
including some of  the following: differentiating pwPD from healthy controls120 
121; identifying acoustic markers in patient who have not received a clinical PD 
diagnosis (pre-clinical)4; chart disease progression64;  identifying gender 
differences122 123; examining the effects of dopaminergic medication on 
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phonatory function121; and examining relationships with non-speech PD 
variables 124  
An array of acoustic measures have emanated from these studies as 
highlighted in the following brief review of some of the literature. Jimenez-
Jimenez et al.,120 compared a group of pwPD and controls on selected acoustic 
measures, fundamental frequency (Fo), jitter, shimmer, harmonic - noise ratio 
(HNR), using the CSL and differentiated the groups, with findings of higher Fo in 
female PD and higher jitter in male PwPD. Goberman et al.,121 identified higher 
mean Fo, higher fundamental frequency variability (SDFo), and lower intensity 
range in nine pwPD versus controls.  
Jitter and shimmer measures which are widely used for clinical and research 
diagnostic purposes in voice studies require mention here125. Also referred to as 
‘short-term’ measures of perturbation, they contrast with ‘long-term’ fluctuation 
measures which are associated with tremor and will be discussed in a later 
section. The ‘short-term’ aspect refers to the fact that variation (perturbation) 
occurs between glottal cycles in less than 10 msec.  Although jitter and shimmer 
measures have been used widely in PD studies, they are considered to be more 
informative in relation to laryngeal pathology than to the study of neurological 
disorders125. This study on voice tremor will not include short-term measures of 
instability. 
Harel at al.,4 in a retrospective longitudinal single case review examined long-
term variation of fundamental frequency (vFo) in speaking using the multi-
speech programme from the CSL and found reduced speech variability, years in 
advance of the PD diagnosis. They carried out the speech analysis from 
archived video recordings from a national television news service which were 
available to them. The authors argued for using acoustic voice measures to 
identify patients in pre-clinical (symptoms appearing before clinical diagnosis is 
made) stages of PD4. Stewart et al.,64 used narrow band spectrogram to chart 
disease progression in a study of twelve patients and identified visually, 
frequency and amplitude tremor in the spectrogram in four patients with early 
stage PD.  
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Acoustic measures have also been used to look at gender differences in a 
comparison study of pwPD and age-matched neurologically healthy controls122. 
Using tremor measures, frequency tremor intensity index (FTRI %), amplitude 
tremor intensity index ( ATRI %), frequency tremor frequency (Fftr Hz), and 
amplitude tremor frequency (Fatr Hz) from the Multi Dimensional Voice 
Programme (MDVP) of CSL, Tanaka et al.,122  reported that tremor measures 
FTRI% and Fftr Hz were significantly higher for male PD patients than for male 
controls.  
Goberman et al.,121 looked at the effects of dopaminergic medication on 
phonatory function  in nine pwPD using acoustic measurement. Although they 
found no group effect from medication, they described an increase in 
fundamental frequency (Fo) in vowels and reading in some individuals.  
Finally, there is evidence of acoustic measures being used to understand ways 
in which speech and non-speech symptoms in PD relate. In a study of nine 
pwPD, Goberman et al.,124 selected Fo and  FoSD as measures of laryngeal 
rigidity and stability respectively. They reported that increased voice instability 
(FoSD) correlated significantly with the total score and the axial (gait, facial 
expression, posture) score from the UPDRS.  
This review highlights the varied ways in which acoustic measures have been 
applied to study PD voice symptomatology. However it is not always clear what 
the acoustic measures are in fact measuring. There is a need to utilise 
additional auditory and visual perceptual measures to give clinical meaning to 
the measures.  The application of acoustic measures to the study of voice 
tremor will be addressed further in section 4.4.  
Kinematic  
Another instrumental approach that has been used albeit with less frequency 
than acoustics is that of kinematics, which measures the amplitude and range of 
movement. Kinematic evaluation involves the placing of markers on target 
muscles and structures for the purpose of measurement 108.  In PD studies, 
kinematic movement of the rib cage, lip, and the jaw have been measured with 
mixed findings126 127. Murdoch et al.,126 studied respiratory function in nineteen 
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pwPD, all of whom had some features of hypokinetic dysarthria, and a matched 
control group. They recorded the circumference of the rib cage and abdomen by 
means of strain-gauge belt pneumographs, and reported that kinematic 
measurement during conversation and reading showed normal results in their 
group of PD patients. They concluded therefore that reduced range and 
amplitude of abdominal and rib cage movement during speaking was not a 
contributory factor to the discernible dysarthria in this group of pwPD. Walsh et 
al.,127 also using kinematics studied lip and jaw movements in sixteen pwPD 
and sixteen age-and sex-matched neurologically healthy controls. The authors 
127 reported decreased amplitude and velocity of lower lip and jaw movements 
in pwPD in comparison to controls. However, when it comes to measuring the 
movement of the more ‘internal’ vocal tract structures, for example the soft 
palate and/or the laryngeal structures during speaking, kinematic 
measurements are not indicated. 
Spirometry 
Continuing with instrumental approaches, spirometry measures a range of 
indices of pulmonary function including respiratory rate, tidal volume, vital 
capacity, residual volume, forced expiratory volume 1 sec (FEV1) and total lung 
capacity. Murdoch et al.,126 in a study combining spirometry and kinematic 
evaluation, found that only a minority of pwPD had lung volumes and capacities 
outside normal limits. However, they reported irregularities in chest wall 
movements of some pwPD on sustained vowels and considered that it may 
have been suggestive of tremor in the respiratory muscles126. The potential role 
of spirometry and other respiratory measures in the evaluation of PD voice 
tremor is acknowledged by this author however respiratory evaluation is outside 
the remit of this thesis. 
Auditory perceptual, visual perceptual and instrumental approaches are clearly 
clinician led and although offering considerable insight into PD speech and 
voice symptomatology, they do not address the effect of the impairment on the 
pwPD.  The next sub-section which looks at the patient’s perspective of speech 
and voice dysfunction, together with the impact on his/her life completes section 
2.4.  
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2.4.4 Patient self-report measures 
Self-report measures help to identify the disability associated with the 
impairment which in turn helps to inform the clinical management of the 
problem, and may assist in decision making in relation to planning and 
allocation of therapy resources.  
Disability, a multi-dimensional concept relates to the relationship between a 
person with a health condition, and a person’s context (environmental, personal 
issues). Voice disorders can impact significantly on a person’s overall health 
and quality of life128, with problems related to psychological, emotional, social 
and work-related issues129.  Evaluating the patient’s perception (self-report) of 
voice impairment and the resultant functional and emotional sequelae is an 
important component of voice studies130.  
Studies have clearly shown that pwPD have greater self-reported voice 
disability than people who do not have PD131, and that voice related disability is 
associated with both mild131 132 and severe disease severity113(Table 2.1). Midi 
et al.,131 studied twenty patients with a less than 5 year diagnosis of PD and 
found that mean total scores on the Voice Handicap Index (VHI) for male and 
female patients were higher (meaning increased voice disability) than sex-
matched controls. The mean (SD) total VHI scores for male pwPD was 34.4 
(3.45) in comparison to 0.60 (1.9) for male controls and 15.5 (2.86) for female 
pwPD in comparison to 0.9 (1.85) for female controls. It is interesting to note the 
higher VHI score (greater disability) in male pwPD than in female pwPD131. This 
is a surprising result when one considers that voice problems in general are 
more prevalent in females than males. Blumin et al.,113 studied fifteen patients 
with advanced PD, and reported that 50% of the patients had VHI scores 
greater than 60 points, suggesting significant self-perceived voice handicap.  
Knowing which aspect of voice-related impairment relates to voice disability is 
an important issue, since it helps to inform treatment decisions, and thus 
minimise voice disability.  Carmichael et al.,132 in a study of respiratory function 
and voice disability in nine pwPD found that  FEV1 was negatively correlated 
with the emotional sub-section of the VHI. The findings imply that negative 
emotions related to voice increase (worsen) as respiratory function decreases. 
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Reduced respiratory function may have a negative effect on voice quality and 
volume. However the authors132 did not include a control group, therefore, the 
study findings are inconclusive regarding reduced respiratory function and voice 
disability in pwPD.  Frost  et al.,71 also using the VHI, reported a significant 
negative correlation between speech intelligibility and voice disability, meaning 
that the more intelligible the speaker the lower the voice disability. However, 
similar to Carmichael et al’s132 study, Frost et al’s 71findings are inconclusive 
regarding relationship between speech intelligibility and voice disability in PD, 
since they did not study people without PD.  
In relation to voice tremor, the nature of the relationship with voice disability is 
unknown and warrants investigation. However, based on the aforementioned 
study findings, it would be important to control for the confounding effect of 
ageing on voice disability, by studying age matched controls also.  
 This review has highlighted the varied evaluation approaches that have been 
applied in PD speech and voice studies. It is evident that each approach has 
value and can potentially increase understanding of PD symptomatology, 
including voice tremor which is the subject of this thesis.  Chapter 4 will address 
specifically voice tremor in PD in the context of ways in which it has and has not 
been evaluated, giving direction to the research questions in this study.  The 
next section 2.5 addresses the potential confounding effect of ageing, 
depression, anxiety and medication on PD speech and voice symptoms. 
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Guide to Abbreviations Table 2.1  
CSL  Computerised Speech Laboratory  
 
DBS:  Deep Brain Stimulation 
 
EGG:  Electroglottography 
 
FEV1  Forced expiratory volume 1 second 
 
FRC:  Functional residual capacity 
 
Fo:   Fundamental frequency 
 
FTRI:  Frequency Tremor Intensity Index (FTRI) (MDVP parameter) 
 
HNR:  Harmonic to Noise Ratio 
 
IC:  Inspiratory capacity 
 
Med:   Medication (dopaminergic) 
 
MDVP  Multi-dimensional voice programme from (CSL)  
 
NHR:  Noise to Harmonic Ratio 
 
NR  Not reported  
 
RV:  Residual volume 
 
SPI:  Soft phonation Index (MDVP parameter) 
 
SLT  Speech & Language Therapist 
 
Sx:  Surgery 
 
TLC:  Total lung capacity 
 
vFo:  Variation in Fo 
 
Vis-P:  Visual Perceptual evaluation 
 
VC:        Vital capacity 
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Table 2.1.Overview of PD studies, evaluation approaches, voice and speech findings 
Reference 
n Method Speech and Voice 
areas  
Findings Rating variables 
Darley et al.
31
 1969 
 
Parkinsonism 
 
Control: No 
 
Med: unknown 
 
32 
 
 
Perceptual 
 
 
38 speech dimensions  
 
7 categories 
[(pitch,loudness, vocal 
quality, respiration, 
prosody, articulation, 
overall (general 
impression)] 
 
Monopitch, monoloudness & 
reduced stress most striking 
characteristic. 
 
 
 
 
Task: varied between reading, 
conversational speech, sentence 
repetition  
 
7 point scale of severity 
 
3 raters 
 
 
Logemann et 
al.
75
1978 
 
(PD & post-
encephalitic) 
 
Control: No 
 
Med: Off 
 
178 
 
Perceptual 
 
 
Voice, speech, rate, 
resonance, articulation 
89% vocal tract features 
(larynx, lip tongue) 
 
45% laryngeal as the sole 
symptom 
 
13.5% tremulous voice 
Task: read & speak 
 
Present/absent 
 
2 raters  
 
Logemann et 
al.
76
1981 
 
PD & post-
encephalitic) 
 
Med: unknown 
 
Control: No 
 
200 
 
Perceptual 
 
 
Articulation 45% misarticulations 
 
Spirantisation: weakened 
plosives, affricates and 
fricatives 
Task: Reading sentences 
 
2 raters 
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Hanson et al.
34
 
1984 
 
Med: On 
 
Control: No 
32 Vis-P 
(Laryngeal exam) 
 
Cine-laryngoscopy Bowing  
 
Contraction of supra-glottic 
musculature 
 
Tremor in strap muscles, 
tongue 
Examiner rated 
Chenery et al. 
89
1988 
 
Med: NR 
 
Control: Yes (age & 
sex matched) 
 
19 
 
 
Perceptual 
 
 
 
32 dimensions 
5 aspects 
(Voice, respiration, 
prosody, articulation, 
intelligibility) 
 
100% 
Voice (hoarseness, strain-
strangled, breathiness), 
prosodic, respiratory, 
articulatory 
Task:  
Dysarthria  ax 
Reading  
  
 
9 judges 
Interval scale 
Murdoch et al. 
126
1989 
 
Med: On 
 
Control: Yes (age/ sex 
matched) 
 
 
19 Instrument 
(Spirometry) 
 
 
 
 
 
 
 
 
 
Kinematic 
Respiration rate, tidal 
volume;VC; FEV1,; FRC; 
IC; TLC; 
expiratory/ 
inspiratory reserve 
volumes; volume/flow 
relationships 
 
 
 
Changes in 
circumference of rib 
cage and abdomen 
 
Spirometry: minority pwPD had 
lung volumes outside normal 
 
 
 
 
 
 
 
 
Kinematic: normal findings 
‘Motion jerks’ in rib cage 
suggestive of tremor in 
respiratory muscles of some 
pwPD 
 
Task:  
conversation & reading 
26 
 
Hartelius et 
al.
133
1994 
 
Med: NR 
 
Control: No 
460 Self-report  Frequency, type & 
severity of speech and 
swallowing symptoms 
70 % experience speech & voice 
problems after PD 
 
Voice  (weak, hoarse, 
monotonous) 
Articulation  
(imprecise) 
Survey  
Hertrich et al.,
123
 
1995 
Med: On 
Control: Yes, (not 
age/sex matched) 
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Instrument 
134
  
 
 
 
 
 
[(Acoustic) (CSL)] 
 
Spectograms of EGG 
recordings 
 
 
 
 
Fo; jitter; shimmer, HNR 
 
 
 
 
 
 
 
Increased Fo in males pwPD 
Task: Sustained /ah/: 1 second 
interval 
Stewart et al. 
88
1995 
 
Med: None 
 
Control: No 
 
12 
 
 
Perceptual 
 
 
 
 
 
Instrument 
(Acoustic) 
(DSP Sonagraph) 
 
Speech, voice, rate, 
prosody,  
 
 
 
 
Tremor 
100% 2 features dysarthria 
Voice (roughness, reduced 
loudness, breathy, monopitch) 
 
 
 
‘Vocal Tremor’ on narrow band 
spectrogram (amplitude & 
frequency) in 4/12pwPD 
Task: dysarthria Assessment 
(Scale 1-7) 
 
Sustained  vowel 
27 
 
Perez et al.,
107
1996 
 
Med: NR 
 
Control: no 
 
n=29 
(22 PD;  
7 PPS) 
Vis-P 
(Laryngeal exam)  
Compare tremor in 
pwPD and PPS patients  
 
 
 
 
Describe vocal fold 
vibratory characteristics 
Laryngeal tremor evident in 55% 
Kinetic i.e. phonation tremor /i/ in 
71% pwPD 
 
 
 
Vertical laryngeal tremor 
predominant 
 
Predominant open phase 
configuration. High incidence of 
phase asymmetry (timing of 
opening and closing of vocal 
cords) 
 
Task:’ rest’; phonation /i/ vowel at 
normal pitch & loudness; loud 
phonation 
Coates et al. 
102
1997 
 
Med: On (excepting 2 
pwPD) 
 
Control: No 
48 
(20males; 
28 females) 
 
 
46 on med 
2 no meds 
Perceptual Speech intelligibility 
(Intelligibility of 
Dysarthric Speech 
Assessment Scale) 
 
 
Reduced speech intelligibility in 
64% of group. 
Mean % score for sentences was 
91.1% 
 
Task: word/ sentences 
Murdoch et 
al
104
1997 
 
Med: On 
 
Control: Yes  
20 Perceptual 
 
 
 
 
 
Instrument 
 9 laryngeal dysfunction 
parameters incuding, 
pitch steadiness, 
excessive pitch 
fluctuations 
 
1.EGG  
2.Computer airflow 
system (Aerophone II) 
89.5% showed deviant laryngeal 
features (hoarseness,glottal fry, 
pitch unsteadiness, breathiness) 
 
 
 
No difference between PD & 
control on EGG measures 
4/5 aerophone parameters 
differentiated the groups 
Task: reading 
Raters: 2 judges (SLT’s) – 
descriptive 4 point rating scale 
 
 
 
28 
 
Jimenez-Jimenez et 
al.
112
1997 
 
Med: Untreated 
 
Control: Yes  
 
22(12M;
10 F) 
Instrumental 
[(Acoustic 
(CSL)] 
 
Vis-P 
[(Laryngeal exam) 
(indirect and/or 
nasendoscopy)] 
 
Self-report 
 
 
 
 
 
 
 
Fo, Jitter, shimmer, 
Harmonic/Noise ratio 
 
 
Presence of laryngeal 
tremor, degree of glottal 
closure, presence of 
hyperphonation.  
 
Voice 
normal/ altered/ very altered. 
Tone: low/normal/high 
Presence/absence: 
monopitch, harshness, voice 
arrests, pitch breaks, tremor, 
struggle 
Significant differences 
between PD & control jitter 
& shimmer and Fo females 
 
45% PD Laryngeal tremor 
versus 0% controls 
Glottal closure ‘good ‘ in 
most pwPD 
Task:  
sustained /ah/ vowel (2 seconds); 
sentence 
 
Rater: 1 (not blinded) 
Gamboa et 
al.
135
1997 
 
Med: On 
 
Control: Yes (age-
sex-matched) 
 
41 (24M, 
17 F) 
Instrumental  
[(Acoustic)(CSL)] 
 
 
 
 
 
Vis-P 
[(Laryngeal exam) 
(indirect and/or 
nasendo)] 
 
Self- report 
 
Fo, Jitter, shimmer, 
Harmonic/Noise ratio 
 
 
 
 
 
Presence of laryngeal 
tremor, degree of glottal 
closure, presence of 
hyperphonation.  
 
Voice: 
normal/ altered/ very altered. 
Tone: low/normal/high 
Presence/absence: 
monopitch, harshness, voice 
arrests, pitch breaks, tremor, 
struggle 
PD significantly higher Fo, 
jitter, lower H/N noise; lower 
intensity & frequency SD in 
sentence microphone 
signal, lower phonational 
range 
 
Tremor in 14.6%; 
hyperphonation signs in 
20%; 2pwPD showed slight 
lack of glottal closure 
 
Most outstanding features: 
monopitch; tremulousness; 
strain/struggle. 
14/27 reported 
tremulousness 
 
Task:  
sustained /ah/ vowel (2 seconds); 
sentence 
 
Rater: 1 (not blinded) 
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Ackermann et 
al.,
136
1997 
 
Med: On 
 
Control: Yes (not 
age/sex matched) 
12 Instrumental 
 
 
 
 
 
 
Perceptual 
(speech) 
Kinematic - lower lip 
gestures during speech) 
 
(Optoelectric movement 
analysis system)  
 
 
Intelligibility  
  
 
 
 
 
 
 
Task: word 
Ho et al.
90
 
1998 
 
Med: On 
 
Control: No 
200 Perceptual Voice, articulation, fluency 
(conversational speech) 
(communication profile) 
 
73%-Voice (change in 
quality, volume reduction); 
Articulation; 
Fluency  
  
2 trained-listeners 
Quantitative and qualitative, presence 
and severity of abnormal features. 
Sapir et al. 
78
 
2001 
Med:  
42 Perceptual Voice, articulation, fluency, 
prosody 
85% voice changes +- 
articulation, prosody, 
fluency 
Task: reading 
Raters:2 SLT 
Presence/absence 
Sanabria et al.
137
 
2001 
 
Med: Off & On 
 
Control: No 
20 Instrument 
(Acoustic) (MDVP) 
 
Effects of dopamine on 
vocal function (tremor, 
noise, frequency and 
amplitude parameters) 
Fo increased with med.  
Jitter, SPI, FTRI decreased 
with med 
Task: sustained /ah/ vowel x 2 
seconds 
Blumin et al., 
113
  
2004 
 
Med: NR 
 
Controls: No 
15 Vis-P 
[(Laryngeal exam( 
Rigid endoscopy)] 
 
 
 
 
Self-report 
(VHI) 
 Baseline of laryngeal 
findings pre DBS (vocal 
tremor, glottal configuration, 
bowing, other lesions) 
 
 
 
Voice disability 
87% significant vocal fold 
bowing 
53% vocal tremor 
(tremulous movement of 
laryngopharynx during 
phonation) 
 
50% significant voice 
handicap (VHI scores > 60) 
 
Task: phonate /i/  
30 
 
Gobermann et al. 
124 2005 
 
Med: On 
 
Control: No 
 
9 Instrument 
(Acoustic 
CSL) 
Articulatory 
Prosodic 
Phonatory 
7/16 speech acoustic 
measures correlated with non-
speech measures. 
Phonatory: FoSD 
Tasks: sustained vowel 
           reading, 
           monologue 
 
Miller et al. 
74
 
2006 
 
Meds: On 
 
Control: No 
37 Self-report Perception of speech 
changes 
Perceived changes to 
communication. (changes to 
voice, making oneself, 
understood, managing 
conversations, reactions of 
others)  
Interview (qualitative) 
Miller et al. 
77
 
2007 
 
Med: Off 
 
Control: Yes (age 
matched) 
 
 
125 Perceptual 
(speech) 
 
 
(Self-rating) 
 
 
 
Speech intelligibility Test 
 
Speech & voice 
 
 
 
Reduced intelligibility (69%) 
 
PwPD felt not as good as pre 
PD (76%) 
Task: single words 
Miller et al.,
82
 
2008 
 
Meds: off 
 
Control: Yes (40 
unaffected 
speakers) 
 
104 
 
Self-rating Perceived impact of PD 
on self-perception of 
communication 
PD- a significant perception of 
deterioration in communication 
after onset of PD  
Survey 
31 
 
Midi et al. 
114
 
2008 
 
Med: On 
 
Control: Yes 
 
20 Perceptual 
 
 
 
 
 
Vis-P [(Laryngeal 
exam) 
(rigid scope)] 
 
Instrument 
[(Acoustic), 
MDVP)] 
 
 
 
Self-report 
(VHI) 
Voice quality (GRBAS) 
 
 
 
 
 
Degree of glottis closure 
 
 
 
 
Jitter, shimmer, NHR, 
vFo, Fo 
 
 
 
 
Voice disability  
Compared to controls: Male 
PD: voice more hoarse, 
breathy, weak 
Female PD: more breathy, 
weak 
 
Nonclosure glottic pattern 
(posterior chink or spindle 
shape) more common in PD 
 
Mean jitter & shimmer higher 
(not significant) 
Higher Fo in female PD than 
controls 
Higher vFo in male PD 
NHR differences not significant 
 
Greater voice disability in PD 
than controls (male & female) 
 
Task: reading 
Raters: 4 (blinded)` 
 
 
 
 
NR 
 
 
 
 
 
Sustained /ah/ 5 seconds 
 
 
 
 
Questionnaire 
Carmichael et al 
132
 
2009 
 
Med: On 
 
Control: No 
 Instrument 
Spirometry 
 
 
 
Self-report 
(VHI) 
Respiratory function & 
muscle strength 
 
 
 
Voice disability  
Weakness & dysfunction of 
respiratory muscles 
 
 
 
Mean total VHI score 39.22 
 
 
 
 
 
Questionnaire 
Plowman-Prine 
103
 
2009 
 
Med: on & off 
 
Control: No 
16 Perceptual 35 speech dimensions 
grouped under 6 speech 
sign-clusters (articulation, 
respiration, resonance, 
phonation, prosody, rate)  
 
Prosody most affected of 
speech sub-systems 
 
 Voice tremor: Overall mean 
score 1.85 (12
th
 highest score 
out of 35 speech dimensions) 
Task: reading  
Raters:3 blinded SLT’s using 7 point 
scale 
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Frost et al. 
71
 
2010 
 
(23 post DBS 
28 non DBS) 
 
Med:  
 
Control: Yes (non-
surgical PD) 
51 Perceptual 
(speech) 
 
 
 
 
 
Self-report  
(VHI) 
 
 
Speech Intelligibility 
(reading sentences) (for 
sx patients only) 
 
 
 
Voice disability   
 
 
79% intelligibility pre-sx 
72% intelligibility post-sx 
 
 
 
 
Disability increased over time 
in both DBS & non DBS group 
Significant relationship 
between VHI and speech 
intelligibility 
Task: 
Reading sentences (for surgery 
patients only) 
 
Rater: 1 (SLT) 
 
Tanaka et al. 
122
 
2011 
 
Med: On  
 
Control : yes 
 (age-matched) 
39 Instrument 
[Acoustic 
(MDVP*)] 
 
Tremor measures (FTRI, 
ATRI,  
Fftr, Fatr) 
 
Higher F0 in PD males versus 
controls 
Task :Reading 
Walsh et al.,  
2012 
127
 
 
Med:  On 
 
Control: yes (age ±3 
years, sex) 
16 Instrument 
(Kinematic) 
 
 
[(Acoustic) (Praat 
software)] 
 
Lip & jaw movements  
 
  
Intensity, speech rate, F2 
slope  
 
Decreased amplitude & 
velocity of lower lip and jaw 
movements  
Decreased vocal intensity 
Reduced 2
nd
 formant slops 
Kinematic system (Northern digital 
Optotrak 3020) 
 
Task: 2 sentences 
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2.5 Speech and voice symptoms and confounders (ageing, 
depression, anxiety, medication) 
 
An evaluation of PD speech and voice symptomatology would be incomplete 
without considering potential confounding variables (ageing, depression and 
anxiety, and dopaminergic medication) that exist in PD and require 
consideration.  
2.5.1 Ageing 
The ageing process has an impact on voice and laryngeal characteristics 
secondary to changes in skeletal and muscular systems of the body 3 138 139 140 
141. There are alterations in respiratory support, atrophy of neural and muscle 
tissues, and calcification of laryngeal cartilages. Further, the vocal folds lose 
their elastic and collagenous fibres which makes them stiffer and thinner140. 
These physiological changes are reflected in the acoustic voice signal. Elderly 
speakers (over 70 years) have been found to have significantly different 
(poorer) acoustic measurements on fifteen selected parameters from the 
MDVP, when compared with young and middle aged adults141. Measured 
parameters included fundamental frequency, jitter, shimmer, harmonic to noise 
ratio, and soft phonation index. Tremor measures were not included in the 
study.  
An increase in fundamental frequency (Fo)  has been associated with male 
pwPD121 123 22 122 and with ageing males140. A bowing appearance of the vocal 
cords has been described in relation to the ageing larynx 142 and to the PD 
larynx 113 142. Voice tremor has been documented in relation to PD and is also a 
positive predictor of increasing age143. A challenge therefore is to determine 
which voice symptoms are secondary to the ageing process, which stem from 
PD144 and which may stem from both processes145. An important and necessary 
step therefore is to study neurologically healthy age-sex matched controls 
alongside pwPD. The issue of controls will be addressed in the current study. 
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2.5.2 Depression and anxiety 
There is a strong association between anxiety and depression, and PD 
(section1.4)  A depressed mood impacts negatively on speech and voice 
manifested in symptoms of reduced stress, monopitch and monoloudness146. A 
salient and prevalent feature of PD voice is reduced variability of pitch and 
loudness, resulting in a monotone voice147. When a person feels anxious or 
nervous, their voice may sound somewhat tremulous and ‘shaky’, a feature 
which is also associated with PD. It is difficult to discern if a perceived 
monotone tremulous voice in pwPD is secondary to disease-related 
physiological changes or to additive anxiety and depression or to both 
processes. Consideration therefore will be given in this study to the possible 
confounding effects of depression, and anxiety by measuring and identifying 
these variables43.   
2.5.3 Dopaminergic medication  
The positive effect of dopaminergic medication on limb motor signs of tremor, 
rigidity and bradykinesia is widely acknowledged 70. However its effect on 
speech and voice is less conclusive 69 148. For example, positive effects have 
been reported in relation to improvement in word intelligibility149, and in 
reduction of voice tremor using acoustic measures 137. Other studies show that 
there has been no significant improvement in acoustic121 150, perceptual103 148 
151, or glottographic  measures134 152 153  following dopaminergic medication.  
However, when one looks at individual data, rather than group data, it appears 
that dopamine may differentially affect speech and voice symptoms121 152. In 
Goberman’s 121 study, six out of nine patients showed increased fundamental 
frequency (Fo), three patients showed decreased pitch variability and two 
showed increased intensity with dopamine medication. Conversely, Jiang et 
al.,152 using a combination of acoustic, airflow, and electroglottography (EGG) 
found no change in Fo, jitter (pitch perturbation) or mean flow rate, with patients 
on medication.  However they found that speed quotient (an EGG measure), 
shimmer (amplitude perturbation) and the extent of tremor measured through 
spectral analysis of the acoustic signal was decreased. It appears therefore, 
that dopamine may have a differential effect on different components of the 
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speech-voice mechanism, and may potentially increase or decrease voice 
tremor. Therefore, it is necessary for the current study to control for the possible 
confounding effects of medication on voice tremor and other speech/voice 
related variables. Following the practice in other studies, the proposal here 
would be to assess individuals in a practically defined ‘off medication’ state, 
which is considered to be at least twelve hours after the last medication dose 72. 
The specific procedure followed in this study is outlined in methods section 5.4. 
Further understanding of PD speech and voice symptomatology can be gained 
from exploring possible relationships with disease variables. 
2.6 Relationship between speech and voice changes, and disease 
variables  
Examining the relationship between speech and non-speech variables is 
worthwhile for a number of reasons. The practice increases understanding of 
the neurological mechanisms underlying dysarthria in PD, and in the PD 
disease process, which in turn contributes to diagnostics and treatment78. In 
addition, there may be greater prediction of which speech/voice variables are 
likely to show more change across dopaminergic medication cycles; greater 
understanding of why levodopa has a stronger and more consistent effect on 
non-speech than speech symptoms; better prediction of the likely effect 
(positive or negative) of deep brain stimulation (DBS) on speech/voice 
parameters124.  
In general, the assumption is that speech/voice symptoms deteriorate with an 
increase in disease severity and/or duration of PD 69. The literature however 
shows mixed findings in relation to this subject. Some studies report a poor 
correlation102, 77 135 others report a moderate correlation78, and others report 
strong correlations124.  Coates et al.,102 in a study of forty eight pwPD found a 
poor correlation between reduced intelligibility of speech using a shortened 
version of the standardized Yorkston and Beukleman assessment scale, 
disease severity (UPDRS III), and disease duration. Miller et al.,77 in a larger 
study of one hundred and twenty five speakers found no significant correlations 
and only weak correlations between speech intelligibility and disease duration 
and severity respectively. Gamboa et al.,135 found that disease severity and/or 
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duration did not influence their findings  using a combination of measures: 
acoustic (fundamental frequency, perturbation measures, harmonic/noise ratio); 
frequency and loudness range; maximum phonation time; s/z ratio.  
Sapir et al., 78 in a study of forty two patients, using auditory perceptual rating 
reported a positive moderate correlation for the number of speech and voice 
abnormalities and the global UPDRS motor score, meaning that as disease 
severity increased a person had a greater number of speech and voice 
symptoms.  Finally, Goberman et al.,124 showed that some acoustic measures 
were significantly correlated with non-speech or motor symptoms when motor 
symptoms were measured with the UPDRS III scale. The acoustic measures 
used in the study 124 were variability of fundamental frequency (FoSD) in 
vowels/reading, F2 slope (rate of tongue movement) for /u/ and /ae/, articulation 
rate in monologue, and percent pause in reading and monologue.  
Analysis of PD speech and voice symptomalogy in the context of the overlying 
disease process enhances understanding of the variability of symptoms across 
patients, intra-subect variability, and the differential effect of treatment on 
speech and voice variables.The relationship between voice tremor and disease 
variables will be discussed in section 4.6. 
Summary: 
• Speech and voice problems, subsumed under the umbrella term of 
‘hypokinetic dysarthria, are pervasive in PD. 
• The ‘hypokinetic dysarthria classification term does not adequately 
capture the heterogeneity of speech and voice symptoms in PD. 
• Voice-related symptoms are central in the disease process and may 
even be evident in advance of the clinical diagnosis of PD. 
• There is less clarity around the nomenclature and defining characteristics 
of voice tremor in PD than the other voice-related symptoms. 
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• A range of evaluation approaches including perceptual, instrumental and 
self-report have been applied to the study of PD speech and voice 
changes. 
• Cognisance should be given to the confounding effects of age, 
depression, anxiety and medication on speech and voice symptoms. 
• Evaluating the relationship between speech and voice symptoms, and 
disease variables offers opportunity to increase knowledge of disease 
pathophysiology. 
The focus of Chapter 3 is tremor and its manifestation in PD.  
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Chapter 3. Tremor 
Chapter 3 introduces the phenomena of tremor and more importantly gives an 
overview of PD tremor. In Section 3.1 tremor is defined, and the distinction 
between ‘normal’ and ‘pathological’ tremor explained. This is an important 
distinction, and has implications for the identification of voice tremor in PD. The 
system of classifying tremors is outlined in section 3.2, the different ways in 
which tremor can be measured are elucidated in section 3.3, and the final 
section 3.4 describes the characteristics of tremor in PD.  
3.1 Definition of tremor 
Tremor is defined as a rhythmical involuntary, periodic, sinusoidal oscillation of 
a body part154 155. It is differentially diagnosed on the basis of three aspects: the 
topography (the specific body part with tremor); the conditions under which the 
tremor is activated; the frequency of the tremor. In relation to the topography, 
the oscillatory behaviour may occur in one or a number of body parts including 
the limbs, trunk, head, vocal folds or facial structures105 156 157. Activating 
conditions for tremor include ‘rest’ and ‘action’ .The frequency or rate of tremor 
is measured in cycles or hertz (Hz) and different rates have been associated 
with different neurological conditions (section 3.2). In addition to the topography, 
activating conditions and tremor rate, tremor can also be described in relation to 
its amplitude and the shape of its waveform. The frequency is relatively fixed, 
whereas the amplitude and waveform shape are variable154. A tremor may be 
considered ‘normal’ or ‘abnormal’, although the distinction between the two 
types is not always clear. 
 Normal tremor 
Normal tremor, also referred to as ‘physiological tremor158, is mostly invisible to 
the naked eye  and is associated with the frequency band 8 -12 Hz (i.e. 8-12 
cycles per second)159 160. An important feature of ‘normal tremor is that it 
typically has a small amplitude and a high frequency161. The term ‘enhanced 
physiological tremor’ is applied to physiological tremor when its rate becomes 
irregular as a result of factors like anxiety, fatigue and hyperthyroidism159. In 
contrast, a tremor is considered to be abnormal or pathological when either the 
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movement is visible to the naked eye or if any frequencies occur that are lower 
than normal tremor, i.e., lower than 8 -12 Hz. However the distinction between 
normal and pathological tremor is not always clear since pathological tremors159 
can occur within the frequency band of physiological tremors. 
Pathological tremor 
Tremor is pervasive in neurological disease162. Pathological tremor is 
associated with a variety of neurological conditions including PD163, pallido-
ponto nigral degeneration (PPND)164, amyotrophic lateral sclerosis (ALS)165, 
essential tremor (ET), dystonia, multiple sclerosis(MS),  and cerebellar 
ataxia166. It is also associated with metabolic diseases, peripheral neuropathies, 
toxins, certain medications (including neuroleptics, lithium) and, emotional 
states of anxiety and stress160.  
3.2 Classification of tremors 
The pathological tremors may be differentiated from each other on the basis of 
different frequency bands and whether they are ‘fast’ or ‘slow’ tremors. For 
example, a tremor with a frequency band of 4-6 Hz associated with PD is a 
‘slow’ tremor. Other ‘slow’ tremors are associated with cerebellar disease (3-5 
Hz), and ET (4-9 Hz).  In contrast, the 7-10 Hz tremor associated with ALS116 
162, PPND 164, and multiple system atrophy (MSA)167, is termed a ‘fast’ tremor or 
‘flutter’. However, there are problems differentiating pathological tremors solely 
on the basis of frequency bands, since the frequency bands can overlap as in 
the case of ET and PD with a frequency band of 4-9 Hz and 4-6 Hz 
respectively159.  
The Movement Disorder Society (MDS) have proposed a clinical classification 
for limb tremor based on the distinction between different tremor ‘types’, which 
are broadly sub-divided into ‘rest’ and ‘action’ tremor,  on the basis of the 
conditions under which they are activated155. Action tremor is further subdivided 
into postural, isometric, kinetic,and  task-specific kinetic-tremor155.These tremor 
terms are delineated in Table 3.2. In addition to the physical characteristics of 
tremor, the medical history and neurological examination are also considered in 
tremor classification155 160. 
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Tremor is not confined to the limbs, and may occur in the head, face, jaw, and 
tongue, termed ‘orolingual tremors’. Orolingual tremors105,or tremors in the 
palate and/or larynx do not fit neatly into a limb classification system105. 
Silverdale et al.,105 has proposed a different classification system for orolingual 
tremors to that for limb tremor with tremors described as being predominantly 
“rest” or predominantly activation-induced. However, the authors stress the 
importance of describing in detail the ‘features’ of the tremors, so that 
classification is less related to knowing the neurological diagnosis and more to 
the discernible features105. Tremor features in the PD vocal tract have not been 
comprehensively described (section 4.5.3). Identification of tremor features is 
achieved through different measurement approaches outlined in section 3.3.  
Table 3.2. Tremor types based on conditions under which the tremor is 
activated  
 
Tremor type Activation Condition 
Rest Tremor Body part is not voluntarily activated 
and is completely supported against 
gravity 
Action Tremor Voluntary contraction of a muscle 
(postural, isometric and kinetic) 
Postural Tremor Voluntarily maintaining a position 
against gravity (hands outstretched) 
Isometric Tremor Muscle contraction against a rigid 
stationary object 
Kinetic Tremor 
  
Voluntary goal-directed or non-goal 
directed movement 
Task-specific kinetic-tremor Goal –directed activities (e.g. 
speaking and hand-writing) 
 
3.3. Measurement of Tremor  
The measurement of tremor is complicated by the fact that tremors behave in 
different and complex ways with natural variations in amplitude and frequency 
168. Notwithstanding the inherent problems, a variety of measurement 
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approaches have been used to measure tremor including clinical rating scales, 
and physiological (instrumental) techniques163 168. 
3.3.1 Clinical Measurement 
Clinical rating scales 
Clinical rating scales (CRS’s) involve rating the presence and/or severity of 
specific tremor features, generally using an ordinal rating scale. CRS’s are used 
extensively in the measurement of tremor across a range of neurological 
conditions, and  include the Fahn-Tolosa Marin Tremor Rating Scale for ET169, 
and the UPDRS 55 for PD. CRS’s have a number of advantages over 
physiological methods: instrumentation is not required; they are low cost and 
easily accessible; the results are more meaningful to professionals and 
patients168.Their disadvantages include subjectivity, poor quantification, and 
issues in relation to reliability170 171,and sensitivity172.  
Reliability between (inter-rater) and within (intra-rater) raters varies with the type 
of tremor and the task. For example, studies have reported good inter- and 
intra-rater reliability for rating postural tremor of the upper limb in patients with 
MS 171, and a mixed group with ET and dystonia170. Inter-rater reliability was 
reported to be better when rating tremor in body parts than it was in a writing 
and drawing task in patients with essential tremor169.However, reliability was 
poorer rating kinetic than postural tremor in the MS group 171. The studies 
indicate, not surprisingly, that tremor is more difficult to rate in structures that 
are in motion in contrast to structures that are ‘at rest’ or ‘holding a posture’.  
3.3.2 Instrumental methods 
The rhythmic nature of tremor lends itself to the objective measurement of its 
frequency and amplitude components using physiological or instrumental 
methods168 173. Instrumentation used to quantify tremor includes digitizing 
tablets 174 175, accelerometry 176 154and electromyography (EMG)177.   
In PD, instrumental measurements have been used to compare tremor rate in 
PD patients and in healthy controls, and to evaluate tremor simultaneously 
across different sites178 177. Aly et al.,178 found that a spectral peak between 5Hz 
and 6 Hz differentiated the PD group from the control group in a shape-tracing 
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task using a graphic (digitizing) tablet.  Using EMG, Hunker et al.,177 found 
uniform rest tremor frequencies across the lips, jaw, tongue and index finger in 
a group of three PD patients. When structures from limb and speech systems 
have a similar rate of tremor, it points towards a central oscillator as a cause of  
tremor 179. Measuring the rate of voice tremor offers exciting opportunities to 
understand more about the complexities of tremor pathophysiology. 
However there are limitations with objective instrumental measures, including 
their unavailability, expense, and the time required in using them168. A further 
problem is the difficulty in obtaining an appropriate sample of tremor for 
measuring, especially in the case of PD which can show great variability and 
even switch on and off during a 30-second recording168. The validity of 
instrumental measures is also an issue. Validity relates to whether an 
instrument measures what it purports to measure 94. One study reported poor 
correlation between an objective measure of limb postural tremor using 
accelerometry and self-reported tremor disability using an Activities of Daily 
Living questionnaire170. In explaining the poor relationship between the 
measures, it may have been that the accelerometer was not sensitive enough in 
detecting the tremor or that the tremor was accurately detected but did not 
result in disability as perceived by the patient. The issue of relationships 
between different measures will be revisited in the context of voice tremor in 
section 4.5.4.  
It is evident that tremor can be measured using a variety of techniques and no 
single evaluation method will comprehensively capture its complexity and 
variability. The type of evaluation method used to measure the oscillatory 
movement  affects the results of the measurement.Thus multi-dimensional 
evaluation of tremor is recommended for assessment of tremor severity in 
clinical trials168. The issues highlighted in this section relating to measuring 
tremor will re-emerge in chapter 4 when discussing evaluation of voice tremor in 
PD. The final section of chapter 3 describes neurophysiological aspects 
together with the different types of tremor associated with PD.  
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3.4 Tremor in PD 
Although the precise pathophysiology of PD tremor is unclear, dopaminergic 
deficit in the striatum is accepted as contributory to the development of PD 
tremor5.  Tremor severity however, does not correlate with the severity of 
dopaminergic depletion in the striatum, confirmed with positron emission 
tomography (PET)5. Further, the clinical severity rating of tremor does not 
correlate with clinical disease progression, in contrast to rigidity and akinesia.  
Therefore, it is argued that other transmitter systems, i.e non-dopaminergic, for 
example the serotenergic system, or other neural circuits (non basal ganglia) 
may also contribute to PD tremor5. Therefore the relationship between PD 
tremor and disease is not a straightforward one. It would be very informative on 
many fronts to explore PD voice tremor in the context of disease severity, to see 
if a similar ‘tenuous’ relationship exists.  
The presence of a 4-6 Hz ‘rest tremor’ is central to the PD diagnosis, and is 
often an early symptom of the disease. However other types of tremor including 
tremor during action (kinetic) or postural tremor may also occur in PD18 
158,singly and in combination complicating differential diagnosis180.  In the 
literature, variable estimates of postural tremor and under-appreciation of kinetic 
tremor occur, due to inconsistencies in the definitions of the different tremor 
types and assessment tasks employed180.To add further to the complexity of 
presentation, tremor does not occur in all pwPD, with reports of up to 30% of 
patients not showing any form of tremor, including rest and postural180 181. PD 
tremor may be difficult to differentiate from normal tremor for a number of 
reasons including, the variable characteristics of PD tremor182, the differing 
physical, emotional and mental state of the individual, and the tremors own 
natural cycle168. A further issue of particular relevance to voice tremor in PD is 
the challenge in differentiating PD voice tremor from ‘normal’ tremor due to the 
association of ageing with PD and with tremor (section 2.5.1). 
In addition to tremor in the limbs, rest tremor is reported to involve the lips, chin, 
and the jaw105. However, Jankovic6 states that rest tremor rarely involves the 
neck/head or the voice. The phenomenon of ‘rest tremor’ cannot easily be 
applied to the ‘voice’, since during voicing the structures in the vocal tract are 
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moving and not ‘at rest’. Jankovic6 did not explain what he meant by the term 
‘voice’. Perhaps he was referring to vocal tract structures associated with the 
production of voice, thereby implying that tremor does not occur in the vocal 
tract during ‘rest’ breathing (non-voicing). Tremor has also been reported in the 
tongue and the larynx in pwPD 34 107 112 113. However, similar to orolingual 
tremors, the classification system used for limb tremor cannot easily be applied 
to the palate, tongue, and larynx, leading to poor characterisation of oral, 
pharyngeal and laryngeal tremor in PD. This core subject of tremor in vocal tract 
structures in PD will be explored in detail in section 4.5.3.   
 
Summary: 
• Tremor is defined as the rhythmical involuntary periodic oscillatory 
movement of a body part.  
• It is pervasive in neurological conditions where it is termed pathological 
tremor; however normal tremor also exists.   
• Tremor is generally classified on the basis of: the body part that has 
tremor; the conditions under which the tremor is activated ( ‘at rest’ or 
during a held posture or movement); and the frequency of the tremor. 
• A limb tremor classification system cannot easily be applied to tremors in 
the oral structures, the pharynx, and the larynx. 
• Tremor is complex and variable in its presentation, and precise 
measurement can be problematic. Clinical rating scales and 
instrumentation are used, and both have value in tremor evaluation. 
• Multi-dimensional evaluation is recommended for assessment of tremor 
severity in clinical trials. 
• Rest tremor is the most common and easily recognised symptom of PD, 
however other types of tremor also occur, and a sizeable number of 
pwPD do not develop tremor.  
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• Although the pathophysiology of PD tremor is related to loss of dopamine in 
the striatum, the non linear relationship between tremor and disease severity 
suggests adjunctive etiological factors. 
Chapter 4 follows with a change in focus, moving closer to the central issue of 
voice tremor in PD. 
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Chapter 4. Voice tremor, and Voice Tremor in PD 
Chapter 4, the final chapter leading to the formulation of the research aims of 
the thesis has two themes. The first theme addressed in sections 4.1 to 4.3 
defines voice tremor, examines voice tremor in neurological disorders, and 
outlines ways in which voice tremor has been evaluated in non-PD conditions. 
The second theme, voice tremor in PD covered by sections 4.4 to 4.7 
addresses the following areas: evaluation approaches in PD voice tremor; 
relationships between voice tremor and PD speech/voice variables, and disease 
specific variables.  
4.1 Voice tremor defined 
Tremor may occur in normal phonation183, and when it does it is termed ‘normal’ 
or ‘physiological’ tremor. Voice tremor is associated with ageing (section 2.5.1), 
and with pathological voice disorders (section 4.2).The difference between 
‘normal’ and ‘abnormal’ voice tremor is not clear cut. ‘Phonatory instability’ is a 
useful term to apply to understand the phenomenon of voice tremor and to 
explore the difference between tremor in ‘normal’ voice and ‘pathological’ 
voice184 185.  The human voice is inherently unstable 186 187 as a result of normal 
oscillatory behaviour that occurs in the respiratory, laryngeal, and articulatory 
muscles of the vocal tract. The oscillatory movements give rise to fluctuations or 
modulations in the fundamental frequency (Fo) and/or amplitude of the voice 188 
189. These modulations are generally not perceptually prominent but contribute 
to the natural quality of the voice 187 190. Singers exploit this normal oscillatory 
behaviour through technique and practice to produce perceptually salient 
frequency modulations, which is termed  ‘singers’ vibrato 191 190. 
 Abnormal (pathological) voice tremor 
In contrast, when oscillatory movement in the vocal tract is involuntary and 
rhythmical, and causes rhythmic fluctuations in the fundamental frequency and 
amplitude of the voice, perceived as rhythmic (quasi-rhythmic) fluctuations in 
pitch and loudness, it is considered ‘pathological’ voice tremor 187. The term 
‘voice tremor’ will be used generically in this study to denote abnormal or 
pathological voice tremor.  Voice tremor related to PD will be termed ‘PD voice 
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tremor’. Regarding the source of the oscillatory tremor movement, the muscles 
of the vocal cords, the larynx, and the respiratory muscles are possible causes 
of voice tremor 166 183.  In addition, changes in articulatory configurations may 
result in alterations of fundamental frequency, through the coupling of the larynx 
and tongue by the extrinsic laryngeal muscles 166. In effect, therefore, voice 
tremor may relate to fluctuations in any one or all of the following muscle 
groups: respiratory; vocal cords; laryngeal; articulatory (jaw, tongue, soft 
palate), also referred to to as the vocal tract. 
Voice tremor has been described as a ‘long-term phonatory instability’ and 
contrasts with ‘short-term phonatory instability’.The ‘long-term’ part of the 
descriptor refers to the fact that the variations in frequency and amplitude,  
which can be (quasi-cyclical) or non-cyclical are slower than the ‘quasi-periodic’ 
glottis vibration (vocal cords) itself 184 185. Conversely, short-term phonatory 
instability relates to variations in frequency and amplitude from one cycle to the 
next, also referred to as jitter and shimmer respectively (section 2.4.3).The 
‘phonatory instability’ part relates to fluctuations in the  frequency and amplitude 
of the voice185.  An important point to highlight here, in advance of acoustic 
measures of voice tremor (section 4.3.3) is that phonatory instability can be 
‘cyclic’ or ‘non- cyclic’. ‘Cyclic’ refers to the fact that the tremor is of sufficient 
regularity and periodicity for a tremor rate to be detected. Voice tremor has 
been referred to as a ‘cyclic phonatory instability’184.  
4.2 Voice tremor and neurological disease 
Voice tremor is pervasive in neurological disease and has been reported in 
association with the following conditions: spasmodic dysphonia (SD)109; ET192 
193; MS 185; parkinsonism 164 75 194; ALS 165 162; and cerebellar ataxia166.  
Additionally, voice tremor has also been reported as an early feature of some 
neurological diseases including ALS, 162 PPND 164 and PD 88.Notwithstanding its 
pervasiveness and early presentation in neurological disease, the classification 
of voice tremors has not developed to the same degree as has the neurological 
understanding of tremor in general 173 or of PD tremor (section 3.4). 
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Little is known about the different ways in which voice tremor is manifested in 
different neurological conditions and the possible basis for those differences 159. 
For example, does PD voice tremor and voice tremor in ET (ETV) sound the 
same or different and if there is a difference, what is the nature of the 
difference? A fundamental problem is that voice tremor in PD has not been 
characterised, and ways in which it can be measured have not been elucidated. 
Studies that have explored voice tremor in other neurological conditions provide 
direction for improved methods of PD voice tremor evaluation (section 4.3). 
4.3 Voice tremor evaluation in the neurological (non-PD) 
literature  
In a previous section 2.4, the different approaches used in the evaluation of 
speech and voice symptoms were described as background information to the 
measurement of voice tremor. The current section focuses on the most clinically 
applicable measures to the study of voice tremor, highlighting issues with each 
approach. The auditory perceptual rating of tremor will be presented first, 
followed by visual perceptual rating and finally, acoustic measurement. Non-PD 
studies will be used to highlight some of the issues. Section 4.4 will then focus 
on voice tremor in PD with particular reference to issues and possible solutions 
related to different voice tremor evaluation approaches. 
4.3.1 Auditory Perceptual Rating 
The centrality of auditory perceptual rating of voice in the analysis of voice 
quality was highlighted in section 2.4.1. Voice tremor is clinically identified in 
sustained vowels [(/a/ and /i/], and during speaking tasks.However voice tremor 
is best perceived auditorily during sustained vowel production of /a/ or /i/195 196. 
The reason being, that a sustained vowel task allows the rater to focus 
specifically on the voice quality without the additional sound artefacts that are 
associated with connected speech, and avoids variability in the signal from 
alternating voiced-voiceless sounds196.  
Not dissimilar to rating limb tremor (section 3.3), the reliability of perceptual 
rating of voice tremor is an issue. For example, Bain et al.,170 carried out a study 
of twenty patients with postural tremor of their upper limbs, twelve of whom had 
a diagnosis of essential tremor and eight had tremor related to dystonia.  ‘Vocal 
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tremor’ was detected in six participants. Four raters (doctors) graded the 
severity of perceived voice tremor using an interval scale of 0-10, during a 
speaking and a sustained singing /a/ task’, in addition to rating tremor in the 
head, leg and hands.  The authors reported that there was poor reliability for 
rating ‘vocal tremor’, with the raters not able to agree on which patients had 
‘vocal tremor’. In contrast, the rating of tremor in the head and upper limbs was 
rated as ‘good’. Lack of clarity around the terminology may have negatively 
impacted on reliability of ratings, since it is not clear from the study if ‘vocal 
tremor’ was defined for the raters in advance of the rating experiment. A further 
confounding factor impacting on poor agreement/reliability may be the type of 
speaking task used in the rating experiment. The raters were asked to rate 
vocal tremor during a speaking task and a sustained ‘singing /a/’. A sustained 
vowel task, resulting in a more perceptually salient tremor, might have improved 
reliability195. Further, it may have been difficult for the raters to perceive  the 
tremor during the singing task, since the magnitude of tremor is reduced with 
high-pitched voicing197.  
Barkmeier et al.,197 in their study addressed some of the aforementioned 
problems. They set out to ascertain if inexperienced raters could match 
experienced raters in rating perceived symptoms of SD and ‘vocal tremor’. The 
outcome of the study was that expert  judges (at least 5 years specialised 
clinical/research experience with SD and vocal tremor) showed high reliability 
between themselves rating voice and tremor features, with inexperienced voice 
clinicians achieving similar levels of reliability as the expert judges197. The 
following factors contributed to the high reliability. At the outset, they defined 
‘vocal tremor’ as ‘periodic fluctuations in pitch and/or loudness’. They used a 
sustained /a/ vowel task for tremor rating. Finally, the raters were required to 
decide if tremor was intermittent or continuously present and then rate its 
severity on a scale of 0 (normal) to 3 (interferes with intelligibility).  
4.3.2 Vocal tract examination and sources of tremor 
Voice tremor is inextricably linked to involuntary oscillatory movement in vocal 
tract structures. The term ‘oscillation’ in general refers to regular periodic 
variations of a measured value about a mean19. Applying this explanation of 
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oscillatory movement to the vocal tract implies that the movement is rhythmic or 
quasi-rhythmic at least. Methods of examination of the vocal tract were 
previously discussed in section 2.4.2. In relation to assessing tremor in the 
vocal tract, the preferred method is using nasendoscopic examination198. The 
examiner can potentially identify rhythmic movements in a number of different 
anatomic sites, including the soft palate, base of tongue, larynx, and pharynx 
during non-phonatory  (breathing, voiceless sounds) and phonatory tasks 
(sustained vowels) 192 193 199.  
There is evidence of characterisation of voice tremor in ET192 200. Warrick et 
al.,192 using nasendoscopy in a botulinum toxin treatment study of ten patients 
with ETV evaluated tremor in the larynx and the palate during ‘rest breathing’, 
during sustained /i/ and /a/ vowels, and fricatives.  They192 reported that most of 
the patients had three to four anatomical sites of tremor, with the vocal cords 
being the most frequent tremor site followed by the soft palate. In a further study 
of patients with ETV, Sulicia et al.,193 also using nasendoscopy applied the 
Vocal Tremor Scoring System (VTSS)200  to their analysis of thirty four patients 
with ET. They 193 identified and graded tremor across six different tremor sites 
[soft palate; base of tongue; pharyngeal wall; global larynx (larynx as a unit); 
vocal folds; supra glottis (above vocal cords)]; using different tasks including 
tongue protrusion, and a sustained /i/ vowel.  The authors193 found that the 
highest rating (most severe) was for tremor in the global larynx, the supraglottis, 
and the vocal folds, and the lowest rating was for the ‘extra-laryngeal’ (outside 
the larynx) sites (palate, tongue, pharyngeal walls). Examining different sites in 
the vocal tract, and rating tremor features during different speech-related tasks 
moves closer to a classification type approach for voice tremor, similar to the 
approach used in limb tremor classification which was outlined in section 3.2. 
 4.3.3 Acoustic measurement of tremor 
The contribution of acoustic measurement to voice analysis was previously 
outlined in section 2.4.3. This section focuses specifically on the contribution 
that acoustic measurement makes to the identification and characterisation of 
voice tremor.  
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Rhythmical (quasi-rhythmic) oscillatory movement of muscles in the vocal tract 
is manifested in the acoustic wave form.Tremor may be manifested in variations 
in the length of the vibratory cycle when it is termed ‘frequency tremor’ and/or in 
the amplitude of the cycle, termed amplitude tremor183.The rhythmic or quasi-
rhythmic fluctuations in frequency and amplitude secondary to oscillatory 
movement in the vocal tract, lend themselves to acoustic measurement183 . 
Ludlow et al.,183  in a study of nine patients, five of whom had ET and four had a 
variety of neurological diagnoses measured ‘slow systematic changes’ in 
frequency and amplitude of the signal over blocks of 50 cycles and found that 
both frequency and amplitude aspects of tremor were affected in their 
group.They related the frequency and amplitude tremor to the 
nasendoscopically observed vocal fold tremor. However no formal correlations 
of this suggested relationship were carried out by the authors. The identification 
of frequency and amplitude tremor in neurological disorders is welcome, 
however conclusions are limited without studying a neurologically healthy 
control group.  
An ongoing challenge is to find appropriate acoustic measures that will 
differentiate between pathological tremor and normal tremor116 . Ramig et al.,116 
compared a heterogenous neurological group including PD, ALS, ETV, 
adductor spasmodic dysphonia (ADSD), spinal muscular atrophy, and a group 
of normal healthy controls. They found that there was greater extent of 
amplitude tremor in the neurological group than in the control group, but the 
difference between the groups was not significant. An even more challenging 
exercise is to differentiate voice tremor in different neurological conditions116 201. 
Lundy et al.,201 wished to differentiate between three groups of participants with 
ADSD, ALS and ETV. (PwPD were excluded from the study). Using MSP from 
the CSL119, they found that the magnitude (extent) of amplitude tremor (Matr %) 
119 differentiated the ETV group from the ALS and ADSD group, on a sustained 
/a/ vowel task. In addition, they found that all three groups had increased values 
of Matr %119 over available CSL normative data. However a word of caution 
when interpreting these study findings, consideration needs to be given to the 
fact that the CSL norms 119 are based on a younger age group for males and 
females than the participants in Lundy et al’s., study201. 
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The role that short-term phonatory instability (section 4.1) measures have in 
identifying and measuring voice tremor is a moot one. Jiang et al.,157 considered 
that jitter (frequency perturbation) in addition to long-term frequency and 
amplitude modulation should be useful for the detection and quantification of 
‘vocal tremor’. However, other authors have not found the short -term 
perturbation (jitter and shimmer) measures to be as useful as the long-term 
measures202.  Zwirner et al.,202 examined three groups of patients: PD, 
Huntington’s disease, and cerebellar ataxia. They reported that the ‘long-term 
measure’ of variability of fundamental frequency (SDFo) differentiated the three 
groups, however fundamental frequency (Fo), jitter, shimmer, and signal to 
noise ratio (SNR) did not differentiate them.  
When selecting acoustic voice tremor measures, it is important to consider their 
clinical utility117(meaning the way in which a specific tremor measure relates to 
a clinical measure of voice tremor). Hertegard et al.,203 found that measures of 
SDFo as a tremor measure did not correlate with a perceptual tremor rating in a 
group of fifteen patients with ETV. The authors surmised that SDFo is probably 
sensitive to parameters other than tremor and highlighted the need for further 
studies to clarify the acoustic parameters that are most useful for measuring 
tremor. Another explanation might relate to the artefact of trying to compare 
perceptual and instrumental measures. 
Acoustic measurement has an important contribution to make in quantifying the 
rate of voice tremor, in an effort to see if measuring the rate of voice tremor 
assists in understanding the underlying pathophysiology (section 3.3.2). 
Drawing from the classification approach used for limb tremor (section 1.5), 
some studies have applied tremor rates (Hz) to differentially diagnose voice 
tremor in different neurological conditions, and to differentiate patients with 
neurological conditions and normal controls159 183.  For example, Boutsen et 
al.,159 compared a group of four patients with ALS and one female pwPD and 
found a high frequency tremor, i.e. flutter (7-10 Hz) in the ALS group and the 
pwPD. Flutter has been associated with ALS 162 and not with PD. Ludlow et 
al.,183 in a study of eight patients with different neurological diseases and twenty 
controls found that mean frequency and/or amplitude tremor rates did not 
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differentiate between patients with ETV, dystonia with tremor, myoclonus, SD 
with tremor, and normal controls. The rate of frequency tremor was 5.45 Hz in 
the neurological group and 6.64 Hz in the control group.  For amplitude tremor, 
the rate in the neurological group was 6.27 Hz and 7.48 Hz in the control group.  
Acoustic measurement offers the opportunity to move closer to a classification 
approach for voice tremor with opportunities to measure the rate, and the 
magnitude of the tremor. A shortcoming of acoustic measurement when used 
for voice tremor analysis is that it does not throw light on the physiological 
correlates of unsteadiness in the vocal tract204. Cannito et al.,205 writing about 
vocal tract steadiness in SD, suggested that more direct observation of specific 
muscles in the vocal tract was necessary to understand the relationship 
between the instability measured acoustically and oscillatory behaviour of a 
related structure. The topic of acoustic tremor measurement will be re-visited in 
the context of PD voice tremor in section 4.5.2. 
The key points from section 4.3 pertaining to measurement approaches that 
have been used in non-PD studies follows. Voice tremor can be perceived more 
easily in sustained phonation than in connected speech. A clear explanation of 
voice tremor facilitates improved reliability of ratings. Nasendoscopy is the 
preferred examination approach for characterising possible sources of voice 
tremor, since it permits the identification of tremor in different vocal tract sites 
and during different tasks. Frequency and amplitude fluctuations secondary to 
involuntary oscillatory movement, together with the rate of tremor can be 
measured acoustically. Long-term instability measures are more appropriate for 
measuring voice tremor than are jitter and shimmer (short-term) measures. An 
increase in the magnitude of amplitude tremor has been associated with 
neurological disease. An ongoing challenge however is to find acoustic 
measures that will differentiate voice tremor in neurological conditions from 
healthy controls. These findings emanating primarily from the non-PD literature 
are brought forward into the final sections on PD voice. The outstanding issues 
driving the main aims of this study will complete chapter 4.  
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4.4. Voice Tremor in PD 
In this section the diversity of voice tremor terminology extant in the PD 
literature and the variable prevalence rates are reported. Section 4.5 reviews 
studies which have reported on voice tremor in PD, highlighting the evaluation 
approach used with subsequent findings.  The literature relating to PD voice 
tremor in association with other voice and speech variables will be reviewed in 
section 4.6. The final section (4.7) of the chapter looks at ways in which PD 
voice tremor relates to disease variables. A short summary will complete the 
chapter with particular reference to the gaps in our knowledge of PD voice 
tremor, leading to the research questions. 
Descriptors 
Voice tremor has been variously described as a feature of the PD speech-voice 
complex. These descriptors include ‘tremorous voice’ 116, ‘tremulousness’75 , 
tremulous pitch (deficit in pitch steadiness)’89, ‘pitch unsteadiness’104, 
‘perceptible vocal tremor’116, ‘flutter’ 159, ‘vertical laryngeal tremor 107,‘laryngeal 
tremor’ 120, ‘rhythmic amplitude tremor’116.The two main reasons for the diversity 
of terminology  are: the majority of studies do not have voice tremor as a main 
focus206 and different evaluation approaches with different types of measures 
are used across studies (Table 2.1). It is difficult to know if the descriptors refer 
to the same or a different phenomenon. For example, it is not clear if the 
perceived ‘tremulousness’ in Logemann et al’s.,75 study is the same 
phenomenon as the ‘tremulous pitch’ and ‘deficit in pitch steadiness’ perceived 
and described in Chenery et al’s.,89 study. It is also unclear if the ‘laryngeal 
tremor’ cited in Schulz’s207 study is the same as the ‘vertical laryngeal tremor’ 
described in  Perez’s study 107. Therefore lack of clear nomenclature is 
problematic and confusing. 
Prevalence 
Variable prevalence rates of voice tremor in PD are reported regardless of the 
evaluation approach used. Perceptual-based voice studies report prevalence 
rates which vary from a low 13.5% 75 to a high 68%89. In Logemann et al’s.,75  
study of two hundred patients with parkinsonism (PD and post-encephalitic PD), 
two raters identified the presence of perceived tremulousness in 13.5% of the 
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sample in a sentence and connected speech task.  In a reading aloud task, 
Chenery et al.,89 identified 68% of a group of nineteen mild-moderate PD 
patients with ‘tremulous pitch’ which they also termed a ‘deficit in pitch 
steadiness’. Based on what is known about the variability of PD tremor, it is 
possible that such widely varying prevalence rates exist.  However, it is also 
possible that methodological differences may account for much of the disparity 
in prevalence figures, between the two studies. The studies differed in relation 
to: tremor ‘descriptor’; homogeneity of the study group; the number of raters; 
and the type of rating scale.  
PD studies using laryngeal examination report similar varying prevalence rates 
of tremor. Gamboa et al.,135 identified ‘laryngeal’ tremor in 14.6% of their group 
of forty one pwPD, using either indirect laryngoscopy or nasendoscopy. In a 
different study, the same group of authors also using indirect laryngoscopy or 
nasendoscopy identified ‘laryngeal’ tremor in 45.5% of a group of twenty two PD 
patients120. The contrasting findings in relation to ‘laryngeal tremor’ findings is 
difficult to explain since the methodologies were similar excepting difference in 
medication schedules and severity of PD symptoms as measured with the 
UPDRS (APPENDIX A). The pwPD in Jimenez-Jimenez et al,’s120 study were 
un-medicated, had a shorter disease duration and milder disease severity than 
the pwPD in Gamoba et al’s study135. Midi et al.,131 used rigid laryngoscopy in 
their study of voice abnormalities in twenty male pwPD and reported  that three 
out of twelve patients (15%) had ‘laryngeal tremor’. They did not describe the 
speech-voice tasks used to elicit the tremor behaviour, or the characteristics of 
the tremor in the larynx.  Blumin et al., 113 identified tremor of the 
‘laryngopharynx’ (tremulous movement of the laryngopharynx during phonation) 
in 53% of a group of fifteen patients with advanced PD, undergoing DBS on a 
sustained /i/ vowel task using rigid laryngoscopy. Finally, Perez et al.,107 
identified ‘vertical laryngeal tremor’, using nasendoscopy in 55% of their group 
of twenty- two PD patients.  Based on the these studies, the exact prevalence of 
‘laryngeal’ tremor is unclear due to the varied evaluation approaches used 
coupled with the lack of detailed information regarding the characteristics of the 
tremor findings.  
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Therefore, studies using auditory perceptual and visual perceptual evaluation 
report varying prevalence rates of voice tremor. It appears that voice tremor 
(similar to PD limb tremor) is not a feature of all pwPD. 
4.5. Voice Tremor Evaluation approaches in PD 
This section outlines the PD studies that have reported voice-tremor features 
with particular attention given to the evaluation method applied. This is 
necessary to give direction to the current study methodology. 
 
4.5.1. Auditory Perceptual Evaluation 
The varied non specific tremor descriptors emanating from auditory perceptual 
based studies frequently relate to incidental findings. As a result, important 
details are not explicit. For example, Ramig et al.,116 reported that four out of 
eight patients (50%) had perceptible ‘vocal tremor’, in a study whose main focus 
was acoustic voice analysis and not perceptual evaluation. The specific 
speech/voice task used to elicit the tremor and the rating procedures used were 
not described, rendering replication of the study difficult 116. Sataloff et al.,208 in 
a single case study of a pwPD undergoing DBS, described perceived tremor 
with a rating of 3 on a scale of 0-5  However, they did not describe the rating 
methodology as in the number of rater/s involved, or indicate whether the rater/s 
were blind to the diagnosis. 
A further issue is that perceptual based PD studies describing voice tremor 
features based their findings on natural speaking and reading tasks 75 89, and 
did not include a sustained /a/ vowel task, which is considered the most 
sensitive method for identifying tremor  (section 4.3.1).The result is that studies 
may underestimate the presence and severity of tremor, since contextual 
speaking tasks (reading, speaking) may mask the underlying tremor. In 
addition, studies describing perceived PD voice tremor have not included 
neurologically healthy participants75 103. Therefore it is not possible to be definite 
that PD is the cause of the perceived voice tremor. This is a very important 
issue to address particularly in the context of the association of ageing and 
voice tremor (section 2.5.1). 
57 
 
The issue of poor reliability in rating voice tremor in non-PD voice studies was 
highlighted in section 4.3.1. Few PD studies have reported on the reliability of 
auditory perceived tremor. Solomon et al. 209 looked at the effects of DBS on 
speech in three men with severe PD. They reported that the highest intra-class 
correlation coefficient (ICC) (a measure of inter-rater reliability) was achieved 
for ratings of tremulousness relative to the reliability for monopitch.  Ratings of 
tremulousness were carried out by six SLT’s, using a four point scale in a 
reading and monologue task. Based on the author’s reporting in the study, it 
appears that tremulousness achieved an ICC of 0.754 for the reading task and 
0.768 for the monologue209. It is not clear from the study if the authors 
addressed reliability by defining the descriptor ‘tremulousness’ at the outset. 
Definite conclusions cannot be drawn regarding reliability of tremor ratings from 
this small study.   
To summarise, consideration has not been given to optimum ways of evaluating 
PD voice tremor perceptually, in relation to the consistency in terminology used, 
the type of task used to elicit tremor, the type of rating scale best suited for the 
purpose, or ways to improve reliability. To begin to address these issues, this 
study on PD voice tremor will include a clear definition of perceptual voice 
tremor; include a sustained vowel task for rating purposes; rate the severity of 
perceived tremor; and have rating carried out in a blinded fashion. Section 4.5.2 
reviews PD studies reporting voice tremor features using instrumental 
evaluation. 
4.5.2. Instrumental evaluation 
In addition to describing PD voice tremor on the basis of auditory perceptual 
evaluation, studies have also described voice tremor features using non-
invasive instrumental methods including: acoustic; aerodynamic; EGG 134; and 
laryngeal electromyography (LEMG).  
Acoustic evaluation 
In section 4.3.3, the use of acoustic voice measurement for the purpose of 
identifying frequency and amplitude tremor in neurological conditions was 
introduced. A smaller number of PD studies have also tried to address this 
question. Some studies have  identified amplitude tremor116 208, and  others 
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have identified frequency and amplitude tremor features in pwPD88 173. Ramig et 
al.,116 described a ‘rhythmic amplitude tremor imposed upon cycle-to cycle 
deviancies’, visually evident in the waveform of one of nine PD patients, which 
differed from the waveform of the patients with Myotonic Dystrophy, and 
Huntington’s disease.  In a single case study of a man with PD undergoing  
DBS, Sataloff et al.,208 reported that there was greater variation in amplitude 
tremor than in frequency  tremor, with a ‘vibrator intensity variation’ of 16% in 
intensity and 1.50% in frequency variation. It appears from the cursory 
description in the methods section of Sataloff et al’s study 208 that the MDVP 
from the CSL was used in the voice analysis. Information was not provided on 
the type of task used or the number of trials elicited for analysis.  
In a larger group, Stewart et al.,88 visually identified (using narrow band 
spectrographic analysis), fluctuations in both amplitude and frequency tremor 
aspects in 33% of a group of twelve ‘early’ pwPD, (mean disease duration less 
than 3.2 years), on a sustained vowel task. They did not quantify the amplitude 
and/or frequency tremor, and did not include a control group, therefore we do 
not know if their findings were specific to PD.  In contrast, Jiang et al.,173 in their 
study, set out to quantify the frequency and amplitude of voice tremor in a 
mixed group of ten neurological patients,  using spectral analysis of the acoustic 
intensity contour. Seven of the group had PD, one had cerebellar atrophy, one 
upper motor neuron dysfunction and one had idiopathic tremor. They also 
studied ten gender and age-matched controls. They reported that the 
pathological tremor group was distinguishable from the normal control group by 
the magnitude of amplitude modulation of the acoustic intensity, and surmised 
that the findings point towards greater fluctuations in the respiratory system, 
vocal fold tension, and/or articulatory configurations in pathological tremor. 
What is not clear from these studies however is the contribution that acoustic 
tremor measures make to the differentiation of pwPD from neurologically 
healthy controls, and the specific measures that might be helpful in 
differentiating between the groups.   
Acoustic measures have been used in PD studies for varying purposes, 
including the monitoring of treatment effects of dopaminergic medication 
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(section 1.7) and DBS 210 211 (section 2.4.3).  D’Alatri et al.,210 applied tremor 
measures [(magnitude of frequency tremor Mftr%);(magnitude of amplitude 
tremor Matr%)] from MSP in CSL, to evaluate the differential effect of 
medication and DBS in a group of twelve pwPD12. The authors reported 
baseline mean Mftr and Matr values of 0.63 and 4.72 respectively, when 
patients were off-medication and without stimulation210. They reported 
improvement in acoustic voice tremor with significantly reduced Mftr and Matr 
values of 0.38 and 2.87 respectively, when patients were ‘on-medication’ and 
‘on-stimulation’. Xie et al.,211 in their study of eleven patients also undergoing 
DBS reported significant changes in Mftr values (females) between the pre- 
surgical ‘on medication’ state and the post-surgical states. However, the authors 
did not indicate if Mftr values had increased or decreased.  De letter et al.,212 
also applied tremor measures of Mftr and Matr from MSP to investigate the 
sequential changes in respiratory, speech, and voice variables across a 
medication cycle in seven pwPD. Using analysis of variance (ANOVA), they 
found significant differences between subjects across the cycle in eighteen out 
of twenty measures including Mftr and Matr. The authors did not report the 
individual or the mean Mftr or Matr values for their group, so it is not possible to 
compare the tremor values with those from D’Alatri et al’s.,210 study. Although 
the findings from these studies suggest that Mftr and Matr may be useful indices 
for charting changes in tremor behaviour secondary to medication and/or 
neurosurgical treatment, their potential role in differentiating pwPD from 
neurological healthy controls has not been established to date. 
A review of the PD studies using acoustic evaluation highlights the value in 
quantifying frequency and amplitude tremor for the purpose of: determining 
differences between pwPD and healthy controls; for measuring pharmacological 
and surgical (DBS) treatment outcomes. However, the findings to date are 
somewhat mixed with no clear conclusions regarding the presence of frequency 
and amplitude tremor in PD due to a combination of:  small sample size, the 
lack of a control group; a heterogenous grouping of patients; the paucity of 
detailed information relating to the methods used. Therefore a major step in this 
direction is to evaluate a group of pwPD and neurologically age and sex 
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matched controls, with clear documentation of the evaluation approaches used 
to identify tremor in the acoustic voice signal. 
Aerodynamic measures 
Another instrumental evaluation approach that has been used in PD studies, 
albeit with limited application to PD voice tremor to date, is aerodynamic 
evaluation. Aerodynamic measures include non invasive measures of the flow 
of air through the glottis (area between the vocal folds), air pressure, and the 
extent to which the larynx offers opposition to the flow of air through the glottis 
(laryngeal airway resistance) 104.  Murdoch at al.,104 examined laryngeal and 
phonatory dysfunction in a study of twenty PwPD and twenty non-neurologically 
impaired subjects, using aerodynamic measures, in addition to EGG 134, and 
perceptual measures. They found significant differences between pwPD and 
controls with reduced sub-glottal pressure and phonatory sound pressure level 
(SPL), and increased laryngeal resistance in the pwPD group in comparison to 
the control group. They considered that incomplete closure of the vocal folds 
causing inadequate valving of the air stream, and rigidity in the laryngeal 
muscles to be related factors in the aerodynamic findings. Interestingly, they 
raised the issue of compromised velopharyngeal function as an additional 
cause of the lowering of intra-oral pressure. However they did not go as far as 
suggesting tremor in the palate could be an underlying cause of reduced velo-
pharyngeal control.  It is reasonable therefore to argue that aerodynamic 
measures, in addition to spirometry (section 2.4.3) could potentially increase 
understanding of PD vocal tract tremor. However, it is not possible to address 
this question in the present study.   
Electroglottography  
Another instrumental tool used in voice studies, albeit with limited application to 
date to voice tremor evaluation is EGG, also referred to as laryngography. EGG 
indirectly measures vocal fold contact, and the opening/closing patterns of the 
vocal cords. Murdoch et al.,104 in their study of twenty pwPD found that EGG 
measures of fundamental frequency (Fo), duty cycle (ratio of time that vocal 
cords are open during the vocal period compared to the duration of the total 
vibratory cycle), and closing time (duration of the closing phase from totally 
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open to totally closed) did not differentiate the pwPD from the healthy control 
group. They concluded that the EGG measures did not contribute to the 
understanding of the pathophysiology of the deviant perceptual characteristics 
including ‘pitch unsteadiness’ 104. It is conceivable  that EGG may not capture 
the long term instabilities of tremor in the vocal tract, since it is designed to 
assess cycle-by-cycle periodicity and contact of vocal cords (‘microfunctions of 
the larynx’) 104. EGG has potential for use when tremor in the vocal folds is the 
main study focus, however its inclusion in the current study is not warranted 
since the focus is tremor in the vocal tract.  
Laryngeal electromyography (LEMG)  
The final instrumental approach described in this review is that of laryngeal 
electromyography (LEMG), which is the application of EMG to laryngeal 
muscles. The only available objective test of the electrical function of the 
intrinsic laryngeal musculature 213, LEMG has been used minimally in the 
measurement of voice tremor. The fact that it is a highly invasive technique and 
that the laryngeal muscles are difficult to access, has contributed to its lack of 
use. LEMG offers the opportunity of determining if tremor in the vocal cords is a 
feature of PD. However PD studies have been inconclusive with respect to 
pinpointing the exact location of tremor in the larynx or vocal tract 213 214. Zarzur 
et al.,213 looked at LEMG findings in twenty six patients with PD and twenty six 
controls with presbyphonia (voice change secondary to ageing). They carried 
out ‘flexible videolaryngoscopy’ (nasendoscopy) for diagnosis and 
documentation. Although a tremor was observed in three pwPD during ‘clinical, 
vocal and videolaryngoscopic’ examinations, they reported that no tremor was 
evident in the intrinsic laryngeal muscles based on the LEMG tracings in any of 
the patients, during a phonatory /i/ task. Zarzur et al.,213 concluded therefore 
that the ‘clinical tremor’ observed during ‘videolaryngoscopic’ examination was 
likely to have originated in muscles other than those chosen for the LEMG. 
Zazur et al.,214 in a later study of twenty six pwPD reported similar findings 
regarding the non-detection of laryngeal tremor using EMG. This time they used 
acoustic voice analysis in addition to LEMG. The authors214 reported  that voice 
tremor was detected acoustically in the spectrogram tracings of 69.5% of  
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pwPD, and perceptually in 61% of the subjects. Of note in the context of this 
study, is that tremor was identified in the acoustic voice signal. Not surprisingly 
however in the context of Zarzur et al’s., 213 previous study, there was no 
correlation found between LEMG and ‘voice analysis’214. However, it is not clear 
from the paper 214 if ‘voice analysis’ included the perceptual and the acoustic 
measures. Further, no information was provided in the text on the perceptual 
rating of voice tremor or the cited acoustic measures of ‘VOXMETRIA ® and 
GRAM 5.1.6. These issues weaken the findings from the study regarding the 
lack of correlation between the different measurement approaches. Finally, 
Kimaid et al.,215 in contrast to the previous studies 213 214reported positive LEMG 
findings of the thyroarytenoid muscle in two pwPD in a mixed group of twenty 
patients with movement disorders. They identified rhythmic bursts of 5-6 Hz 
muscle activity at rest that disappeared with phonation.  
Therefore, the findings to date in relation to the use of LEMG for measuring PD 
voice tremor suggest that it may have an adjunctive role to play in identifying 
tremor in the vocal cords, during ‘rest breathing’ and during phonation. 
However, considering its invasiveness coupled with its application only to 
tremor in the vocal cords, it will not used in the current study for the evaluation 
of voice tremor. 
To conclude this section on instrumental evaluation of PD voice tremor, it is 
evident that acoustic measurement can increase understanding of ways in 
which tremor affects the frequency and amplitude aspects of the PD voice, and 
contribute to quantifying differences between pwPD and healthy neurological 
controls. The final evaluation approach for consideration is that of identifying 
tremor in structures in the vocal tract. 
4.5.3. Visual Perceptual Evaluation and sources of voice tremor  
In PD, there is speculation about the possible source of perceived voice tremor. 
For example, Solomon et al.,209 in a study of three males with severe PD 
queried if limb tremor acting on the chest wall resuIted in ‘perceived vocal 
tremulousness’.  However the authors did not consider that the perceived 
tremor might be related to tremulous structures in the vocal tract 209. As 
discussed in section 4.5.2, tremor in the vocal cords is not considered to be a 
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main source of PD voice tremor 34 213 214. An outstanding and important 
question therefore pertains to which ‘tremulous’ structure/s in the vocal tract are 
associated with PD voice tremor. 
PD studies using laryngeal examination have described tremor in the larynx, the 
tongue and the strap muscles120 131 216. Jimenez-Jimenez et al.,120 noted 
‘laryngeal tremor’ in three patients out of a group of twenty-two pwPD, using 
stroboscopy. Midi et al.,131 also using stroboscopy documented ‘laryngeal 
tremor’ in three patients out of a group of twelve male pwPD. There is no detail 
in either studies120 131 regarding the specific location of the tremor. For example, 
was the tremor behaviour manifested in the entire larynx structure (global 
larynx), in the vocal cords, or the arytenoid cartilages. Further, the non-
phonatory/phonatory tasks used to elicit the identified ‘laryngeal’ tremor are not 
described. Following the limb tremor classification approach (section 3.4), Perez 
et al.,107 reported that ‘resting laryngeal tremor’ was a feature in 35% (n=22) of 
a group of pwPD. The author’s107 documentation of laryngeal tremor in an non-
phonatory or ‘resting’ condition is a step towards improved classification of PD 
vocal tract tremor. However Perez et al.,107 did not describe the characteristics 
of ‘resting laryngeal tremor’, making it difficult to relate their findings to other 
study findings or indeed to replicate their study. 
Hanson et al’s.,216 study suggests that PD voice tremor is not confined to the 
larynx. The authors 216 described tremor in the tongue, and the ‘strap muscles’, 
in addition to the ‘supraglottic’ (above the vocal cords) muscles and ‘arytenoids’, 
in thirty two male PD patients. However, it is not clear how tremor in the strap 
muscles was identified during the laryngeal examination. Strap muscles are 
also referred to as the infra-hyoid muscles, and their function is to lower the 
larynx during speech and swallowing. Perhaps the authors 216  identified 
‘vertical laryngeal tremor’ 107during the examination and inferred tremor in the 
infrahyoid (strap) muscles. The reporting of tongue tremor in Hanson et al’s216 
study is an important finding in relation to understanding more about the 
possible sources of voice tremor in PD, since other studies, have reported 
laryngeal tremor only107. However it is important to note that the ‘rigid 
laryngopharyngoscope’ (rigid laryngoscopy) used by Hanson et al.,216 would 
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have resulted in a forward fixed tongue position. This is not a natural tongue 
posture during phonation and may have confounded the examination findings.   
Perez et al.,107 carried out the largest prospective laryngeal tremor study using 
‘flexible nasendoscopy’ in twenty two pwPD. They wished to differentiate 
between pwPD (n=22) and patients with atypical Parkinsonism (n=7) 
(progressive supra-nuclear palsy; multiple systems atrophy), on the basis of the 
location of laryngeal tremor. They identified ‘vertical laryngeal tremor’ as being 
the prominent feature in the PD group versus tremor in the arytenoids in the 
atypical Parkinsonism group. The authors did not define what they meant by the 
term ‘vertical laryngeal tremor’. It is understood by this author to refer to ‘global 
laryngeal tremor’ described by Bove et al.,200 as ‘motion in the vertical 
dimension of the larynx, as a unit, relative to the surrounding upper 
aerodigestive tract’.  It is possible that the terms ‘vertical laryngeal tremor’ 107, 
‘tremor in the strap muscles’ 34, and ‘global laryngeal tremor’ 200 are describing  
the same phenomenon. Clearly, greater clarity is required regarding the location 
of tremor sites to improve classification of PD voice tremor. Consistency in 
terminology and explanation of terms would be helpful. The focus of Perez  et 
al’s.,107 study was laryngeal tremor. Thus, no information is available regarding 
other possible sources of voice tremor in the vocal tract, for example the  
tongue216 or the soft palate.There was no control group in the study therefore it 
is not possible to say if their findings are pertinent only to the PD population. 
Finally, since the medication status is not reported in the study, the possible 
relationship between medication effects (section 2.5.3), and tremor findings 
cannot be discussed. 
Other important aspects of characterising PD voice tremor include making 
explicit the condition/s under which the tremor was identified and the type of 
rating scale used. The following questions require answers: was the presence 
and/or the severity of tremor documented; what type of measurement scale was 
used (ordinal scale versus continuous scale); were the raters blinded to the 
diagnosis; did the raters hear the voice when they were rating the tremor 
visually; what was the reliability data.  
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The few studies that have described vocal tract tremor in pwPD have rated the 
presence and not the severity of tremor and have not reported reliability 
results107 216. Greater sensitivity in rating methods through the use of scales 
documenting the severity of tremor, together with information on rater reliability 
is important towards the identification and characterisation of PD voice tremor. 
Based on studies to date therefore, it appears that for some pwPD, possible 
sources of tremor are the ‘larynx’, the arytenoid cartilages, and the tongue. 
Tremor may be observed as ‘vertical movement of the larynx’. The 
documentation of tongue tremor in addition to ‘laryngeal’ tremor, suggests that 
PD voice tremor is a wider vocal tract phenomenon rather than a laryngeal one. 
Therefore it is argued by this researcher that tremor in pwPD is not confined to 
the vocal cords and ‘vocal tract tremor’ is thus an appropriate term to use in this 
study.  
Interestingly, there are no reports in the PD studies to date of tremor findings in 
the velopharynx or soft palate, in contrast to reported finding of palatal tremor in 
ETV, on a sustained /i/ vowel task193. Hypernasality (excessive air coming 
through the nasal cavity) during speech has been identified in the PD dysarthria 
profile 217. It is conceivable that tremor in the velopharynx may contribute to 
hypernasality due to the difficulty sustaining velopharyngeal closure. A notable 
omission is that no study to date has set out to determine if palatal tremor is a 
feature of PD. Therefore an important question pertains to whether palatal 
tremor is a feature of PD and the conditions under which it can be elicited. A 
further question relates to the amount of tremor evident in structures in the 
vocal tract and the way in which raters agree or disagree on rating tremor 
severity.  
‘Activating conditions’ or speech ‘tasks’  
An important aspect of limb tremor classification is differentiating between ‘rest 
tremor’ and ‘action tremor’ (section 2.2). It is noted from a review of the studies 
that there is a lack of clarity around the specific tasks that were associated with 
the identification of laryngeal and tongue tremor in pwPD. For example, in 
relation to Hanson et al’s.,216 study, information is not provided on the specific 
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non-phonatory/phonatory tasks that gave rise to tremor in the ‘strap muscles’, 
and the tongue.   
Drawing from the classification approach used in limb tremor, Perez et al.,107 
reported the presence of  ‘resting tremor’ and ‘kinetic’ (phonation) tremor in their 
study group. The authors107 did not define the term ‘resting tremor’, but it is 
understood by this author to relate to tremor behaviour identified during ‘quiet 
breathing’. The term ‘rest breathing’ will be used in this study to describe the 
vocal cords opening (abducting) and approximating (adducting) when a person 
is not phonating (vocal cords not involved in vibratory movement). 
Important questions therefore remain unanswered in relation to the presence 
and severity of tremor in the vocal tract of pwPD, and the relationship with 
perceived voice tremor including: the likely source or sources of voice tremor; 
the activating conditions or tasks that elicit tremor in the vocal tract. Therefore to 
identify possible sources of PD voice tremor, it is important to examine 
laryngeal and extra-laryngeal sites, including the soft palate, the tongue, 
larynx/pharynx and vocal cords using nasendoscopy. To assist in the 
characterisation of voice tremor, it is important to evaluate tremor using non-
phonatory and phonatory tasks. The following tasks should be included: rest 
breathing; sustained voiceless /s/; sustained /a/ and /i/ vowels. This author 
considers the sustained /s/ task to be an appropriate vocal tract ‘postural’ task 
in that during /s/ production the tongue is held against the teeth or gingival 
(gums), the soft palate is held in an elevated position and the vocal cords are 
held in an open albeit approximated (between fully closed and fully opened) 
position. The sustained vowel tasks (/a/, /i/) may be considered an appropriate 
vocal tract ‘kinetic’ task since the vocal cords are involved in sustained vibratory 
movement. The reason for including an /i/ vowel in addition to an /a/ vowel 
(considered the easiest for perceiving tremor), is because /i/ facilitates elevation 
of the larynx through the action of an elevated tongue position. This 
physiological adjustment in the vocal tract affords a view of the vocal cords and 
surrounding structures. Therefore, in pursuit of the goal of characterising PD 
voice tremor, the researcher considers it important to include non-phonatory 
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[(rest breathing, sustained /s/] tasks, in addition to phonatory tasks (sustained 
/a/, /i/) during vocal tract examination in this study.  
The core aspects of voice tremor are: perceptually salient rhythmic or quasi-
rhythmic modulations in the voice, involuntary oscillatory movement of muscles 
in the vocal tract; and fluctuations in the frequency and amplitude of the voice 
(section 4.1). Reviewing these defining tremor features highlights that multi-
dimensional evaluation incorporating auditory perceptual, visual perceptual and 
acoustic evaluation is required to identify and fully characterise the complexities 
of PD voice tremor. The next sub-section 4.5.4 reviews the small number of 
studies that have alluded to relationships between different tremor measures. 
4.5.4. Relationship between different tremor measures 
Considering ways in which auditory perceptual, visual perceptual and acoustic 
evaluation measures relate to each other improves understanding of the effect 
of involuntary oscillatory movement on the acoustic voice signal and the 
perceived voice quality. Further, exploring the relationship between acoustic 
tremor measures for example and perceived tremor demonstrates the clinical 
relevance or utility of the acoustic measure. However the way in which the 
different tremor measures relate to each other has not been seriously 
addressed in the PD literature. Extending the review to include non-PD voice 
tremor, Ludlow et al.,183 in their study of nine patients with ETV, reported that 
acoustic measures of frequency and amplitude tremor related to ‘fiberoptically’ 
observable vocal fold tremor.  However, information was not provided in relation 
to the speech task or the rating procedures used in the nasendoscopic 
examination to identify ‘vocal fold tremor’. Further they did not report the results 
of any correlational analyses between acoustic and visual-perceptual ratings. 
Therefore a further question that needs to be addressed in this PD voice tremor 
study pertains to the way in which different tremor measures relate to each 
other. 
This review now moves away from the specifics of PD voice tremor to a broader 
view looking at PD voice tremor in the context of speech and voice 
symptomatology (section 4.7) and disease variables (section 4.8).  
68 
 
4.6. Voice tremor and PD speech-voice variables  
This section places voice tremor in the context of other PD speech and voice 
variables that have been reported in the literature. In addition to voice tremor, 
changes in voice quality, voice disability and speech intelligibility have all been 
described in the context of PD However, little attention has been given to the 
way in which voice tremor might or might not relate to these variables.  
Dysphonia-related parameters  
Voice changes are inextricably linked with the PD speech-voice symptom 
complex (section 2.3). Although perceived ‘breathiness’ and ‘roughness’ are 
frequently reported in the PD literature there are no reported studies in which 
voice tremor has been explored in the context of the overall severity of 
dysphonia. A step in this direction is to measure the severity of dysphonia in 
addition to measuring tremor in a group of pwPD.  
Speech Intelligibility 
Speech intelligibility is a measure of communication efficiency 218, which reflects 
the level of functioning of the numerous sub-systems, including verbal and non-
verbal aspects. A more balanced view of speech intelligibility is to be gained 
from consideration of dimensions other than articulation,  considered to be a 
dominant factor in reduced intelligibility 219. 
 PwPD have been shown to have reduced intelligibility of speech in a number of 
studies 77 102. Although sound imprecision and monopitch 103 have been found to 
be contributory factors to reduced intelligibility in pwPD, it is probable that other 
speech and voice systems are also involved. It is conceivable that voice tremor 
may impact negatively on speech intelligibility through its disruption of 
phonatory and articulatory configurations in the vocal tract. However, the 
relationship between PD voice tremor and speech intelligibility is unknown, 
since studies have not specifically addressed this question. D’Alatri et al.,210 in a 
treatment study using DBS, stated that improvement in acoustic measures of 
tremor and glottal vibration was not associated with an improvement in 
intelligibility. It is not possible to draw firm conclusions from one study. Further, 
the authors based their intelligibility findings on item 18 from the UPDRS motor 
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section55, which is a global measure of speech and voice function rather than an 
intelligibility scale. Therefore the issue of the effect of voice tremor on 
intelligibility rating is open to further exploration in this study. 
Voice disability  
The impact of voice-related problems on self-perceived voice handicap in pwPD 
was previously discussed in section 2.4.4. It is important to identify the 
phonatory features that are contributing to voice disability, so that they can be 
prioritised for treatment. Two studies which reported on greater voice disability 
in pwPD than in controls, reported the presence of ‘laryngeal tremor’ 131 113. 
However, neither study addressed the relationship between laryngeal tremor 
and voice disability.  
Exploring the way in which voice tremor relates to other speech-voice variables 
helps to improve the understanding of the pathophysiology of voice tremor, 
assists in targeting specific areas for rehabilitation in an effort to improve 
intelligibility and ultimately communication. Therefore, consistent with the overall 
aim of this work to increase understanding of PD voice tremor, voice tremor 
features will be analysed in the context of overall severity of dysphonia, speech 
intelligibility, and voice disability.   
4.7 Voice tremor and disease specific variables  
This section presents a review of the studies that have reported in relation to 
voice tremor and disease specific variables.  
Hanson et al.,216 in their study of thirty two male pwPD stated that visually 
perceived tremor of the vocal tract, using rigid laryngoscopy correlated with 
‘general neurological symptoms’. However they did not describe the 
‘neurological symptoms’ or clarify the nature of the relationship between 
neurological symptoms and vocal tract tremor. Two studies, both using 
laryngeal examination, related voice tremor to greater disease severity135 113. 
Gamboa et al.,135 reported that the presence of laryngeal tremor was 
significantly more frequent in the PD patients with a higher score on the total 
UPDRS i.e. greater disease severity. They identified tremor in 60% (6/10) of 
patients with total UPDRS scores greater than 24.3, which was the mean score 
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for the group. Tremor was not identified in any of the patients with scores less 
than 24.3. However, there were methodological variations across patients in 
relation to the equipment used to examine the larynx, with an indirect laryngeal 
examination used for some patients and nasendoscopy with others. It is 
possible that mild or subtle laryngeal tremor was not visually perceptible in 
patients with milder disease severity. Using acoustic tremor measures in 
addition to or in lieu of vocal tract examination may have helped to identify voice 
tremor in these patients with mild PD symptoms. Finally, the ratings were 
carried out by the same person who carried out the examination, resulting in 
rater bias. Blumin et al., 113 reported the presence of tremulous movement of 
the laryngopharynx in 53% (n=8) of a group of fifteen patients with advanced 
PD (stage III) identified using  the Hoehn & Yahr Scale 59. However the authors 
did not include a comparison group with milder disease severity, therefore the 
relationship between laryngeal tremor and disease severity is inconclusive 
based on the study findings. 
Two  further studies have linked voice tremor with ‘early stage’, and with ‘early’ 
and ‘later stage’ or more severe PD symptomatology, using acoustic88 and 
perceptual measures220. Stewart et al.,88 identified ‘vocal tremor’, using narrow 
band spectrogram in four out of twelve ‘early stage’ PD patients. The group had 
average disease duration of 3.2 years, and a mild disease severity with a mean 
score of 1.2 on the H & Y scale. Holmes et al.,220 examined voice 
characteristics using eleven auditory perceptual measures and a range of 
acoustic measures in thirty ‘early’ stage and thirty ‘later’ stage (severe disease) 
PwPD and compared data with thirty normal control subjects. They used a 
combination of the Webster motor disability scale, disease duration, and 
presence/absence of motor fluctuations to classify patients into early or later 
stages of PD. They reported that perceived ‘vocal tremor’, rated in a monologue 
task was only associated with later stage disease and was not apparent in 
patients with early stage PD. The authors considered therefore that vocal 
tremor was related to advanced stage PD only. Based on the findings from 
these studies, it is difficult to draw strong conclusions regarding a definite 
relationship between voice tremor, disease duration, and disease severity.  
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PD phenotypes 
The relationship between voice tremor and PD phenotype (sub-type) is 
unknown (section 1.6.3). In fact, there is little evidence in the PD clinical 
research literature of pwPD being classified into tremor-dominant or postural 
instability gait disorder (PIGD) phenotypes65.  
A logical conclusion would be that voice tremor is more likely to be associated 
with tremor dominant PD, rather than PIGD phenotype. However, dysarthria in 
PD has been linked to the PIGD phenotype68 70. Studies that have linked 
dysarthria to PIGD have based the dysarthria diagnosis and severity rating on 
item 18 from the UPDRS section III, which is non-specific regarding the nature 
of the dysarthria symptomatology55. The tenuous link between dysarthria and 
PIGD phenotype appears to be based on the findings of a limited effect of 
dopaminergic medication on speech symptoms, rather than any relevant 
research on the topic.  
Exploration of the relationship between voice tremor and phenotype may 
increase understanding of the pathophysiology of PD voice tremor. For 
example, if voice tremor was considered to be related to tremor dominant PD, 
this would suggest a more benign disease course than if voice tremor was 
associated with PIGD phenotype (section 1.6.3). 
From a review of studies carried out to date, it is not possible to determine how 
voice tremor fits into the overall disease profile. Further exploration of voice 
tremor in the context of disease duration and disease severity and PD 
phenotype is warranted, and could potentially contribute to the important 
discussion on the relationship between speech-motor and limb motor 
symptoms.   
In summary of chapter 4 
• Instability of the voice is a feature of normal voice however the 
oscillations in the vocal tract muscles are so small that they are not 
perceived visually or auditorily. 
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• In neurological disease, involuntary oscillatory movements may result in 
frequency and amplitude tremor with perceptually prominent voice 
tremor.  
• A range of evaluation methods including auditory perceptual, visual 
perceptual (vocal tract examination) and acoustic are available for the 
measurement of voice tremor. 
• In PD, there is lack of clarity surrounding the presence and 
characteristics of voice tremor, and how pwPD differ from neurologically 
healthy age-sex matched controls. 
• The varied voice tremor descriptors used in PD studies emanate from 
generic rather than tremor specific studies, contributing to the overall 
confusion. 
• A tremor specific study, using a sustained vowel task, nasendoscopic 
examination of the vocal tract and long-term phonatory instability 
measures is necessary to document and characterise voice tremor in 
PD. 
• The important relationship between PD voice tremor and (a) speech and 
voice variables and (b) disease specific variables has not been properly 
addressed previously in the literature.  
Research Questions  
It is clear from this literature review that there is a lack of clarity about voice 
tremor in PD on a number of fronts. From this researcher’s perspective, there 
are three fundamental issues which need addressing in order to move towards 
the identification and characterisation of PD voice tremor; determining if voice 
tremor is a feature of PD; using a multi-dimensional approach to measurement; 
understanding where PD voice tremor fits into the greater scheme of the 
speech-voice disorder and the overall disease process. These issues may be 
addressed in the following research questions.  
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1. Is there a difference between pwPD and neurologically healthy age-
sex matched controls in relation to voice tremor, when voice tremor is 
measured using (a) acoustic tremor measures (b) auditory perceived 
tremor and (c) visually perceived tremor in the vocal tract? If there is 
a difference between pwPD and healthy controls, is the difference 
statistically significant? 
2. What is the nature and degree of the relationship between acoustic 
voice tremor measures and perceptual measures, and visual 
perceptual measures in pwPD? 
3. What is the nature and the degree of the relationship between 
acoustic voice tremor measures and (a) severity of dysphonia (b) 
voice disability (c) speech intelligibility?  
4. What is the nature and degree of the relationship between acoustic 
voice tremor measures and disease variables: (a) disease duration 
(b) disability (c) motor symptom severity (d) phenotype? 
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Aims of Study 
Given the above questions, the aims of my study are as follows: 
 
1.  To determine if voice tremor is a feature of PD in comparison to a 
group of age and sex matched neurologically healthy controls and if 
the difference is statistically significant, using a multi-dimensional 
approach of (a) acoustic evaluation (b) auditory perceptual (c) visual 
perceptual evaluation. 
2. To evaluate the relationship between acoustic voice tremor, auditory 
perceptual and, visual perceptual tremor measures.  
3. To examine acoustic voice tremor in the context of other voice and 
speech variables for analysis of relationships with: (a) dysphonia 
severity (b) self-reported voice disability (c) speech intelligibility. 
4. To identify a relationship if any between acoustic voice tremor 
measures and PD disease measures: (a) disease duration (b) 
activities of daily living (disability) (c) motor symptoms (d) PD 
phenotype. 
Methods of tremor evaluation 
The adoption of a multi-dimensional approach poses a challenge when 
examining relationships between voice tremor measures and other variables 
(research questions 2, 3 and 4). This author considered it prudent to select 
acoustic measures over perceptual measures as the key tremor measure when 
examining voice tremor relationships. This is not to say that acoustic measures 
are the gold standard for measuring voice tremor. The main reason for selecting 
acoustic measures as the lead measure is to minimise issues that arise from 
reliability rating of voice tremor. 
Chapter 5 covers the methodology designed to address the main research 
questions. 
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Chapter 5. Methods 
5.1 Ethical approval and consent 
Ethical approval for the study was granted by the Ethics committee of the Mater 
Misericordiae University Hospital (MMUH) on the 19th May 2009. Written 
informed consent was obtained from all participants prior to taking part in the 
study. There were two main ethical-related issues which required consideration 
by the researcher in conducting the study. (a) Asking pwPD to refrain from 
taking their dopaminergic medication on the morning of testing, in addition to 
fasting for food and liquids excepting water. (b) For pwPD and controls, carrying 
out the vocal tract examination which is an ‘invasive’ procedure. The way in 
which these issues were addressed is outlined in section 5.6. 
 
5.2 Participants 
Two groups were recruited for the study: a group comprised patients with 
idiopathic Parkinson’s disease (PD) termed the ‘PD group’; a group comprised 
neurologically healthy controls called the ‘control group’.  
PD group 
In order to be eligible for inclusion in the study, every patient had to have a 
diagnosis of PD made by a consultant neurologist specialist in PD, based on the 
UK Brain Bank criteria55. The presence of a speech and/or voice disorder, or 
voice tremor as rated by a clinician or as self-rated by a patient was not an 
inclusion criteria for entry into the study.  The rationale for this decision was 
based on the fact that the primary aim of the study was to determine if voice 
tremor is a feature of PD and to determine ways in which it should be 
measured. Setting down strict inclusion criteria at the outset in relation to 
speech and voice symptomatology would have biased the study towards pwPD 
with more severe symptomatology. As a result, patients with subtle or very mild 
perceptual changes in voice and/or voice tremor would have being excluded 
from the study. In addition, the researcher hypothesised that acoustic tremor 
measures might identify tremor features in pwPD, before tremor was 
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perceptually salient and thus wanted to ensure that pwPD were not excluded 
from the study because of difficulties identifying tremor using auditory 
perceptual methods.  
The researcher identified potential participants for the PD group, during their 
scheduled appointment at the neurology out-patient Movement Disorder Clinic, 
a specialised clinic held three times per month at the Dublin Neurological 
Institute, Mater Misericordiae University Hospital, in Dublin. Patients with a 
documented diagnosis of PD were ‘screened’ for eligibility to take part in the 
study. The following exclusion criteria were applied for entry into the study. 
Exclusion criteria 
Patients were excluded from the study if they:  
• Reported a diagnosis of a concomitant neurological disease 
• Had a dementia [identified in this study as a score of 23 or less on the 
Mini-Mental State Examination (MMSE)] 221  
• Had received a diagnosis from, or were under the care of a 
psychiatrist/pschologist for a psychological disorder 
• Were taking any medication that is known to cause tremor, including 
lithium, anticonvulsant medication, immune-suppressants, or 
bronchodilators 
• Were currently a ‘smoker’ or were an ex-smoker for less than five 
years (Smoking is a known cause of laryngeal and voice-related 
dysfunction) 
• Had a history of cancer of the head and neck region, including 
laryngeal cancer 
• Had a history of speech or voice problems unrelated to and prior to 
the onset of PD, and/or reported receiving speech/voice treatment or 
received Lee Silverman Voice Treatment (LSVT) for PD in the 
previous two years. The effect of speech and/or voice treatment on 
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voice tremor is unknown. Therefore it was important to control for the 
confounding effects of speech/voice treatment on tremor features, so 
that tremor findings could be related to the disease process and not 
treatment effects 
• Reported inadequate hearing (defined as being unable to hear 
conversational speech comfortably), and/or wore hearing aids. The 
researcher wished to ensure that any speech and voice problems 
identified were related to PD only and not hearing deficits  
• Were not agreeable to postponing their dopaminergic medication for 
twelve hours in advance of study testing, and to fasting for food and 
liquids (excepting water) on the morning that testing was taking place 
[(termed ‘off-medication’ state) (5.3)]  
• Reported any significant dyskinesias. The reason for this exclusion 
was that one of the tests involved a fiberoptic nasendoscopic 
examination which is contraindicated in patients who have excessive 
extraneous/involuntary movements (dyskinesias) 
• Were not a native English speaker. Difficulty in comprehending and/or 
producing the english language would affect  the participants ability to 
follow instructions and pronounce sounds/words, and therefore  
confound the results 
 
Control group 
A healthy neurological age-and-sex matched group i.e., without PD and other 
neurological disease was recruited as the ‘control’ group. In order to be eligible 
to enter the control group, the participants had to be without PD. Otherwise, the 
same inclusion and exclusion criteria that applied to the PD group applied to the 
control group. Participants for the control group were recruited by inviting family 
members of PD participants, staff at the hospital, and parents of colleagues to 
get involved in the study.  
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5.3 Screening procedure  
PD group 
Potential participants for the PD group were ‘screened’ for the purpose of 
evaluating their eligibility for the study. The researcher attended the out-patient 
movement disorder clinic over a period of fourteen months, and reviewed the 
charts of attending patients to identify the patients with a PD diagnosis. If the 
diagnosis was unclear from the chart, the opinion of the consultant neurologist 
was sought to confirm the diagnosis. Once the PD diagnosis was confirmed, 
patients were invited to take part in a screening evaluation, which took 
approximately ten minutes to complete. The screening form outlined in 
APPENDIX E was applied to all potential participants. They were interviewed 
using standard questions in a questionnaire format, which covered all the areas 
outlined under exclusion criteria in section 5.2.  If a pwPD satisfied the 
inclusion/exclusion criteria, the Mini-Mental State Examination (MMSE) 221 was 
then administered by the researcher to out-rule cognitive impairment. 
Cognisance was not given to whether patients were ‘on-medication’ or ‘off-
medication’, during the screening of cognition. 
 
Control group 
Potential participants for the control group were recruited by: inviting relatives of 
pwPD to take part; asking staff at the hospital to get involved if age and gender 
appropriate, and/or to seek out appropriate family members. Control 
participants were screened using the same protocol that was used with the PD 
group (APPENDIX E). None of the control participants recruited for the study 
were involved in voice therapy, or in voice and/or singing training at the time of 
recruitment. 
Participant expenses 
Participants were not paid for taking part in the study. However, every effort was 
made to reimburse participants from both groups who incurred expenses due to 
travelling to the hospital, or through parking charges. A book token in the 
amount of €20.00 was offered to the participants in the control group. 
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Participant expenses were covered by a research grant from the Mater Hospital 
post-graduate college. 
5.4 General procedures 
PwPD on a dopaminergic medication regime were tested in a practically defined 
“off” medication state, i.e., after a 12-hour overnight withdrawal of anti-
parkinsonian medication72.They had been instructed not to take dopaminergic 
medication after 8pm the evening prior to the scheduled assessment date, and 
not to eat or drink excepting water during that time. They were evaluated in the 
morning between 08.00am and 10.00am. This advice was similar to other 
studies that tested patients in an off-medication state22 77. The rationale for 
testing patients ‘off-medication’ was outlined in section 2.5.3. 
All assessments for PD and control participants were carried out in a single visit 
to the Speech and Language Therapy (SLT) department of the Mater Hospital. 
It took approximately eighty minutes to carry out the battery of assessments for 
each participant in the PD group. For the control group, testing duration was 
shorter because an evaluation of PD symptoms  was not required. All 
participants were given a glass of water during the testing period.  
The speech and voice recordings were carried out in a sound-treated audiology 
room,  with ambient noise levels measured at 50 dB sound pressure level 
(SPL). The remainder of the assessments were carried out in the adjacent 
researcher’s clinical office. In relation to the ordering of tasks, the researcher 
decided that the nasendoscopic exam should follow the audio recordings, and 
in the case of the PD group, the Activities of Daily Living and motor symptom 
exam, to reduce participant anxiety relating to the nasendoscopic examination. 
The same protocol and order of testing was carried out for the study and control 
group participants.The only exception was that the UPDRS was not 
administered to the control group. The flow chart outlines the assessments used 
in the study and the order in which they were carried out (Figure 5.1). 
  
 Figure 5.1. Flow chart showing order of assessment
 
 
Audio Recordings
Acoustic recordings
Unified Parkinson's 
Disease Rating 
Scale (UPDRS)
Head and Jaw 
tremor evaluation
Flexible 
Nasendoscopic 
Vocal Tract 
Examination (VTE)
Hospital Anxiety & 
Depression Scale 
(HADS)
Voice Handicap 
Index (VHI)
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s 
• Voice quality rating (Consensus 
Auditory Perceptual Evaluation of Voice 
(CAPE-V)
• Speech Intelligibility Test (SIT)
• Voice and tremor protocol from Motor 
Speech Profile (MSP) of the CSL
• UPDRS II:  patient-report Activities of 
Daily Living (ADL)
• UPDS III: Motor symptoms
• Document the presence of tremor in 
the head and jaw
• Examination of structures: soft palate,  
tongue base, pharynx, larynx for 
subsequent severity rating of tremor in 
vocal tract structures
• Evaluate anxiety and depression
• Evaluate nature and level of disability 
related to voice symptoms
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5.5 Assessments 
Section 5.5 describes the assessments employed to acquire the data for the 
study, section 5.6 addresses problem solving related to ethical issues. 
Management of data and preparation for analyses is covered in section 5.7, 
rating procedures in section 5.8 and finally, section 5.9 describes the data 
analyses.   
5.5.1 Auditory perceptual evaluation 
Firstly, the audio recording set up is described, followed by a description and 
rationale for using (a) the Consensus Auditory Perceptual Evaluation of Voice 
(CAPE-V)100 and (b) the Speech Intelligibility Test (SIT) 222. 
Audio-recording set-up 
A Sony digital mini-disc coupled with an AKG 520 headset microphone was 
used to obtain the recordings. The microphone was positioned at the side of the 
mouth, approximately 5 cm and at the same level as the oral angle. All 
recordings were carried out with the participants seated. Volume of speech was 
not measured in this study. However every effort was made to optimise the 
signal capture by setting the recording gain on the mini-disc. The following 
procedure was followed in advance of the recording.   
• The microphone was placed on the participant’s head 
• While listening on a head set, the researcher put the mini-disc into 
‘record’ mode 
• The microphone position was adjusted, so that there were no 
microphone popping sounds when the participant produced /puh/ and 
/buh/ sounds 
• The record gain was set so that the average level was in the upper half 
of the recording meter and that the loudest speech was at least one bar 
below the maximum position of the meter.  
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(a) Consensus Auditory Perceptual Evaluation of Voice (CAPE-V) 
The researcher selected  the CAPE-V100 for perceptual rating of voice 
quality,considering it to have advantages over the GRBAS for the purpose of 
the current study.  The strengths of the CAPE-V are: the inclusion of different 
speech tasks, i.e sustained vowels and sentences; the option of including 
additional perceptual parameters in addition to the standard roughness, 
breathiness, strain features; detailed guidelines for the administration and 
scoring of the instrument.  In addition, the CAPE-V100 uses  interval scale 
measures by incorporating millimeter measures on a visual  analogue scale 
(VAS), which has been shown to a more sensitive method of voice analysis 
than an ordinal scale223. The CAPE-V protocol was followed as outlined by the 
authors in their published work100, and is outlined in APPENDIX F. The rating 
procedures followed for the CAPE-V are outlined in a later separate section 
5.8.1.  
Auditory perceptual parameters  
Tremor features and overall severity of dysphonia specifically, were the auditory 
perceptual parameters of interest in this study. The researcher wished to 
determine if there were features of tremor and/or instability  in the voice of 
pwPD. Tremor was defined as rhythmic or nearly rhythmic fluctuations in pitch 
and/or loudness of the voice. Instability or unsteadiness was defined as 
irregular fluctuations in pitch and/or loudness. Perceptual descriptions of voice 
features in pwPD include tremor and unsteadiness (section 4.4). Since, it is 
unclear from the literature if different phenomena are encapsulated by the 
descriptors tremor and instability, this researcher decided to include both 
paramers for perceptual rating. The researcher was cognisant of the fact that 
asking raters to differentiate between two conceptually similar features,i.e. 
tremor and instability was challenging and potentially confusing, with the 
potential to affect the ratings applied to both features. However, notwithstanding 
these issues, she felt that it was important to include both parameters for 
reasons highlighted above. Tremor and instability were therefore additional 
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auditory perceptual parameters included on the CAPE-V form for rating 
(APPENDIX K). 
The parameter ‘overall severity’ from CAPE-V100, defined as ‘a global integrated 
impression of voice deviance’  was maintained in this study for the purpose of 
quantifying the extent or overall severity of voice deviance in pwPD. The 
parameters roughness and breathiness from the CAPE-V rating protocol were 
also maintained for this study (APPENDIX K). 
  (b) The Speech Intelligibility Test (SIT) 
The SIT 222 is a computerised windows application for evaluating speech 
intelligibility, and is similar to the sentence portion of the Assessment of 
Intelligibility of Dysarthria Speech (AIDS)224. The SIT generates eleven 
sentences at random from the computer programme. The random generation of 
the sentences coupled with the computer scoring of the transcribed sentences 
was considered an advantage over the AIDS, for this study. In the SIT, the 
sentences may be presented to the speaker directly from the computer or the 
examiner may print the eleven sentences and the participant reads aloud the 
text. In this study, the latter option was chosen.  
In the sound-treated room, the participants read aloud eleven sentences which 
had been generated a priori by the examiner from the SIT. As per the SIT 
protocol, the examiner read aloud a sentence with the participant following the 
text. This was followed by the participant reading the sentence. The researcher 
and the participants sentence reading was recorded onto the Sony mini- disc 
recorder. A new tape was inserted for each participant and labelled with 
patient’s ID number. The rating procedures for the SIT are outlined in section 
5.8.2. 
  
5.5.2 Acoustic recordings 
The recordings for the acoustic analysis were carried out in the sound treated 
audiology room, immediately following the audio recordings for the CAPE-V and 
SIT. The Voice and Tremor Protocol (VTP) from the Motor Speech Profile 
Advanced (MSP Advanced), which is a module of the Computerised Speech 
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Laboratory (CSL), Model 5141 from Kay Pentax (Lincoln Park, NJ), was used 
for the analysis.  The VTP was specifically developed to analyse voice problems 
associated with cycle-to-cycle variations and to assess tremor characteristics 
commonly associated with motor speech disorders119. The built-in protocols are 
designed to perform the procedures necessary to acquire the speech signals, 
analyse the signals and present numerical and graphical results for screen 
display and for printed reports119. The VTP yields a range of nine to thirteen 
voice and tremor related parameters, based on a sustained /a/ vowel task. 
 Recording set up; practice and test trials 
The participants were seated beside the computer desk and the CSL. An AKG-
C420 head-mounted microphone connected to the CSL was placed on the 
participant’s head and placed 10 cms from the angle of the mouth. The authors 
of the MSP recommend a microphone distance of 10-15 cms119.  In the VTP, a 
sustained /a/ vowel of 4.5 second duration is recorded directly on to the CSL, at 
a sampling rate of 50,000 Hz.  
The VTP in CSL provides an example of a sustained /a/ vowel audio signal from 
a male voice (5 second duration), records the input from the participant, and 
analyses the data. Firstly, the participants were asked to listen to the registered 
voice from CSL, and then repeat the task. However, they were advised that they 
should not strive to imitate the male voice recording, but rather to produce their 
own natural voice. A range of one to three training trials was carried out by each 
participant, prior to the test trials.  The reason for the practice trials was to 
ensure that the participant understood the task and that any technical problems 
that might arise could be rectified in advance of the test trials. For example, the 
input level was lowered if the red section of the VU meter lit up, since this 
signified that the input signal was overloaded. For the test, each participant 
sustained the vowel /a/ three times and each recording was saved to the Kay 
data file for later analysis (Figure 5.2). 
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Figure 5.2. Volunteer wearing AKG head set microphone and recording 
sustained /a/ directly onto the Voice and Tremor Protocol of the CSL 
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5.5.3 Parkinson’s disease symptoms 
For the PD group only, the symptoms pertaining to Parkinson’s disease were 
evaluated with the Unified Parkinson’s Disease Rating Scale (UPDRS). Two 
sections of the UPDRS were used: the patient-derived questionnaire of 
Activities of Daily Living (ADL, part II) (APPENDIX A) and the clinician-derived 
test of motor function (UPDRS-motor, part III) (APPENDIX B).  The UPDRS II 
and UPDRS III contain thirteen and fourteen items respectively, with a range of 
possible scores from 0 to 52 for UPDRS II and from 0 to108 for UPDRS III. 
Some items have two components for example upper and lower limb tremor are 
both rated under tremor component. The assigned scores range from 0 (absent 
behaviour) to 4 (severe behaviour) with each item recorded in rank order (mild, 
moderate, severe), but without uniform intervals. For example a tremor score of 
4 is not twice as bad as 2.  
It was not possible to have a neurologist or a doctor with experience in using 
the UPDRS involved in the administration and/or rating of the UPDRS items. 
The researcher administered and rated UPDRS II and UPDRS III, having 
received training through observation of a specialist neurologist conducting the 
exam, and through following the MDS training video225 .The researcher used 
the UPDRS data collection form used by the doctors in the Movement Disorder 
Clinic, for rating and recording the scores from the different items. A speech and 
language therapy (SLT) assistant was present for the motor examination. This 
was especially important for the postural instability task, which required the 
researcher to pull the pwPD backwards and catch the person if he or she was 
going to fall.  
5.5.4 Head and jaw tremor clinical evaluation 
A clinical rating of the presence/absence of head and jaw tremor was carried 
out in pwPD and controls, immediately prior to the nasendoscopic vocal tract 
examination (VTE). Tremor was defined as ‘any observable involuntary 
tremulous movement of a structure’.   The researcher carried out the rating with 
the participant seated upright. The participant was instructed to look straight 
ahead and not to speak. The head and then the jaw were observed for signs of 
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tremor, for a period of 5 seconds approximately. Any observable movement of 
the head in any direction (up and down; left to right) considered to be 
involuntary and abnormal was documented as tremor present. The jaw was 
evaluated with the mouth closed for five seconds, and then with the mouth open 
for five seconds. Both postures were used since the jaw opens and closes 
during speaking. Following the rating of head and jaw tremor, the participants 
were asked to sustain the voiceless sound /s/ and the vowels /a/ and /i/. This 
gave the researcher the opportunity to trial the speech tasks with the 
participants in advance of the nasendoscopic VTE examination.  
5.5.5 Nasendoscopic Vocal Tract Examination (VTE) 
One of the primary aims of this study is to characterise vocal tract tremor in PD. 
Nasendoscopy was the examination tool used to evaluate tremor behaviour in 
anatomical structures in the vocal tract. The advantages of nasendoscopy over 
rigid laryngoscopy for the purpose of this study were detailed in section 2.4.2. 
Exam set up 
The researcher, trained and highly experienced in the use of nasendoscopy for 
voice and swallowing evaluation, carried out the VTE. An SLT assistant was 
present during all examinations to assist with recording and supporting the 
participants. 
The examination set up was as follows: both examiner and participant were 
seated; the participant faced the examiner; the stack holding the computer, 
monitor, and camera processor was behind the participant. Therefore the 
participants were unable to view the monitor during the examination. However 
the researcher offered all participants the opportunity to view the video 
recording of the nasendoscopy exam after all the tests were completed. In 
advance of the examination, the researcher inquired regarding history of nose 
bleeds and previous injury to the nose. The current or recent use of anti-
coagulants was noted. Neither a topical anaesthesia nor a vasoconstrictor was 
used for the exam however a surgical lubricant ‘surgilube’ was applied to the 
distal end of the endoscope to assist passage through the nasal cavity. To 
ascertain the side of the nose that was likely to be most comfortable, the 
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participant was instructed to sniff whilst closing off one nostril and then the other 
nostril.  
Equipment 
A flexible video endoscope, Olympus ENF type V2 with an external diameter of 
3.2mm diameter and an Olympus constant xenon light bulb was used for all the 
examinations for pwPD and controls (Figure 5.3).The camera system was 
coupled to a digital archiving system which permitted the researcher to view the 
exam on the monitor, and enabled video and audio recording of the exams onto 
the computer hard drive (Figure 5.4). 
 
 
 
 
 
 
 
 
  
Figure 5.3. Videoendoscope used 
in vocal tract examination 
Figure 5.4. Camera control unit, 
monitor and digital archiving 
system 
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Exam protocol 
The same protocol for passing the scope and for eliciting the different tasks was 
followed for the PD and controls participants. For the purpose of this study, the 
researcher applied a modified version of the ‘Vocal Tremor Scoring System 
(VTSS) 200 protocol. The VTSS was developed by Bove et al.,200 specifically for 
the purpose of identifying  anatomical sources of tremor in essential tremor of 
the voice. The protocol 200 involves the evaluation of tremor at six anatomical 
sites: palate; base of tongue; pharyngeal walls; larynx (global); supraglottis; and 
true vocal cords, using the sustained /i/ vowel for all sites excluding base of 
tongue which is evaluated with sustained tongue protrusion.   
For this study, the VTSS protocol was modified in relation to the anatomical 
sites and the activating tasks used to identify tremor (APPENDIX G). For 
example, tremor was not specifically evaluated in the pharyngeal walls like in 
the VTSS. Further, tremor was evaluated using additional tasks to that used in 
the VTSS protocol 200, including ‘rest breathing’, sustained /s/ voiceless sound, 
and sustained /a/ vowel [(International Phonetic Alphabet (IPA)]. 
Anatomic sites & tasks 
The flexible scope was introduced into the nares and advanced through the 
nasal cavity along the floor of the nose to the nasopharynx. The scope was held 
in position with the soft palate and pharyngeal walls in view to observe the soft 
palate during the tasks ‘rest breathing’, sustained /s/, and sustained /a/. The 
scope was then advanced to the oropharynx to view the tongue base during the 
tasks ‘rest breathing’, sustained /s/, and sustained /a/. Finally, the scope was 
advanced to the laryngopharynx (also referred to as the oropharynx) to view the 
larynx during the following tasks: ‘rest breathing’; sustained /s/; sustained /a/; 
and the vocal cords during sustained /i/ [(International Phonetic Alphabet (IPA)] 
(APPENDIX G). The position of the scope in the laryngopharynx affords a view 
of the entire larynx and the posterior and lateral pharyngeal walls, necessary for 
the identification of tremor in the ‘global’ larynx also referred to as ‘vertical 
laryngeal tremor’226.Tremor in the global larynx is described as ‘motion in the 
vertical dimension of the larynx, as a unit, relative to the surrounding upper 
aerodigestive tract’ 200.During endoscopy, the entire larynx structure (vocal 
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cords,arytenoid cartilages, aryepiglottic folds,laryngeal surface of epiglottis) 
engages in movement in a vertical dimension relative to the lateral and posterior 
pharyngeal walls. Figure 5.5 shows a screen shot of the larynogopharynx during 
endoscopy with a participant sustaining an /a/ vowel. 
 
Figure 5.5. Screen shot of ‘global larynx’ during production of sustained 
/a/ vowel 
 
Additional laryngeal sites for tremor identification were the vocal cords 
(oscillation of the vocal folds in the lateral dimension), and the arytenoid 
cartilages (oscillation of the arytenoid cartilages in the lateral dimension200. 
The sustained vowel /i/ was selected specifically to evaluate tremor in the vocal 
cords. The production of the /i/ vowel involves the elevation of the tongue 
towards the roof of the mouth (referred to as a high vowel). During production of 
/i/, the tongue connected to the hyoid bone in the laryx pulls the larynx forward 
permitting an unobstructed view of the vocal cords. The voiceless sound /s/ was 
selected to evaluate tremor in a non-phonatory task, in the palate, tongue base, 
and arytenoid cartilages. During a sustained /s/ sound: the soft palate is 
elevated and contacts the posterior pharyngeal wall; the arytenoid cartilages 
move towards the midline, but do not contact. The position of the soft palate 
and the arytenoid cartilages is ‘held’ in position during sustained /s/, therefore a 
sustained /s/ task could be considered a ‘postural’ non-phonatory tremor task. 
pharyngeal wall 
arytenoid 
aryepiglottic fold 
epiglottis 
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For all tasks, the researcher aimed to view each anatomic site for duration of 
five seconds. All exams were video and audio recorded. On completion of each 
examination, the exam file was saved into either a ‘PD’ folder, or a ‘control’ 
folder on the computer hard drive. 
At this juncture in the testing schedule with the completion of the tremor 
measures, and in advance of administering the Hospital Anxiety and 
Depression Scale (HADS) and the Voice Handicap Index (VHI), the PD 
participants were invited to take their medication. 
  
5.5.6 Hospital Anxiety and Depression Scale (HADS) 
In consideration of the known prevalence of anxiety and depression in pwPD, 
together with the association between anxiety and a ‘shaky’ voice, the author 
considered that it was prudent to collect data on emotional status as 
background information.  The Hospital Anxiety and Depression Scale (HADS), 
227 a short self-rated scale yielding a global measure of mood disorder, with 
separate sub-scores for anxiety and depression was selected since it has been 
found to be valid, consistent, precise and a potentially responsive scale for use 
with the PD population 228.  An advantage of the HADS over other measures is 
that it does not include somatic items, therefore the test findings are not 
confounded by PD physical problems, which can also relate to depression and 
anxiety 54. A score in the range of 0-7 is considered normal. Scores in the range 
of 8 -10, 11-14, and 15-21 are considered a mild, moderate and severe effect 
respectively227. The authors recommend that the distinction between the two 
scales is retained, lest a ‘nebulous’ estimate of emotional distress is given. 229 
The HADS was administered as per the protocol in the manual, with the 
participants instructed to rate their responses on the basis of the previous seven 
days229.  
5.5.7 Voice Handicap Index (VHI) 
Finally, the Voice Handicap Index (VHI)165 was used to measure voice 
handicap/disability in the PD and the control group. The VHI is a 30 - item scale 
with thirty different questions in three different categories, functional, physical 
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and emotional and yields a total score between the ranges of 0-120 
(APPENDIX H). Scores that fall between 0 and 14 are considered to be within 
the normal range, and the higher the score the greater the voice disability. In 
this study, the participants were instructed to give a rating to the questions in 
the questionnaire based on their own perception of their voice in the previous 
four weeks. 
On completion of the assessments, the pwPD were strongly encouraged to 
have breakfast before leaving the hospital. In a number of cases, the researcher 
accompanied the pwPD to the café for breakfast.  
5.6 Ethical issues and problem solving 
The way in which the two main ethical issues highlighted in section 5.1 were 
addressed is described below.  
(1) Asking pwPD to refrain from taking their dopaminergic medication on the 
morning of testing, in addition to fasting for food and liquids excepting 
water.  
This issue was addressed in the following ways: discussing it at length 
with pwPD during the screening process; carrying out the testing in the 
morning once it was twelve hours after the last medication dose; advising 
the patients to bring their medication with them to the testing session so 
that they could take it immediately after the vocal tract examination; 
ensuring that patients had water during the test session; inviting patients 
to the hospital café for ‘breakfast’ so that they could eat before leaving 
the hospital; The cost of breakfast was covered by a research grant 
obtained from the post-graduate college of the Mater Hospital. 
(2) For pwPD and controls, carrying out the vocal tract examination which is 
an ‘invasive’ examination.  
This issue was addressed by scheduling the exam towards the end of 
the session, giving participants the chance to become familiar with the 
testing process and thus encouraging relaxation. All participants were 
reassured that the researcher (the endoscopist) was experienced in the 
93 
 
procedure, and that it would be discontinued if the participant found it too 
uncomfortable. 
An Ear Nose and Throat consultant (ENT) working in the same hospital as the 
researcher agreed to provide clinical support, in the event of the researcher 
identifying any abnormal anatomical findings that may require an ENT opinion.  
 
5.7 Data management and preparation for analysis 
The management of the scores from the following measures: Mini Mental State 
Examination (MMSE), UPDRS II, UPDRS III, head/jaw tremor rating, HADS) 
and Voice Handicap Index (VHI) is outlined in section 5.7.1. 
5.7.1 MMSE, UPDRS II & III, Head/jaw tremor rating, HADS, VHI scores 
The raw scores from the following measures: MMSE; UPDRS II; UPDRS III; 
head/ jaw rating; HADS; and VHI, were inputted into excel sheets from the raw 
data score sheets, with a research assistant’s help. Once entered into excel, the 
researcher and the assistant cross-checked the scores for accuracy. The 
researcher subsequently imported the individual scores into a file on SPSS 
v.17, excepting the head/jaw tremor ratings since they did not require statistical 
analyses. Further preparation of data was required for some measures as 
outlined below. 
• UPDRS II: the scores for items 5 to 17 were summed yielding an UPDRS 
II score.  
• UPDRS III: the scores for items 18 to 31 were summed yielding an 
UPDRS III score. 
UPDRS II & UPDRS III: scores from specific items from both measures were 
combined to obtain: 206 a mean tremor score (items included tremor from 
UPDRS II, tremor at rest of either face, lips or chin, all four limbs, and action or 
postural tremor  in both arms from UPDRS III; (2) a mean score for the complex 
of postural instability and gait difficulty (PIGD), [(items included falling, freezing, 
walking difficulty (UPDRS II), and gait and postural instability (UPDRS III)] 61.  
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The ratio of the mean tremor score to the PIGD mean score was calculated for 
pwPD to determine the PD phenotype. Disease subtype was classified as PIGD 
when the ratio of total tremor score/total PIGD score was equal to or less than 
1.0, whereas pwPD with a ratio of 1.5 or more were defined to have tremor-
dominant subtype. When the tremor/PIGD ratio was more than 1.0 and less 
than 1.5, patients were classified to be in the indeterminate class. 
• Head & Jaw tremor: for the head and the jaw, a score of 1 was assigned 
if tremor was present and a score of 0 if tremor was absent. For scoring 
tremor in the jaw, no differentiation was made between jaw closed and 
jaw opened position. A score of 1 was assigned if tremor was evident in 
either position.The scores for the head and jaw were entered into the 
participant’s score row on excel. 
• HADS:  For the PD and control group, the individual scores for the 
Anxiety and Depression items were summed to yield a separate total 
Anxiety and total Depression score.  
• Voice Handicap Index (VHI): In addition to obtaining a summed total VHI 
score, the scores from the physical, emotional and functional items were 
also summed yielding three different subscale scores.  The excel scores 
were then imported into SPSS v. 17 for later descriptive statistics and 
statistical analyses. 
5.7.2 Acoustic recordings 
From a sustained /a/ vowel, the voice and tremor protocol (VTP) analysis in 
MSP from CSL generates a minimum of nine and a maximum of thirteen voice 
measures, their respective values, and corresponding mean values. The reason 
for the variation in the number of measures is that the values for rate of 
frequency tremor (Rftr) and rate of amplitude tremor (Ratr) and the 
corresponding periodicity measures are produced by MSP only when the 
detected tremor is somewhat regular. 
For this study, the rate, periodicity, and magnitude of frequency and amplitude 
tremor were selected from the VTP as the key tremor measures for further 
analyses. The rate of tremor refers to the rate of modulation of fundamental 
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frequency and/or amplitude in the voice signal, measured in cycles per second 
(Hz). In order for the rate of tremor to be determined the voice tremor has to 
have a certain level of regularity. Periodicity is a measure (%) of the regularity of 
the tremor. The higher the periodicity the more regular is the tremor. The 
magnitude (%) of tremor (frequency and amplitude) is a measure of the extent 
of variation in frequency and/or amplitude secondary to the effect of involuntary 
movement in the muscles of the vocal tract. 
Adjunctive measures of unsteadiness were also included. The selected VTP 
measures for the study are outlined below and for the purpose of completeness, 
descriptions of all the measures119 generated from the VTP are outlined in 
APPENDIX I. 
Key tremor measures 
• Rate of frequency tremor [Rftr (Hz)]  
• Rate of amplitude tremor [Ratr (Hz)]  
• Periodicity of frequency tremor [Patr (%)] 
• Periodicity of amplitude tremor [Patr (%)] 
• Magnitude of frequency tremor [Mftr (%)] 
• Magnitude of amplitude tremor [Matr (%)] 
. Adjunctive measures of unsteadiness 
• Coefficient of variations in the Fundamental Frequency [vFo)(%)] 
• Coefficient of variations in amplitude [vFo) (%)] 
 
The acoustic recordings for each participant were trimmed and re-digitised. 
Trimming (excluding) the initial and final segment of the signal is standard 
practice in voice analysis to avoid the confounding effects of phonatory-onset 
and phonatory-offset230 231.The researcher opened the saved trials, i.e. trial 1, 
trial 2, trial 3 on the CSL, with the acoustic waveform visible on the screen, and 
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then trimmed each waveform, placing the first blue cursor (left side) on the 1.0 
second mark and the second blue cursor (right side) on the 4.0 second mark, 
leaving the middle 3 seconds for analysis (Figure 6.5). Consistent with other 
studies, the value of 3 seconds was chosen since it was considered to be 
sufficiently long to afford reliable analysis230 231. 
 
First blue cursor on the 1.0 second mark  Second blue cursor on 4.0 second mark 
Figure 6.5. The waveform (VTP) trimmed to middle 3 seconds showing 
placing of blue markers  
 
The trimmed voice signals for the PD and control group were then re-analysed 
using the Voice and Tremor Protocol (VTP), with the trimmed voice signal and 
associated measures saved in a sub-folder on the Kay data file. The values for 
the selected acoustic measures (trimmed signals) for the three trials for pwPD 
and controls were entered into an excel spread sheet. Due to technical 
difficulties with the re-digitisation, seven of the pwPD group had data on two 
trials instead of three trials. For controls, three participants had data on two 
trials and one participant had data on one trial. The mean value across three 
trials was calculated for each acoustic measure. For pwPD and control 
participants with two trials, the mean value of the two trials was calculated. 
5.7.3 Audio recordings 
The Speech Intelligibility Test and Consensus Auditory Perceptual Evaluation of 
Voice (CAPE-V) recordings from the Sony Mini disc recorder were imported into 
a MAC book Pro laptop, using the Audacity 2.0.1 software sound editing 
programme (http:// audacity.sourceforge.net). The researcher was instructed in 
the use of Audacity software by a staff member in the department of clinical 
photography. The imported audio files were cleaned, anonymised, and exported 
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as MP3 recordings using the MAC book. The term ‘cleaning’ refers to deleting 
the researcher’s voice when it was present in the recording and extraneous 
sounds (coughs, restarts, hums). 
Speech Intelligibility Test (SIT) 
There were no SIT audio files for two PD participants (PD 13, PD 27) and three 
controls (C30, C31, C32) due to technical problems with the recording 
procedure, leaving a total of fifty-three files. Five (10%) audio SIT files (3 pwPD, 
2 controls) from the total sample were randomly selected for duplication. This 
was necessary for intra-rater reliability ratings. The final total was 58 SIT files. 
The order of the anonymised MP3 recordings from the PD and control group 
was randomised. Subsequently, the entire file containing the randomised audio 
files was burnt to CD for subsequent independent rating of speech intelligibility. 
The rating procedure is described in section 5.8.2. 
 Consensus Auditory Perceptual Evaluation of Voice (CAPE-V) 
There were technical problems with the original audio recordings of three 
participants (PD 7, PD 14, control 22), leaving fifty-five recordings (twenty eight 
in the PD group, twenty seven in the control group). In preparing the audio 
recordings for independent perceptual rating of tremor features and overall 
voice deviance, the sustained vowel and sentence tasks were exported as MP3 
recordings. The ‘spontaneous’ speech task was not exported since the 
researcher considered that the sustained vowels and connected speech 
captured in the reading task were sufficient. Ten percent [(n=6) (three PD and 
three controls] of the total number of recordings were randomly selected for 
duplication for reliability rating, resulting in sixty one recordings.  The order of 
the recordings was then randomised, saved to a folder and all the CAPE-V 
recordings were copied to a CD for independent rating at a later stage (section 
5.8.1). 
5.7.4 Vocal tract exam video recordings 
There were fifty six video exams (thirty PD and twenty six controls) and the 
average length of each recording was five minutes. The preparation of the video 
recordings for independent visual perceptual rating was time consuming and 
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technically challenging. A clinical photographer from the clinical photography 
department agreed to help with the editing of the videos in preparation for 
independent rating of the video recordings.     
(1) Firstly, the researcher systematically viewed each video recording of the 
vocal tract examination (VTE) and decided which parts needed to be 
‘cleaned’. The first trial of the sustained /s/ and vowel tasks was deleted 
in all samples, except in the case when there was only one trial recorded. 
Using the time indicator on windows media player, the researcher played 
the video with the accompanying sound and recorded in writing the 
starting time of a task and the completion time. For example, at the start 
of a task, the video recording was paused, the time on the display was 
noted, the play button was activated again and the video stopped at the 
completion of the task, with the time on the display noted. The same 
protocol was followed for all the anatomical sites and tasks in the VTE.  
The video file in CD format with the edits in writing using start and finish 
times was given to the clinical photographer for editing. 
(2) The clinical photographer’s first task was to import the mpeg files from 
the individual participant’s CD into Final Cut Pro, a Mac software video 
editing programme. She then edited the clips in Final Cut Pro as detailed 
by the researcher. The researcher then reviewed the edited video file of 
each participant with the clinical photographer to ensure that the 
recordings had been edited correctly. When all the mpegs (n=56) were 
imported and edited, she exported the work using a compressor and then 
made a DVD of the work. 
All sound was removed from the video recordings (‘silent’) requiring the 
raters to rate tremor on the basis of visually perceived involuntary 
movement solely, without contribution from perceived auditory tremor in 
the voice signal. The researcher considered that it was important for this 
study to remove the potential confounding effect of perceived voice 
tremor on ratings of tremor behaviour in vocal tract structures. However 
one could question the clinical utility of such an approach considering 
that tremor in the vocal tract is identified clinically endoscopically when a 
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person is phonating. However, a key aspect of this study is to identify PD 
tremor using different evaluation approaches, therefore rating tremor 
from ‘silent’ video recordings was chosen by the researcher.  
A particular challenge in preparing the video exams for subsequent rating 
was how best to indicate for the rater the particular task that was being 
trialled at a particular time on the video, since the video recordings were 
silent. The decision was made to label the task with text, so for example 
when the video was showing the soft palate as the participant was 
sustaining /s/, the text on the screen was ‘palate /s/. The text was placed 
at the bottom of the screen so as not to obscure the view of the 
anatomical structures.This protocol was followed for all tasks of the 
examination. The end product was an anonymised silent video file 
showing the vocal tract during different tasks, differentiated by text 
prompts. The video moved from one task to the other with text prompts 
demarcating the video into different tasks. A blank screen (black) was 
inserted between the anatomic areas to assist the rater in moving from 
one site to the next.  The average length of each edited video file was 
one to two minutes. 
(3) The entire sample, comprising sixty-two exams including four repeats for 
reliability analysis was then randomised by the researcher. The clinical 
photographer then copied the files to CD in the randomised order. The 
final video file CD with the anonymised randomised recordings was 
copied four times to CD by clinical photography, for the purpose of later 
independent rating (section 5.8.3). 
5.7.5 Preparation for reliability rating  
In order to evaluate reliability of acoustic, auditory-perceptual and visual 
perceptual ratings it was necessary to carry out the following steps as described 
below. 
Acoustic data 
The saved acoustic signal files from ten PD and ten control participants were 
randomly selected by the researcher for independent re-analysis. Three trials 
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had been saved for each participant. The first trial only was selected for re-
analysis. The decision to choose the 1st over the 2nd and 3rd trial was not based 
on any scientific reasoning. However, the researcher considered that it was 
important to be consistent in the selected trial across the twenty files, i.e. 
choosing the first trial for all the participants selected.  An SLT colleague 
opened the trimmed acoustic signal file, and re-digitised the signal, saving the 
measurements to a separate folder.  
Auditory perceptual ratings 
Ten percent (10%) of the audio recordings of the Consensus Auditory 
Perceptual Evaluation of Voice (CAPE-V), and the Speech Intelligibility Test 
(SIT) were repeated for the purpose of determining intra- rater reliability. 
Visual perceptual ratings 
Ten percent (10%) of the vocal tract tremor exam recordings were repeated for 
the purpose of intra-rater reliability. Four PD (PD1, PD4, PD13, PD16) and two 
control participants (C13, C28), were selected resulting in sixty-two exams for 
rating. The researcher selected the exams for repeating with the aim to capture 
a range of tremor severities. 
5.8 Rating procedures  
An important component of auditory perceptual and visual perceptual evaluation 
is the degree to which a particular rating or score assigned to a particular 
feature is considered to be a valid and reliable measurement. In clinical 
evaluation, it is important that different clinicians agree on the 
presence/absence and severity of a particular feature. For example, if one 
clinician gives a rating of 1 (mild/intermittent tremulous movement) for tremor in 
the soft palate on a sustained /a/ vowel, it is important that a different clinician 
or clinicians assigns the same rating. This indicates that the rating scale is 
clinically useful and can be used across different clinicians and settings. To 
address this issue of reliability, a number of raters were recruited for each rating 
experiment. In this study three different rating experiments were required for 
evaluation of the perceptual data from the following assessments: 
• Consensus Auditory Perceptual Evaluation of Voice (CAPE-V)  
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• Speech Intelligibility Test (SIT)  
• Vocal Tract Tremor (VTE) evaluation  
It is important to highlight at this juncture that three completely different 
group of raters were recruited for each rating experiment. The researcher 
considered that having different raters for the three rating experiments was 
important, particularly in the case of the auditory perceptual rating tasks, 
since a rater might recognise a participant’s voice from CAPE-V tasks and 
SIT tasks for example, which would introduce a possible source of bias. The 
rating procedures for the three rating experiments are described in the 
following sub-sections.  
5.8.1 Consensus Auditory Perceptual Evaluation of Voice (CAPE-V) 
Raters  
For CAPE-V ratings, four SLT’s experienced in working with voice disorders 
were recruited by the researcher The SLT’s experience in assessment and 
treatment of patient with voice disorders ranged from ten to twenty years. One 
of the raters was unable to attend on the designated day of the rating session, 
due to an injury leaving three raters to carry out the rating task. The raters were 
not given any information about the speakers, other than their gender.  
Rating protocol 
The rating experiment was carried out in a quiet room in the SLT department at 
the National Univeristy of Galway (NUIG), Ireland. All ratings were completed 
on the same day, over a period of five hours, with breaks given for coffee and 
lunch. 
The raters had theoretical but not experiental knowledge of the CAPE-V, 
therefore a short training session was given at the beginning of the experiment 
to explain the CAPE-V protocol (APPENDIX J). In addition the inclusion of two 
perceptual tremor measures (instability, tremor) on the CAPE-V form was 
highlighted. Instability also referred to as unsteadiness, was defined as irregular 
fluctuations in pitch and/or loudness. Tremor was defined as rhythmic or nearly 
rhythmic fluctuations in pitch and/or loudness of the voice.  
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The rating session started with an introduction and explanation of the task 
followed by a rating of twenty samples, a refreshment break, a further 20 
samples, lunch and the final 32 samples. The recordings were played through a 
Mac book Pro lap top with a Logitech Speaker System Z320. The Mac book and 
speakers were placed on a table. The three raters sat at individual student 
desks which were positioned  equidistant from the speakers. They were 
instructed not to confer regarding any of the ratings. The researcher was 
present in the room for the duration of the rating session. 
Each rater had a ‘rating booklet’ containing all the CAPE-V rating forms needed 
for each participant (APPENDIX K). The researcher announced the 
identification number, for example ‘ID 1’ and played the recording twice. The 
raters rated voice quality features (overall severity; roughness; breathiness) on 
the sustained vowels and sentences tasks. They rated tremor features 
(instability, tremor) on the sustained /a/ vowels only.  The parameters 
‘roughness’ and ‘breathiness’ were maintained in the CAPE-V protocol for 
rating, even though they were not required for the purposes of the current study.  
In keeping with the CAPE-V protocol, the raters placed a perpendicular mark on 
the 100 mm visual analogue continuous scale. The extreme left of the 100m line 
corresponds to a score of 0 and the extreme right to a score of 100. Using a 
ruler, placed directly under the continuous 100mm line, the researcher 
determined the number (score) corresponding to the location of the 
perpendicular mark. The number relating to the point on the ruler was written 
above the perpindicular line. This method was applied for the three perceptual 
parameters: overall severity, instability and  tremor. The scores were later 
recorded in the excel  score sheet for each PD and control participant. The 
raters were unable to rate two ratings from the PD group (PD03, PD04) due to 
low volume of voice on the recording. This resulted in twenty six PD participant 
ratings going forward for data analysis (section 5.9). 
5.8.2 Speech Intelligibility Test (SIT) 
Raters  
Four female students who were in the third year of a four year degree in SLT 
were recruited as independent raters for the SIT.  All students were on clinical 
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placement in the Mater Hospital, when they carried out the rating task. They all 
reported normal hearing at the time of the experiment. Some of the students 
reported that they had used the Assessment of Intelligibility of Dysarthria 
Speech (AIDS),224 (non-computerised version), however none of the students 
had prior experience of the computerised SIT.  Therefore some time was 
allocated pre-rating tasks to explain the protocol as laid out in the SIT 
manual222. The raters were blinded to the target sentences, the client groupings, 
and gender. 
Rating protocol  
The SIT software was installed on two desktop computers in the researcher’s 
office. This set-up facilitated one rater to use one computer and another rater to 
use a different computer simultaneously, however conferring between raters 
was not allowed. The SIT software allows for ratings by multiple ‘judges’. 
Therefore each rater was assigned to be either ‘rater 1’, ‘rater 2’, ‘rater 3’, ‘rater 
4’, and inputted the respective rater number into the SIT software programme. 
The raters listened to the recordings using sennheiser headphones, which were 
connected to the computer for the rating task. They were instructed that they 
should listen to each sentence twice only, before transcribing (typing) the 
perceived words.  In the SIT programme, misspelled words and/or typing errors 
reduce intelligibility scores, therefore the raters were advised to check the typed 
sentence for spelling errors and correct accordingly before saving and moving 
on to the next sentence.  
The audio CD containing the sixty-two participant’s files of twelve sentence 
recordings was saved to the desktop on each computer. A shortcut for the SIT 
software programme was also placed on the desktop. This set-up was to 
facilitate the raters switching from the audio file to the computer software 
programme, when listening to and then transcribing the sentences. The 
following steps were followed: The rater opened an anonymised audio recording 
(file 01) from the CD, which contained the twelve recorded sentences for the 
participant.  Using the SIT software programme, the rater opened file 01. 
Sentence 1 was listened to and then transcribed (typed) by the rater using the 
SIT programme continuing until all twelve sentences were transcribed, and then 
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saving the file. Regarding volume level, the raters were advised to regulate the 
volume from the volume control on windows media player. The computer 
programme automatically scores the sample and computes the intelligibility 
score.  
It took an average of five minutes for a rater to transcribe twelve sentences, and 
approximately six hours to transcribe the complete data set. The raters 
controlled the rate at which they worked through the recordings however, they 
were encouraged to take a ten minute break after a one hour listening period. 
Following a break, rater 1, for example could re-open the SIT file and continue 
transcribing from where she had stopped before the break. Since the four raters 
were carrying out the rating task in addition to their student placement work, it 
took five days for them to work through the sixty-two participant recordings. 
There was a technical problem with four of the SIT computer files, and the 
raters could not upload them on the computer. In these four cases, the raters 
transcribed sentences into a word document and the intelligibility score was 
computed manually. 
.   
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5.8.3 Vocal Tract Tremor Video Recordings 
Raters  
The researcher found it difficult to recruit SLT’s to act as raters for the visual 
perceptual rating of tremor, primarily because there are only a small number of 
SLT’s in Ireland who routinely view and evaluate laryngeal images.  Four SLT’s 
were recruited, all of whom had clinical experience in voice disorders, ranging 
from three to sixteen years. Three of the four raters had some experience in 
viewing dynamic images of the larynx and pharynx. Exposure to rating soft 
palate movement was limited for all raters.  
Training protocol 
Time was given before the rating task for the raters to view video clips of 
participants not included in the research experiment, for the purposes of 
orientating them to the different vocal tract structures and to discuss possible 
ratings of video clips. The researcher explained the terms on the rating forms 
and the manner in which the forms were to be completed (APPENDIX L). For 
example, the term global laryngeal tremor was described as ‘motion in the 
vertical dimension of the larynx as a unit, relative to the surrounding upper 
aerodigestive tract’, and an example was shown with an endoscopy clip. 
Rating protocol 
The rating task using four different computers was carried out in one room in 
the SLT department at the Mater Hospital. The DVD containing the complete 
data set of video files was saved in advance, to the desk top of each computer.  
The recordings were silent hence there was no need for sound equipment.  
Each rater sat at the computer with a folder containing all the anonymised rating 
sheets required for the task. There was one rating form for each participant 
labelled ID 1, ID 2, etc. The raters were required to rate the presence and 
severity of ‘tremor’ movement on a scale of 0-3, where 0=absent, 
1=mild/intermittent tremulous movement, 2=moderate tremulous movement, 
3=severe tremulous movement (APPENDIX L). 
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In total, the raters were required to rate ten different tasks, across the palate, 
tongue and larynx. A text prompt at the bottom of the screen indicated to the 
rater the task that was being carried out on the video recording. They were 
asked to indicate on the form reasons for not giving a rating using the symbols 
(UR) for ‘unable to rate’ and (PV) for ‘poor view’. They were allowed to view the 
recording twice and encouraged to use the first viewing to get an overall 
impression of the vocal tract and to score the ten tasks on the second viewing. 
The raters were blinded to group and to repeats. They were not informed that 
some of the recordings were from pwPD and some from neurologically healthy 
controls, or that some of the exams were repeated.  The order of the recordings 
was the same for the four DVD’s, however the raters worked through them at 
their own pace. The raters completed the ratings on the same day, excepting 
one rater who had to go home before the session was complete. She took the 
DVD with her, completed the ratings at her home on a desk top computer and 
posted the rating forms to the researcher.  
After the rating sheets were completed, and in preparation for analysis of the 
data, the individual scores for the tasks were inputted by the research assistant 
into the appropriate score row on the excel sheet. The individual scores for the 
ten tasks, for the four raters were cross checked with the researcher and then 
imported into SPSS v. 17.  
 
5.9 Data Analysis  
Statistical analysis was carried out using the SPSS programme version 17.0 for 
windows. Differences were considered significant at alpha level < 0.05. Prior to 
statistical analysis, the ordinal data (UPDRS II and UPDRS III, visual-perceptual 
ratings of vocal tract tremor, VHI), and continuous data (acoustic measures, 
auditory-perceptual ratings) scores for the PD and control groups were 
analysed for normality of distribution using the Kolmogorov - Smirnov test from 
SPSS v.17.  
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Descriptive statistics  
Central tendency measures of mean and median, and distribution measures of 
standard deviation (SD), range and interquartile range were computed to 
describe the data for the PD group and for controls where appropriate. The data 
included were: demographical (age, disease duration), PD status (UPDRS II, 
UPDRS III, Hoehn & Yahr stage); MMSE and HADS scores; acoustic measures 
previously outlined in section 5.5,; Consensus Auditory Perceptual Evaluation-
Voice (CAPE-V) measures outlined in section 5.5,visual-perceptual ratings of 
tremor in the vocal tract previously outlined in section 5.5, Speech Intelligibility 
Test % scores; Voice Handicap Index (VHI) total and subscale scores. 
Reliability measures 
Inter-rater and intra-rater reliability measures were carried out for auditory- and 
visual perceptual ratings using a two-way mixed effects model (consistency 
definition) intra classcorrelation coefficient (ICC) based on a single rater, using 
SPSS ( v.17).  
Intra-rater reliability for visual perceptual rating of tremor severity was measured 
in the following ways: percentage (%) exact agreement [the percentage of times 
that a rater assigned exactly the same score (range 0-3)]; 206 percentage % 
agreement within one point (the number of times a rater assigned a score within 
one point of the previous score).  
Twelve (20%) acoustic signal wave forms were independently re-digitised by an 
SLT colleague of the researcher. Identicial  values were found for repeated 
analyses of the same segments, therefore no further measures of agreement 
were calculated. 
Differences between groups 
To determine whether statistically significant differences existed between 
median scores of the PD and control group, a Mann-Whitney U test was applied 
to the following data: acoustic measures; auditory perceived dysphonia severity; 
visually perceived ratings for ten vocal tract tremor tasks, VHI scores; HADS 
scores; sentence intelligibility scores. A t test was applied to auditory perceived 
ratings for instability and tremor.  
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Question 2 
For question 2, spearman’s rho correlation was carried out to examine the 
relationship between acoustic tremor measures (Rftr, Ratr, Mftr, Matr, vFo, 
vAm), and auditory perceptual tremor measures (instability, tremor), and the 
relationship between acoustic tremor measures and visual perceptual tremor 
measures. The visual perceptual tremor measures selected for the correlational 
analysis are outlined below.  
• Palate /a/: (tremor in the palate on a sustained /a/ vowel)  
• Tongue /a/ (tremor in the tongue on a sustained /a/ vowel) 
• Larynx /a/ (vertical laryngeal tremor on a sustained /a/ vowel) 
• Larynx /i/ (tremor in the vocal cords on a sustained /i/ vowel) 
The visual perceptual vowel based tasks only were selected over ‘rest 
breathing’ and voiceless /s/ tasks for inclusion in the correlational analysis 
across measures. The reason for this selection was that the acoustic measures 
(‘gold standard’ for this study) are based on a sustained /a/ vowel.Therefore,in 
order to examine the relationship between acoustic and visual perceptual 
measures, without the confounding effect of task, it was necessary to keep the 
task constant across measures and use a sustained /a/ vowel. A further reason 
is that voice tremor is best identified on a sustained vowel and not on a 
voiceless and/or breathing task.  
Question 3 
For question 3, which looks at the relationship between acoustic voice tremor 
measures and voice and speech variables, Spearman’s (rho) was applied. The 
acoustic tremor measures included in the correlation were Rftr (Hz), Ratr (Hz), 
Mftr (%), Matr (%), vFo (%) and vAm (%).  The voice variables were: mean 
values (3 raters combined) of auditory perceived instability and tremor from 
CAPE-V; VHI total and subscale scores and mean values. The speech 
variables were mean values (4 raters) for % scores speech intelligibility. 
109 
 
Question 4 
For question 4, which examines the relationship between acoustic voice tremor 
measures and disease variables, [disease duration, activities of daily living 
(UPDRS II), motor symptoms (UPDRS III)], spearman’s rho was calculated.  
PD phenotype calculation 
To explore the relationship between acoustic measures and PD phenotype, the 
following steps were carried out. The phenotype [(tremor-dominant, posture and 
gait instability (PIGD) or indeterminate)] was derived from the UPDRS score as 
follows. 
The mean of the following nine tremor items was calculated to give an overall 
global tremor score: right and left arm tremor determined from history (UPDRS 
II), tremor at rest (face, lips or chin, four limbs), and action or postural tremor 
based on researcher’s rating (UPDRS III).The mean of the following five items 
was calculated to give a postural instability and gait difficulty (PIGD) score:  
falling; freezing; walking difficulty (UPDRS II), and gait and postural instability by 
examination (UPDRS III). 
The ratio of tremor score to PIGD score was calculated. Participants with a ratio 
of mean tremor /mean PIGD score greater than or equal to 1.5 were considered 
tremor-dominant. Those with a ratio less than or equal to 1.0 were considered 
PIGD. Indeterminate did not fall into either category.Three of the pwPD were 
identified as ‘indeterminate’ on the basis of the above formula and were not 
entered into any further analysis. Tremor-dominant and PIGD pwPD were 
coded as 1 and 2, respectively on SPSS v. 17. 
A series of Mann Whitney U tests were carried out to examine differences 
between tremor- dominant and PIGD pwPD on the basis of the six acoustic 
measures (Rftr, Ratr, Mftr, Matr, vFo, Vam). Further analyses followed of 
differences between tremor dominant and PIGD phenotypes on the basis of 
auditory perceptual (instability; tremor) measures and visual perceptual (palate 
/a/, tongue /a/,larynx /a/, larynx /i/) measures, using Mann Whitney U tests.  
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Chapter 6. Results 
The findings from the screening protocol for eligibility of the study for the PD 
and control group will be presented in section 6.1, followed by the participant 
characteristics in section 6.2. The main and supplementary results for the four 
research questions are presented in section 6.3. 
6.1 Screening  
PD group 
A total of seventy six pwPD (50 males; 26 females) were screened for eligibility 
to join the study. Thirty-five pwPD (21 males; 14 females) were not eligible for 
inclusion and were therefore excluded from the study. Forty one pwPD (29 
males: 12 females) were therefore deemed to be eligible but a further nine 
subjects (5 males; 4 females) declined to participate in the study.  
Consequently, thirty-two (24 males; 8 females) pwPD proceeded to assessment 
(Figure 6.7). 
  
 Figure 6.7. PD group flow 
 
Exclusions 
Table 6.3 shows the 
from the study.The most frequent reason for exclusion was smoking, followed 
by cognitive impairment
was 66.26 years. 
 
Consented & evaluated
n=32
(M 24: F  8)
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diagram from screening to entry into study 
number of participants and the reason for 
. The mean age of the group excluded from the study 
 
PD patients identified & 
screened
n=76
(M 50;F 26)
Eligible
n=41
(M 29;F 12)
Declined to take part
n=9
(M 5;F 4) 
 
 
their exclusion 
Not eligible
n=35
(M 21;F14)
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Table 6.3. PD participants excluded from study: number (n) and reason  
for exclusion 
 
Reason for exclusion  
 
n* 
Smoker in past five years 6 
Cognitive impairment 5 
Depression 4 
Head trauma 4 
Previous surgery to neck or spinal region   4 
Dyskinesias 3 
Voice treatment in past year (Lee Silverman Voice Treatment) 2 
History of CVA 2 
Bell’s Palsy 1 
Lesion to basal ganglia 1 
Lewy Body disease 1 
Hearing difficulties 1 
Dysarthria & hypotonia related to non-PD medication 
 
1 
Radiotherapy 1 
*n = 35 (21 males, 14 females). Mean age: 66.26 years 
 
Control group 
Twenty eight participants (20 males; 8 females) were recruited for the study by 
the cut off date. Recruiting controls proved more difficult than initially anticipated 
by the researcher. Some controls were reluctant to have a nasendoscopic 
examination, and this was the main contributory factor to the lower number of 
healthy controls than pwPD in the study. 
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6.2 Participant characteristics 
Following assessment for the study, two further participants from the PD group 
were excluded since they were identified with neurological co-morbidities. This 
knowledge was not available to the researcher prior to testing. One participant 
had an occipital lesion (PD 22, male), and the other (PD 8, female) had a 
lacunar infarct, leaving thirty pwPD participants for data analysis. 
Gender distribution, mean (SD), range, median and interquartile range (IQR) for 
chronological age, Mini Mental State Examination (MMSE) and anxiety and 
depression scores from the Hospital Anxiety and Depression Scale (HADS) are 
shown in Table 6.4, together with p values for the comparison of the PD and 
control group. The raw data for demographical, MMSE, HADS, and disease 
variable data for the PD group are shown in APPENDIX M. The raw data for 
demographical, MMSE, HADS and VHI scores for the control group are shown 
in APPENDIX N.   
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Table 6.4. Mean (SD), range, median, (IQR) values for age, MMSE, HADS 
scores, and p values for PD and control group  
 
 PD group (n=30) 
 
Control group (n=28) 
 
  p  
Gender [n (%)] 
Males 
Females 
 
22 (73) 
8  (27) 
 
20 (71) 
8 (29) 
  
 
Age (years) 
    
 
Group 
    
Mean (SD) 
Range  
Median (IQR) 
 
Males 
Females 
61.40 (10.31) 
(34 - 76) 
61.00 (54.75 -70.25) 
 
60.95 (10.82) 
62.63 (9.29) 
60.11 (9.54) 
(36 - 74) 
60.50 (53.25 -68.50) 
 
59.55 (10.24) 
61.50 (7.96) 
0.495 1 0.623  
 
MMSE 
    
Mean (SD) 
Range 
Median (IQR) 
 
28.87 (1.00)  
(26 -30) 
29.00 (28.00 -30.00) 
28.82 (1.21) 
(25 -30) 
29.00 (28.00 -30.00) 
 
 
412.000 2 
 
 
0.895 
 
 
HADS 
 
n=30 
 
n=27  
  
Anxiety  
Mean (SD) 
Range 
Median (IQR) 
 
Depression 
Mean (SD) 
Range 
Median (IQR 
 
4.47 (3.46) 
(0 -14) 
4.00 (1.75 - 7.00) 
 
 
3.97 (3.33) 
(0-18) 
3.50 (2.00-5.25 
 
2.63 (2.27) 
(0 -8) 
2.00 (1.00-4.00) 
 
 
1.52 (1.69) 
(0-7) 
1.00 (0.00-2.00) 
 
 
 
275.500 2 
 
 
 
 
176.00 2 
 
 
 
0.037 * 
 
 
 
 
0.000 * 
 
1
Independent t-test: 
2
Mann Whitney U 
MMSE:Mini-Mental State Examination 
HADS: Hospital Anxiety & Depression Scale 
 
As can be seen from Table 6.4, a total of fifty eight participants completed the 
study.There were more males than females in both groups, with a ratio of 2.75:1 
and 2.50:1 respectively. There was no statistically significant difference 
between the two groups with respect to age (p >0.05), or MMSE (p>0.05) 
(Table 6.4).These findings confirm homogeneity of the PD and control group for 
age and cognitive functioning.  
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Hospital Anxiety and Depression Scale (HADS) 
The PD participants had higher scores for anxiety and depression than the 
control group when measured on the Hospital Anxiety and Depression Scale 
(HADS) and this was statistically significant (p<0.05). The guidelines in the 
HADS manual were followed for interpretation of the individual pwPD and 
control total scores232. A score in the range of 0-7 is considered normal. Scores 
in the range of 8 -10, 11-14, and 15-21 are considered a mild, moderate and 
severe effect respectively. Six pwPD scored outside the normal range: 3 
indicated mild anxiety; 2 indicated moderate anxiety and 1 indicated moderate 
depression. The HADS was not administered to one control participant due to 
researcher error, hence the reason for 27 participants in the control group. 
Unified Parkinson’s  Disease Rating Scale (UPDRS), and Hoehn & Yahr (H & Y) Scale 
Table 6.5 shows the mean (SD), range, median and interquartile (IQR) range 
for age at disease onset, years since disease onset, Unified Parkinson’s 
Disease Rating Scale (UPDRS) part II, UPDRS part III, and Hoehn & Yahr 
Scale (H&Y) for the PD group.  
 
Table 6.5. Mean (SD), range, median, (IQR) for age at disease onset 
(years), disease duration, UPDRS II, UPDRS III & Hoehn & Yahr for PD 
group  
 
  
PD group 
(n=30) 
    
 Age disease 
onset (years) 
Disease 
duration 
 
UPDRS II UPDRS III Hoehn & 
Yahr  
Mean (SD)  
Range  
Median 
(IQR) 
56.17 (9.56) 
32 - 70 
56.00  
(47.75 -65.25) 
5.23 (3.17) 
1 - 12  
5.00 
(2.75-7.25) 
10.20 (3.85) 
4-19 
9.50  
(7.00-13.25) 
25.00 (9.23) 
8-41 
24.50  
(17.75-
33.00) 
2.17 (0.74) 
1-4 
2.00 
(2.00-3.00) 
Disease duration= number of years post diagnosis 
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Head and jaw clinical tremor evaluation 
The number (%) of pwPD and control participants rated with head and jaw 
tremor is shown in Table 6.6. 
 
Table 6.6. Head and Jaw tremor [(n)(%)] in PD and control group 
 
 PD group (n=31) 
 
Control group (n=23) 
 
 
Tremor present n (%) Tremor present n (%) 
Head tremor 2 (6.4%) 
 
0 (0%) 
Jaw tremor 11 (35.4%) 
 
1 (4.3%) 
 
 
Head tremor was present in two pwPD.  Jaw tremor was more frequent, and 
was present in eleven pwPD. For the control group, head tremor was not 
identified in any participant and jaw tremor was identified in just one participant.                                                                                           
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6.3 Research questions 
The findings for the four research questions are presented in section 6.3. A 
similar lay out is followed across all four questions.  For example, the results 
relating directly to the research questions are presented first. When 
supplementary findings are reported, these will be presented under 
‘supplementary findings’ and raw data when appropriate will be presented in the 
relevant appendix.   
 6.3.1 Question 1 
The over-riding aim of Question 1 was to determine if there was a difference 
between pwPD and neurologically healthy controls in relation to voice tremor. 
There are three parts to question 1, and the results for each part will be 
reported separately as Part (a), Part (b) and Part (c).  At the end of question 1, 
the salient findings from the three parts will be summarised. 
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6.3.1 Question 1. (Part A)  
Is there a difference between pwPD and neurologically healthy age-sex 
matched controls in relation to voice tremor, when measured using 
acoustic tremor measures? 
 
The key and ancillary acoustic voice tremor measures applied to question 1 are 
listed below to assist in interpretation of the results. The specific measures with 
brief explanations from the Motor Speech Profile (MSP) manual119 are outlined 
in APPENDIX I.  The raw data for the acoustic measures for the PD and control 
group are displayed in contained in APPENDIX O  and APPENDIX P 
respectively.  
Key voice tremor measures 
• Rate of frequency tremor [Rftr(Hz)]:  
• Rate of amplitude Tremor [(Ratr(Hz)]:  
• Periodicity of the frequency tremor [Pftr (%)]:   
• Periodicity of the amplitude tremor [Patr(%]):  
• Magnitude of the frequency tremor [Mftr (%)]:  
• Magnitude of the amplitude tremor [Matr (%)]: 
Ancillary tremor measures 
• Coefficient of variations in the fundamental frequency [vFo (%)]:   
• Coefficient of variations in the amplitude [vAm (%)]:  
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Tremor detection, rate, periodicity and magnitude of tremor 
Table 6.7 shows the descriptive statistics for the number (%) of participants in 
the PD and control group in which frequency tremor and amplitude tremor was 
detected by the voice and tremor protocol from the motor speech profile (MSP). 
The mean (SD), median, and inter quartile range (IQR) with p values are also 
shown in Table 6.7 for rate (Hz), periodicity, and magnitude of frequency and 
amplitude tremor for the PD and control group. 
Table 6.7. Tremor detection rate [(n) (%)], & mean (SD), range, median, and 
IQR values for tremor rate, periodicity & magnitude of frequency and 
amplitude tremor for PD and control group  
 
 Frequency 
Tremor 
 Amplitude 
Tremor 
 
Tremor detected 
 
PD Control PD Control 
n (%) 
 
13 (43.3)  10 (35.7) 16 (53.3) 17 (60.7) 
Tremor rate (Hz)     
Mean (SD) 4.39 (2.59) 3.03 (1.33) 4.94 (2.25) 2.85 (0.72) 
Median 3.25 2.66 4.44 2.66 
IQR 2.43-6.54 2.29-3.03 3.40-5.69 2.30-3.35 
 p = 0.19 a  p = 0.001 b  
Periodicity %     
Mean (SD) 30.22 (16.50) 24.09 (8.11) 45.07 (10.64) 37.12 (12.35) 
Median 25.14 22.61 43.40 38.84 
IQR 19.67-39.52 18.44-27.53 34.21-55.39 31.33-44.37 
 p = 0.38 a  p = 0.057 b  
Magnitude %     
Mean (SD) 0.91 (0.73) 0.71 (0.12) 3.23 (2.08) 2.27 (0.91) 
Median 0.69 0.68 2.50 2.10 
IQR 0.40-0.69 0.37-0.63 1.49-3.11 1.59-2.22 
 p = 0.71 a  p = 0.16 a  
 
a
 Mann Whitney U test  
b
 Independent t test 
 
Frequency tremor was detected in almost 50 % of the pwPD. The detection rate 
was lower in the control group. In the 13 pwPD in whom frequency tremor was 
detected, the mean rate of tremor (Hz) was higher than in the control group, 
however the difference between the groups was not statistically significant when 
a Mann Whitney U test was applied (Table 6.7). 
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Frequency tremor was more periodic and had greater magnitude in pwPD than 
in controls however the difference between the groups for Pftr and Mftr did not 
reach statistical significance.  
Amplitude tremor was detected in more than 50% of pwPD. There was a 
marginally higher rate of detection of amplitude tremor in the control group.  In 
pwPD in whom amplitude tremor was detected, the mean rate (Hz) of amplitude 
tremor was higher than in controls. The difference between the groups for rate 
of amplitude tremor was statistically significant (p<0.001), when an independent 
t test was applied. Amplitude tremor showed greater periodicity in pwPD than 
the control group, with the difference approaching significance (p=0.057), 
(Table 6.7). The pwPD had a greater magnitude of amplitude tremor than the 
controls had, however the difference between the groups did not reach 
statistical significance. 
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Magnitude of frequency tremor (Mftr), magnitude of amplitude tremor (Matr)  
Table 6.8 reports the mean, standard deviation (SD), median, interquartile 
range (IQR) and p value for Mftr and Matr for the PD and control group.  
Table 6.8. Mean (SD), median, interquartile range (IQR) & p values for Mftr, 
Matr, for PD & control group 
 
 PD 
(n=30) 
Control 
(n=28) 
U p 
Mftr     
Mean(SD) 0.661(0.531) 0.510 (0.191) 329.000 0.157 
Median 0.602 0.482   
IQR 0.404-0.695 0.377-0.638   
      
Matr     
Mean(SD) 2.496 (1.74) 2.059 (0.787) 402.000 0.779 
Median 1.999 1.882   
IQR 1.496-3.115 1.594-2.228   
 
The PD group had a higher mean (SD) Mftr% value than the control group but 
this difference was not statistically significant (p>0.05). The mean (SD) Matr% 
value was higher for the PD group than the control group, but again the 
difference did not reach statistical significance (p>0.05).  It is important to note 
that the Mftr% and Matr% mean values in Table 6.8 include periodic and non- 
periodic modulations in contrast to Table 6.7, which showed Mftr and Matr for 
periodic modulations only.  
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Co-efficient of variation of frequency (vFo), coefficient of variation of amplitude 
(vAm) 
Table 6.9 reports the mean, standard deviation (SD), median, interquartile 
range (IQR) and p value for vFo and vAm for the PD and control group.  
Table 6.9. Mean (SD), median, interquartile range (IQR) & p values for vFo, 
& vAm for PD & control group 
 
 PD 
(n=30) 
Control 
(n=28) 
U p 
vFo     
Mean(SD) 1.577(2.499) 1.057 (0.482) 330.500 0.164 
Median 1.060 0.930   
IQR 0.862-1.355 0.710-1.221   
      
vAm     
Mean(SD) 7.857(3.428) 8.259 (3.034) 358.000 0.335 
Median 6.852 7.929   
IQR 5.981-8.491 6.116-9.269   
p≤ 0.05: Mann Whitney U test 
Similar to the other measures, the mean (SD) vFo value for the PD group was 
higher than the control group but the difference between the groups was not 
statistically significant (p>0.05). For vAm, the mean (SD) value for the PD group 
was lower than the mean value of the control group, however the difference 
between the groups was not statistically significant (p>0.05) (Table 6.9). The 
finding of higher vAm values for the control group in comparison to pwPD was 
not anticipated and will be discussed in section 7.1. 
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6.3.1 Question 1 (Part B)  
Is there a difference between pwPD and neurologically healthy age-sex 
matched controls in relation to voice tremor measured auditory 
perceptually?  
 
To answer this question, two different perceptual measures of voice tremor, 
instability and tremor, were rated independently by three experienced listeners 
using a 100mm visual analogue scale. The inter-rater and intra-rater reliability 
findings for instability and tremor are presented first, followed by the main 
research question findings. 
 Inter-rater reliability for perceived instability and tremor 
The intraclass correlation coefficients (ICC) and confidence intervals for inter-
rater reliability for instability and tremor are outlined for the PD and control 
group in  
APPENDIX Q.  Applying the guidelines for Kappa coefficients233, a kappa of 
0.01 indicates poor agreement and a kappa of 0.81 to 1.00 indicates almost 
perfect agreement. The raters achieved ‘substantial’ agreement when rating 
instability in the PD (ICC 0.780) and control group (ICC 0.717). However, 
agreement for rating tremor was lower with ICC values of 0.306 for pwPD and 
0.481 for controls, suggestive of only ‘fair agreement’. 
Intra-rater reliability for perceived instability and tremor  
The intraclass correlation coefficients (ICC) and confidence intervals for intra-
rater reliability of instability and tremor are outlined in APPENDIX R.  The ICC’s 
relate to the rating of repeat recordings from six participants (3 pwPD and 3 
controls). For rating perceived instability, Rater A achieved a moderate level of 
agreement. Rater B, showed no consistency in ratings, and rater C achieved 
almost ‘perfect agreement’ within herself (Kappa guidelines233). For perceived 
tremor ratings, Rater A showed poor agreement within herself. In contrast Rater 
B and rater C achieved moderate agreement. The confidence intervals for 
instability and tremor show a wide range of values for each rater. Overall, Rater 
C was the most consistent of the three raters.  
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Research question findings 
The mean (SD), median and interquartile range (IQR) values, and t test results 
for perceived instability and tremor are displayed in Table 6.10. The raw data for 
perceived  instability for the PD and control group are shown in APPENDIX S. 
The raw data for perceived tremor for the PD and control group are displayed in 
APPENDIX T and APPENDIX U respectively.  
Table 6.10. Mean (SD), range, median values for perceived instability and 
tremor and p values for PD and control group  
 
 PD (n=26) Control (n=27) t p 
 Perceived 
Instability 
   
Mean (SD) 27.27 (14.92) 24.37 (12.73) 0.762 0.450 a 
Median 
(Range) 
24.00 (4.00-63.00) 23.00 (5.00-
56.00) 
  
IQR 15.00-37.50  14.00-34.00    
 Perceived Tremor    
Mean (SD) 18.54 (11.63) 18.07 (12.08) 0.142 0.887 a 
Median 
(Range) 
16.50 (2.00-55.00) 18.00 (4.00-
48.00) 
  
IQR 11.25-24.25 7.00-28.00   
a: t-test 
 
For perceived instability, the PD group had a higher mean (SD) value than the 
control group, however the difference was not statistically significant . For 
perceived tremor, the PD group had a similar mean (SD) value to the control 
group, without statistical significance (Table 6.10). 
Table 6.10 shows that the PD group had higher mean (SD) values for instability 
in comparison to tremor. Supplementary analyses showed that the difference 
between ratings for instability and tremor for the PD group was statistically 
significant using a paired samples t test (p<0.01) (Table 6.11). 
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The control group also showed a similar trend with higher ratings for instability 
than tremor and the difference was also found to be statistically significant  
(p<0.01) Table 6.11. 
 
Supplementary analysis results 
Instability and tremor mean value comparison, and p values for PD and control 
group  
Table 6.11. Mean (SD) IQR and p values for perceived instability and 
tremor ratings and p values for pwPD and for control group 
 
 PD  
(n=26) 
   Control 
(n=27) 
   
 Instability Tremor t p Instability Tremor t p 
Mean 27.27 18.54 4.760 <0.01 24.37 18.07 6.280 <0.01 
SD 14.920 11.635   12.728 12.086   
IQR 15.00-
37.50 
11.25-
24.25 
  14.00-
34.00 
7.00-
28.00 
  
 
Relationship between perceived instability and tremor 
Instability and tremor were positively and strongly correlated in the PD (p< 0.01) 
and control group (p<0.01) with pearson r values of 0.77 and 0.91 respectively 
(Table 6.12). 
Table 6.12. Pearson r correlation between perceived instability and tremor 
for the PD & control group 
 
 Perceived Tremor 
 PD (n=26) Control (n=27) 
Perceived  
Instability  
0.779** 0.913** 
 
**. Correlation is significant at the 0.01 level (2-tailed). 
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6.3.1 Question 1 (Part C) 
Is there a difference between pwPD and neurologically healthy age-sex 
matched controls in relation to voice tremor measured visually 
perceptually? 
 
The final part of question 1 relates to the visual perceptual rating of tremor in 
the vocal tract, using nasendoscopy. Four speech and language therapists 
(SLT’s) independently rated tremor behaviour from silent video recordings of 
nasendoscopic examinations, using a four point interval rating scale (0=absent 
tremor, 1 = mild/intermittent tremulous movement, 2= moderate tremulous 
movement, 3 = severe tremulous movement). The inter- and intra-rater reliability 
findings will be presented first followed by the main research question findings. 
 
Inter-rater reliability for visually perceived tremor in the vocal tract  
The intraclass correlation coefficient (ICC) results for inter-rater reliability is 
shown in APPENDIX V. Kappa guidelines233 were applied in interpreting the 
results (kappa of 0.01 indicates poor agreement and a kappa of 0.81 to 1.00 
indicates almost perfect agreement). Overall, ICC’s for inter-rater reliability were 
higher in the PD than the control group. The ICC results show a wide range of 
coefficients for rating tremor severity in the PD group. The highest ICC (0.7) 
was for rating tremor in the palate during ‘rest breathing’ and the lowest was for 
rating tremor in the vocal cords on a sustained /i/ vowel (ICC of 0.2). For the 
control group, the highest ICC (0.5) was for rating tremor in the palate on a 
sustained /a/ vowel and the lowest was for rating tremor in the tongue on a 
sustained /a/ vowel (ICC of 0.07). 
Intra-rater reliability for visually perceived tremor in the vocal tract 
Intra-rater reliability based on the percentage of times that the raters assigned 
exactly the same score (exact agreement) on a scale of 0-3, on repeat viewing 
of the exams shown in (APPENDIX W) for pwPD and controls.  The results for 
tremor severity ratings show that agreement is generally higher for pwPD 
ratings than it is for controls.  
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Exact agreement scores for pwPD range from a high 94% (tongue tremor rest 
breathing) to a lower 43% (tongue tremor sustained /s/). For controls, exact 
agreement scores ranged from 75% (four different tasks) to 38% (palate tremor 
rest breathing).  
Agreement within one point (%) is also shown in APPENDIX W  for pwPD and 
controls.  Overall, percent agreement within one point is higher than it is for 
exact agreement, with 100% agreement for 9/10 tasks, for pwPD and controls.  
The percentage of time that the raters agreed within themselves regarding the 
presence /absence of tremor in pwPD and controls is shown in APPENDIX X. 
For pwPD, the highest agreement (100%) was achieved for rating  tremor in the 
palate on a sustained /s/, /a/, and in the larynx on sustained /a/, and the lowest 
(62.5%) for rating tremor in the larynx on a sustained /i/. Again, raters show 
much higher agreement within themselves when rating the presence/absence of 
tremor in pwPD than in controls. The percent agreement for rating 
presence/absence of tremor in controls ranged from 87.5 % to 50%.  
Research question findings  
The mean (SD), median, range, p values and effect sizes for severity ratings of 
visually perceived tremor in the palate, tongue and larynx (vocal tract) during 
different tasks, for the PD and the control group are displayed in Table 6.13. 
Figure 6.8 graphically displays the mean and p values for the ten tasks across 
the palate, tongue and larynx. Figure 6.9 graphically shows the mean vocal tract 
tremor score (mean of scores for ten tasks) for thirty individual pwPD. 
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Table 6.13. Mean (SD) median, range, p values and effect sizes for rating 
tremor in vocal tract structures, for PD and control group 
 
 PD   Control     
 Mean (SD) 
n=30 
 
Median 
(Range) 
Mean (SD) 
n=24 
 
Median 
(Range) 
U/Z p  Effect 
size 
Palate 
Breathe 
1.19  
(0.88) 
1.12  
(0.00-3.00) 
0.70 
(0.42) 
0.62 
(0.00-1.50) 
254.00/ 
-1.861 
0.063 a N/A 
 
 
 
n=29 
  
n=25 
    
Palate  
/s/ 
1.43 
(0.68) 
1.25 
(0.00-2.75) 
0.72 
(0.51) 
0.50 
(0.00-1.75) 
152.00/-
3.665 
p<0.001* a 0.49 c 
 
 
 
n=28 
  
n=25 
    
Palate  
/a/ 
1.60 
(0.81) 
1.50 
(0.00-3.00) 
1.04 
(0.57) 
1.00 
(0.00-2.00) 
 0.006* b 0.37 c 
 
 
 
n=30 
  
n=24 
    
Tongue 
Breathe 
0.74 
(0.81) 
0.50 
(0.00-3.00) 
0.32 
(0.43) 
0.25 
(0.00-2.00) 
226.500/ 
-2.384 
0.017 * a 0.32 c 
 
 
 
n=29 
  
n=24 
    
Tongue 
/s/ 
0.81 
(0.72) 
0.50 
(0.00-3.00) 
0.36 
(0.32) 
0.25 
(0.00-1.25) 
208.00/ 
-2.552 
0.011 * a  0.35 c 
 
 
 
n=30 
  
n= 25 
    
Tongue 
/a/ 
0.78 
(0.65) 
0.50 
(0.00-3.00) 
0.40 
(0.26) 
0.50 
(0.00-1.00) 
237.500/-
2.379 
0.017 * a  0.32 c 
 
 
 
n=30 
  
n=26 
    
Larynx 
Breathe 
0.95 
(0.69) 
1.00 
(0.00 -2.50) 
0.43 
(0.38) 
0.25 
(0.00-1.33) 
230.00/-
2.654 
0.008 * a  0.35 c 
 
 
 
n=29 
  
n=26 
    
Larynx 
/s/ 
1.27 
(0.82) 
1.25 
(0.00-3.00) 
0.51 
(0.44) 
0.41 
(0.00-1.50) 
167.00/-
3.556 
p<0.001 * a  0.47 c 
  
n=30 
  
n=26 
    
Larynx 
/a/ 
1.04 
(0.63) 
1.00 
(0.00-2.25) 
0.35 
(0.30) 
0.25 
(0.00-1.00) 
131.00/-
4.309 
p<0.001 * a  0.57 c 
 
 
 
n=30 
  
n=26 
    
Larynx 
/i/ 
0.68 
(0.45) 
0.62 
(0.00-1.75) 
0.30 
(0.30) 
0.25 
(0.00-1.25) 
185.00/-
3.439 
0.001 * a  0.45 c 
a: Mann Whitney U test:  
b: t-test 
c: r effect size [(Cohen (1988)] 
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Palate 
For tremor in the palate, the mean (SD) values were higher (indicating greater 
severity) in the PD group than the control group for the three tremor conditions: 
breathing, sustained /s/, and /a/ vowel (Table 6.13).  For rating of palatal tremor 
on a sustained /s/ and on a sustained /a/ vowel, the difference between the 
groups was statistically significant (p<0.05). For rating palatal tremor during rest 
breathing, the difference between the groups was not statistically significant. 
The sustained /a/ vowel task achieved the highest tremor rating in the palate in 
comparison to rest breathing and sustained /s/ with a mean (SD) of 1.60 (0.81). 
Tongue 
For tongue tremor, the PD group had higher mean (SD) values than the control 
group for rest breathing, sustained /s/ and /a/ vowel (Table 6.13).The difference 
between the groups for all three tasks was statistically significant (p<0.05). The 
sustained /s/ task achieved the highest  mean tremor rating in comparison to 
rest breathing and sustained /a/ tasks with a mean value of 0.81 (0.72). 
Larynx 
For rating tremor in the larynx for all tasks, rest breathing, sustained /s/, /a/ and 
/i/ vowels, the PD group had higher mean (SD) values than the control group 
(Table 6.13). The difference between the groups was statistically significant 
(p<0.05) for all tasks. The sustained /s/ task achieved the highest mean tremor 
rating in comparison to rest breathing, sustained /a/ and sustained /i/,with a 
mean value of 1.27 (0.82). 
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Figure 6.8 graphically displays the mean and p values for the ten tasks across 
the palate, tongue and larynx for PD and control group. 
 
 
Figure 6.8. Mean ratings across 4 raters for different tasks across the 
palate, tongue, and larynx, for PD and control group 
 
Supplementary findings 
Effect sizes for rating ten vocal tract tasks 
Analysis of effect sizes using Cohen’s r 234 shows that the majority of the tasks 
achieved a medium to large effect size (Table 6.13).The ‘larynx /a/ task (tremor 
in the global larynx /vertical laryngeal tremor) had the highest effect size at 0.57.   
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Individual pwPD mean vocal tract tremor scores 
Figure 6.9 shows the dispersion of mean vocal tract tremor scores (3 anatomic 
sites and four tasks combined) for individual pwPD across thirty pwPD.  
Rating scale: 0 = no visually perceived tremor, 1= mild/intermittent, 2= moderate, 3= severe 
 
Figure 6.9. Individual mean scores for vocal tract tremor ratings (10 tasks 
combined) for 30 pwPD  
 
Fourteen pwPD obtained mean scores between 1 and 2 (1=intermittent/ mild 
tremor, 2 = moderate tremor), whilst 16 pwPD achieved a mean tremor score of 
1 or less.  Therefore close to 50% pwPD could be considered to have definite 
evidence of tremor in the vocal tract and 55% to have minimal or no tremor on 
visual perceptual analysis (Figure 6.9). 
Patient ‘experience of nasendoscopy exam 
Thirty pwPD (n=30) tolerated the nasendoscopy exam. The findings from a 
short questionnaire completed by pwPD post examination showed that the 
experience of the examination was ‘acceptable’ with low levels of discomfort 
and anxiety associated with it. The findings from the self-report questionnaire 
for rating of ‘experience’, ‘pain’, and ‘anxiety’ are graphically shown in 
APPENDIX CC. 
 
  
0
0.5
1
1.5
2
2.5
PD 
01
PD 
02
PD 
03
PD 
04
PD 
05
PD 
06
PD 
07
PD 
09
PD 
10
PD 
11
PD 
12
PD 
13
PD 
14
PD 
15
PD 
16
PD 
17
PD 
18
PD 
20
PD 
21
PD 
22
PD 
23
PD 
24
PD 
25
PD 
26
PD 
27
PD 
28
PD 
29
PD 
30
PD 
31
PD 
32
M
e
a
n
 s
co
re
 1
0
 t
a
sk
s
Mean vocal tract tremor scores PwPD (n=30)
132 
 
Summary main results for question 1  
 
Evaluating voice tremor using different approaches yielded varied findings with 
differences between pwPD and controls identified with some measures and not 
with others. The salient findings were: 
• For acoustic measures, the rate of amplitude tremor differentiated the PD 
from the control group.  The periodicity of amplitude tremor, the extent 
(magnitude) of frequency and amplitude tremor, and overall variation in 
frequency was greater in the PD than in the control group, but the 
difference was not statistically significant 
• PwPD were rated as having more perceived instability in their voice than 
the control group. However, this difference did not reach statistical 
significance. For tremor ratings, the PD and control groups were closely 
matched in severity. Comparing tremor and instability mean values within 
the PD group, the PD group were rated as having more instability than 
tremor with statistical significance.  A similar trend for higher ratings of 
instability than tremor occurred in the control group with statistical 
significance achieved 
• In relation to visually perceived tremor in the vocal tract, the PD group 
were rated as having higher levels (greater severity) of tremor in the 
palate, tongue and larynx than the control group when evaluated on ten 
different tasks. Statistical significance was achieved for all sites and 
tasks with the exception of the task ‘palate breathe’  
• There were medium to large effect sizes for the visually perceived 
tremor ratings. Almost 50% of pwPD were considered to have 
definite evidence of tremor in the vocal tract, 55% were rated as 
having less than mild/intermittent tremor 
• Inter-and intra-rater agreement tended to be higher for ratings of 
vocal tract tremor in pwPD than in the control group 
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• The majority of pwPD considered the nasendoscopy procedure to 
be an ‘acceptable’ experience with a small number experiencing 
mild pain/discomfort and anticipatory anxiety  
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6.3.2 Question 2 
Question 2 explores the nature of the relationship between acoustic and 
auditory perceptual tremor measures, and between acoustic and visual 
perceptual tremor measures. The following ten measures were entered into the 
correlational analysis to answer question 2. 
• Acoustic measures: rate of frequency tremor (Rftr Hz); rate of amplitude 
tremor (Ratr Hz); magnitude of frequency tremor (Mftr %); magnitude of 
amplitude tremor (Matr %); variation in frequency (vFo %); variation in 
amplitude (vAm %) 
• Auditory perceptual measures: instability; tremor 
• Visual perceptual measures  of tremor in the vocal tract: palate /a/; 
tongue /a/; larynx /a/; larynx /i/ 
 
To gain further insight into the relationship between different measurement 
approaches, a further supplementary corrrelational analysis was carried out. 
The relationship between auditory perceptual (instability, tremor) and visual 
perceptual (palate /a/; tongue /a/; larynx /a/; larynx /i/) measures was explored 
for the PD and control group separately.The research question results will be 
presented first, followed by the results for the supplementary analysis. 
 
Question 2: What is the nature and degree of the relationship between 
acoustic and auditory perceptual voice tremor measures, and visual-
perceptual measures? 
 
PD group 
The relationship between the acoustic measures and auditory perceptual 
measures, and between the acoustic and visual perceptual tremor measures, 
for pwPD are displayed in the correlation matrix in Table 6.14, with significant 
associations in bold and with asterisk to denote significance.  
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Table 6.14.Spearman correlations (rho) for acoustic voice tremor 
measures and auditory perceived instability and tremor, and visual 
perceptual ratings for PD group 
 
  Auditory perceptual 
measures 
 Visual-perceptual measures 
Acoustic 
measures 
 Instability Tremor  Palate  
/a/ 
Tongue 
/a/ 
Larynx 
/a/ 
Larynx  
/i/ 
 
Rftr (Hz)  -0.471 
n=12 
 
-0.212 
n=12 
 0.281 
n=12 
 
0.118 
n=13 
0.063 
n=13 
-0.120 
n=13 
Ratr  (Hz)  0.221 
n=15 
0.106 
n=15 
 -0.126 
n=16 
 
-0.173 
n=16 
 
-0.147 
n=16 
 
0.118 
n=16 
 
Mftr (%)  0.454* 
n=26 
 
0.515** 
n=26 
 
 0.196 
n=28 
 
0.347 
n=30 
 
0.182 
n=30 
 
0.472** 
n=30 
 
Matr (% )  0.309 
n=26 
 
0.349 
n=26 
 
 0.359 
n=28 
 
0.068 
n=30 
 
0.358 
n=30 
 
0.271 
n=30 
 
vFo (%)  0.518** 
n=26 
 
0.565** 
n=26 
 
 0.198 
n=28 
 
0.244 
n=30 
 
0.021 
n=30 
 
0.401* 
n=30 
 
vAm (%)  0.341 
n=26 
 
0.110 
n=26 
 
 0.256 
n=28 
 
0.221 
n=30 
 
0.251 
n=26 
 
0.145 
n=30 
 
** correlation is significant at the 0.01level (2-tailed) 
*correlation significant at 0.05 level (2-tailed) 
 
Relationship between acoustic measures and auditory perceptual measures 
Two out of six acoustic tremor measures showed significant positive 
correlations with auditory perceived instability and tremor (Table 6.14). 
Specifically, an increase in Mftr% was associated with an increase in auditory 
perceived instability and tremor.This means that as the magnitude of tremor in 
the frequency domain increased the amount of instability and tremor perceived 
in the voice increased also. Similarly an increase in vFo% was associated with 
an increase in instability and tremor. As the overall variation in frequency of the 
voice increased, there was an increase in the amount of instability and tremor 
perceived auditorily in the voice (Table 6.14). 
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Relationship between acoustic measures and visual perceptual measures 
There were significant correlations for two of the acoustic measures with 
visually perceived tremor in the vocal tract. Mftr and vFo showed significant 
positive correlations with tremor in the vocal cords, identified on a sustained /i/ 
vowel (Table 6.14). 
Combining the acoustic, auditory perceived and visually perceived tremor 
findings for the PD group, the results show the following: As the magnitude of 
frequency tremor and /or the overall variation in the frequency of the voice 
increase, there is an increase in auditory perceived tremor and instability, and 
an increase in tremor in the vocal cords on a sustained /i/ vowel. 
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Control group 
The correlational matrix in Table 6.15 displays rho values for relationships 
between acoustic tremor measures and perceived instability and tremor and, 
visually perceived tremor in the vocal tract. 
 
Table 6.15. Spearman correlations (rho) for acoustic voice tremor 
measures and auditory perceived instability and tremor, and visual 
perceptual ratings, for control group 
 
  Auditory perceptual 
Measures 
 Visual-Perceptual Measures 
Acoustic 
measures 
 Instability Tremor  Palate 
/a/ 
Tongue 
/a/ 
Larynx 
/a/ 
Larynx 
/i/ 
 
Rftr (Hz)  -0.503 
n=10 
-0.661* 
n=10 
 0.807* 
n=8 
 
0.504 
n=9 
-0.196 
n=9 
-0.936 ** 
n=9 
Ratr (Hz)  0.041 
n=17 
0.098 
n=17 
 
 0.394 
n=16 
0.029 
n=17 
0.114 
n=17 
0.423 
n=17 
Mftr (%)  0.429* 
n=27 
0.340 
n=27 
 
 0.136 
n=25 
0.141 
n=25 
-0.118 
n=26 
-0.151 
n=26 
Matr (%)  0.569** 
n=27 
0.500** 
n=27 
 
 0.152 
n=25 
0.072 
n=25 
-0.156 
n=25 
-0.097 
n=25 
vFo (%)  0.632** 
n=27 
0.488** 
n=27 
 
 0.081 
n=25 
-0.014 
n=25 
-0.240 
n=26 
-0.188 
 n=26 
vAm (%)  0.203 
n=27 
0.048 
n=27 
 
 0.046 
n=25 
0.365 
n=25 
0.001 
n=27 
0.029 
n=27 
** correlation is significant at the 0.01level (2-tailed 
*correlation significant at 0.05 level (2-tailed) 
 
Relationship between acoustic measures and auditory perceptual measures 
The control group shows a different correlational pattern to the PD group, for 
the acoustic measures.Table 6.15 shows that, three acoustic tremor measures 
(Mftr%, Matr%, vFo%) correlated positively and significantly with auditory 
perceived instability, and tremor. In contrast, RftrHz had a significant negative 
correlation with auditory perceived tremor. This suggests that an increase in the 
rate of tremor (frequency component) is associated with a decrease in auditory 
perceived tremor.  
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Relationship between acoustic measures and visual perceptual measures 
For relationships with visually perceived tremor in the vocal tract, the rate of 
frequency tremor (RftrHz) showed a significant positive correlation with tremor 
in the palate and a negative correlation with tremor in the vocal cords, on a 
sustained /i/ vowel (Table 6.15). 
Supplementary results 
The relationship between auditory perceptual (instability, tremor) and visual 
perceptual tremor measures for the PD group is shown in the correlation matrix 
in Table 6.16.  For the control group, the correlational matrix for auditory 
perceptual (instability, tremor), and visual perceptual measures is shown in 
Table 6.17. Significant associations are denoted in bold, with an asterisk to 
denote significance.  
 
Table 6.16. Spearman correlations (rho) for auditory perceptual and visual 
perceptual ratings for the PD group 
 
  PD group 
  Visual-perceptual measures 
Auditory perceptual 
measures 
 
 Palate /a/ Tongue /a/ Larynx/a/ Larynx /i/ 
 
Instability  0.226 
n=25 
0.183 
n=26 
0.372 
n=26 
0.344 
n=26 
Tremor  0.347 
n=25 
0.098 
n=26 
0.399* 
n=26 
0.436* 
n=26 
** correlation is significant at the 0.01level (2-tailed 
*correlation significant at 0.05 level (2-tailed) 
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Table 6.17. Spearman correlations (rho) for auditory perceptual and visual 
perceptual ratings for the control group 
 
  Control group 
  Visual-perceptual Measures 
Perceptual  
Measures 
 Palate /a/ Tongue /a/ Larynx/a/ Larynx /i/ 
 
Instability  0.374  
n=24 
0.081 
n=24 
0.068 
n=25 
0.194 
n=25 
Tremor  0.499* 
n=24 
-0.011 
n=24 
0.127 
n=25 
0.307 
n=25 
** correlation is significant at the 0.01level (2-tailed 
*correlation significant at 0.05 level (2-tailed) 
 
 
 
PD group 
The correlational matrix shows that there was a significant positive correlation 
between auditory perceived tremor and visually perceived tremor in the vocal 
tract for pwPD (Table 6.16). Specifically, with an increase in the perception of 
tremor in the voice on a sustained /a/ vowel there was a greater amount of 
tremor evident in the larynx (vertical laryngeal dimension) and the vocal cords 
on sustained vowels. 
Control group 
In contrast, a different relationship to that for pwPD is evident for the control 
group for auditory perceptual and visual perceptual measures (Table 6.17). 
There was a significant positive relationship between perceived tremor and 
visually perceived tremor in the palate on a sustained /a/ vowel. 
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Summary results for question 2 
 
For pwPD: 
• An increase in the magnitude of tremor (frequency aspect), and the 
overall variation in frequency is associated with a greater amount of 
auditory perceived instability and tremor. 
• As the magnitude of frequency tremor, and the amount of overall 
variation in the frequency of the voice increases on a sustained /a/ vowel, 
there is an increase in the amount of tremor identified in the vocal cords 
on a sustained /i/ vowel. 
• An increase in the amount of tremor perceived auditorily on a sustained 
/a/ vowel is associated with an increase in tremor in the larynx (vertical 
larynx dimension) on a sustained /a/ vowel, and with tremor in the vocal 
cords on a sustained /i/ vowel. 
For controls: 
• As the rate of frequency tremor increases, there is a lesser amount of 
tremor perceived auditorily in the voice. 
• With greater magnitude of amplitude tremor and overall variation in 
frequency, there is a greater amount of perceived instability and 
tremor in the voice.  With greater magnitude of frequency tremor, 
there is a greater amount of perceived instability in the voice.  
• As the rate of frequency tremor increases there is an increase in 
tremor perceived in the palate on a sustained /a/ vowel. As the rate of 
frequency tremor increases there is a decrease in the amount of 
tremor perceived in the vocal cords on a sustained /i/ vowel. 
• An increase in the amount of tremor perceived auditorily on a 
sustained /a/ is associated with a greater amount of tremor perceived 
in the palate on a sustained /a/ vowel. 
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6.3.3 Question 3  
Question 3 explores the nature of the relationship between acoustic voice 
tremor measures and speech and voice variables. Measures of the rate (Hz) of 
frequency and amplitude tremor (Rftr, Ratr), the magnitude (%) of frequency 
and amplitude tremor (Mftr, Matr), together with overall variation (%) in 
frequency and amplitude (vFo, vAm) were selected for analysis. The 
computerised speech laboratory (CSL)119 explanations of the acoustic 
measures are outlined in APPENDIX I. 
There are three parts to question 3. Part (A) examines the relationship between 
acoustic tremor measures and overall severity of dysphonia, the results are 
presented in section 6.3.3 (A). Part (B) examines the relationship between 
acoustic voice tremor measures and voice disability, with the results outlined in 
section 6.3.3 (B). Finally, part (C) reports the relationship between acoustic 
tremor measures and speech intelligibility in section 6.3.3 (C). For each part, 
the main results will be presented first followed by the supplementary results. 
The tables showing reliability findings for dysphonia severity ratings (CAPE-V) 
are presented in the Appendices section.  
6.3.3 Question 3 (Part A)  
What is the nature and degree of the relationship between acoustic voice 
tremor measures and overall severity of dysphonia? 
 
The results of the Spearman’s Correlation Coefficient (rho) examination of the 
relationship between acoustic tremor measures and dysphonia severity ratings 
from the Consensus Auditory Perceptual Evaluation of Voice (CAPE-V) are 
displayed in Table 6.18, for the PD and the control group. The descriptive 
statistics for CAPE-V dysphonia severity scores and the inter- and intra-rater 
reliability results are outlined in the supplementary results sub-section. 
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Table 6.18. Spearman’s (rho) for Rftr, Ratr, Mftr, Matr, vFo, Vam and 
severity of dysphonia, for PD and control group 
 
 CAPE-V Dysphonia Severity 
Acoustic Measures PD group (n=26) Control group ( n =27) 
Rate frequency tremor [Rftr (Hz)] -0.499 (n=12) -0.297 (n=10) 
Rate amplitude tremor [Ratr (Hz)] 0.138  (n= 15) 0.191   (n=17) 
Magnitude frequency tremor [Mftr (%)] 0.358 0.589 **  
Magnitude amplitude tremor [Matr (%)] 0.158 0.429 *   
Variation in frequency [vFo (%)] 0.454 *  0.764 **  
Variation in amplitude [vAm (%)] 0.387 0.230 
**Correlation significant at the 0.01 level (2-tailed);*Correlation significant at the 0.05 level (2-tailed) 
 
For pwPD, there was a statistically significant moderately weak positive 
correlation between vFo and severity of dysphonia ratings with CAPE-V 
(p≤0.05). In contrast, there was a moderate negative correlation between Rftr 
and severity of dysphonia, which failed to reach statistical significance, possibly 
because of the small sample size for Rftr measures. There were moderate to 
weak positive correlations between Mftr, vAm, Ratr, Matr and CAPE-V scores, 
without statistical significance (Table 6.18). 
 For the control group, there was a statistically significant, strong positive 
correlation between Mftr, vFO, and dysphonia severity (p≤0.01). For Matr, there 
was a statistically significant moderate positive correlation with severity of 
dysphonia (p≤0.05) (Table 6.18). 
Supplementary results for Question 3 (Part A) 
Descriptive statistics for CAPE-V ratings of dysphonia severity for PD and control 
group 
The mean (SD), median and interquartile range (IQR) scores, and p values for 
CAPE-V severity ratings of dysphonia for the PD and control group are 
displayed in Table 6.19. 
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Table 6.19. Mean (SD), median IQR and p value for perceived severity of 
dysphonia for the PD and control group 
 
 CAPE-V dysphonia severity   
 PD (n=26) Control (n=27) U p 
Mean (SD) 
Range 
24.46 (10.63) 
6-42 
20.41 (11.37) 
6-52 
  
Median  
(IQR) 
26.00 
(15.25-34.00) 
16.00 
(12.00-31.00) 
1.443 0.149 
 
Table 6.19 shows that the PD group achieved a higher mean rating for severity 
of dysphonia (greater severity) than the control group, however the difference 
between the groups was not statistically significant, when a Mann Whitney U 
test was applied.  
Inter-rater reliability for dysphonia severity (CAPE-V) ratings of PD & control group 
The inter-rater reliability results for three raters for rating severity of dysphonia 
(CAPE-V) in pwPD and controls are shown in APPENDIX AA.The guidelines for 
Kappa233 coefficients were applied for interpretation of the intraclass correlation 
coefficients (ICC). The ICC’s indicate moderate to moderately strong agreement 
for perceptual ratings of dysphonia severity in the PD and the control group.  
Intra-rater reliability for CAPE-V dysphonia severity ratings of PD & control 
participants 
The findings for intra-rater reliability of perceived severity of dysphonia for three 
raters, using CAPE-V are shown in APPENDIX BB.The intraclass correlation 
coefficients show ‘moderate’ to ‘substantial’ agreement within the three raters 
when rating dysphonia severity in six participants (three pwPD and three 
controls).  
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6.3.3 Question 3 (Part B) 
What is the nature and the degree of the relationship between acoustic voice 
tremor measures and patient-reported voice disability, in pwPD? 
 
The results of the Spearman’s correlation (rho) for the examination of the 
relationship between acoustic tremor measures and Voice Handicap Index (VHI) 
total and subscale scores, for the PD and control group, are displayed in Table 
6.20.The descriptive statistics together with p values for differences between pwPD 
and control groups for VHI total and subscale scores are displayed in Table 6.21, in 
the  supplementary results section.  
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Table 6.20. Spearman’s (rho) for Rftr, Ratr, Mftr, Matr, vFo, vAm and VHI total and subscale scores, for PD and control 
group 
 
  
VHI total and subscale scores 
 
 
        PD group (n=30) 
 
     Control group (n=27) 
Acoustic 
Measures 
 
Total Functional Physical Emotional Total Functional Physical Emotional 
Rftr a (Hz) 0.280 0.265 0.188 0.170 -0.351 -0.436 -0.149 -0.114 
Ratr b (Hz) -0.096 0.034 -0.044 -0.299 -0.219 -0.173 -0.173 -0.364 
Mftr (%) 0.007 -0.049 0.047 -0.061 0.333 0.312 0.269 0.107 
Matr (%) -0.107 -0.150 -0.011 -0.123 0.213 0.186 0.185 0.049 
vF0 (%) 0.052 0.085 0.028 0.026 0.145 0.161 0.078 0.112 
vAm (%) -0.155 -0.212 -0.126 -0.129 0.264 0.354 -0.042 0.251 
a :pwPD (n=13), Controls (n=9); b pwPD (n=16); Controls(n=16) 
 
The findings show that there were no significant correlations (positive or negative) between any of the acoustic measures and the 
VHI total or subscale scores for the PD, or for the control group (Table 6.20). 
146 
 
Supplementary results for Question 3 (Part B) 
Descriptive statistics with p value for VHI total and subscale scores for PD and control 
group 
The mean, standard deviation (SD), range, median, interquartile range (IQR) and p 
values for Voice Handicap Index (VHI) total and subscale scores for the PD and 
control group are displayed in Table 6.21. 
 
Table 6.21. Mean (SD), range, median, (IQR) and p values for total and subscale 
VHI scores for PD and control group 
 
 PD (n=30) 
M22, F8 
Control (n=27) 
M19, F8 
U Z  p-value 
 
Total VHI 
     
Mean (SD) 19.50 (15.11) 4.00 (6.02) 156.000 -4.012 <0.001 a 
Range  (0-49) (0-24)    
Median (IQR) 19.00 (5.75-33.25) 1.00 (0.00-6.00)    
      
Subtests      
      
Functional      
Mean (SD) 6.53 (4.92) 2.00 (2.51) 185.500 -3.558 <0.001 a 
Range  (0-16) (0-9)    
Median (IQR) 6.50 (1.00-11.00) 1 (0.00-4.00)    
      
Emotional       
Mean (SD) 4.97 (5.16) 0.67 (2.13) 179.000 -4.025 <0.001 a 
Range  (0-17) (0-10)    
Median (IQR) 3.50 (0.00-9.00) 0.00 (0.00-0.00)    
      
Physical      
Mean (SD) 8.00 (6.16) 1.33 (2.34) 164.500 -3.964 <0.001 a 
Range  (0-18) (0-10)    
Median IQR 9.50 (0.75-13.00) 0.00 (0.00-2.00)    
a
 t-test 
The mean total VHI and subscale (functional, emotional, physical) scores were 
higher (meaning greater severity), in the PD than the control group. The difference 
between the groups for the total and the three subscale VHI scores was statistically 
significant (p<0.05).  
 
147 
 
 
6.3.3 Question 3 (Part C) 
What is the nature of the relationship between acoustic voice tremor measures 
and speech intelligibility? 
 
The results of the correlational analysis with rho values for the relationship between 
acoustic voice tremor measures and the computerised Speech Intelligibility Test 
(SIT) percentage correct scores are displayed in Table 6.22. The descriptive 
statistics with p values for the SIT scores for pwPD and controls are outlined in the 
supplementary results section in Table 6.23. The inter- and intra-rater reliability 
findings for SIT ratings are also reported in the supplementary results section. 
Table 6.22. Spearman’s correlation coefficient (rho) showing values for 
strength of association of Rftr, Ratr, Mftr, Matr, vF0 & vAm with Speech 
IntelligibilityTest % scores 
  Speech Intelligibility Test (SIT) 
Acoustic measures PD group (n=28) Control group (n=25) 
Rate frequency 
tremor 
Rftr (Hz) 0.469 (n=12) 0.492 (n=10) 
Rate amplitude 
tremor 
Ratr (Hz) 0.230 (n=16) -0.253 (n=17) 
Magnitude 
frequency tremor 
Mftr (%) 0.122 -0.162 
Magnitude 
amplitude tremor 
Matr (%) 0.074  0.063 
Variation in 
frequency 
vFo (%) 0.078 -0.143 
Variation in 
amplitude 
vAm (%) -0.005 -0.271 
 
To interpret the rho values from the correlational analysis, Cohen’s guidelines were 
applied234. For the PD group, Rftr showed a positive medium correlation and Ratr 
and Mftr showed a weak positive correlation with SIT scores. However, neither 
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correlation showed statistical significance. Matr, vFo, and vAm did not show any 
meaningful correlations with speech intelligibility ratings (Table 6.22). 
For the control group, Rftr showed a moderate positive relationship with SIT scores 
without statistical significance. There were weak negative correlations with SIT 
scores for Ratr Mftr, vFo and vAm, without statistical significance (Table 6.22). 
 
Supplementary Results for Question 3 (Part C) 
Descriptive statistics with p values for Speech Intelligibility Test (SIT) % correct scores for 
PD and control group 
The mean (SD), range, median, IQR and p value for the SIT scores, for the PD and 
control group are displayed in Table 6.23. 
Table 6.23. Mean (SD), median, interquartile range (IQR) and t-test for SIT 
values for PD and control group 
 
 Speech Intelligibility Test (%) scores    
 PD (n=28) Control (n=28) t p 
Mean (SD) 94.56 (2.82) 94.79 (2.56) -.328 0.74 
Range 87.73-98.92 86.14-98.41   
Median (IQR) 94.89 (93.07-96.14) 95.23 (93.35-96.70)   
 
The mean percentage intelligibility scores for the PD and control group were closely 
matched. The t-test results show that there was no statistically significant difference 
between the mean values for the PD and control group (Table 6.23). 
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Inter-rater reliability for SIT ratings of PD and control group 
The findings from the Intraclass Correlation Coefficient (ICC) for inter-rater reliability 
rating for the PD and controls group are shown in APPENDIX Y. The results show 
moderate agreement between the raters for their ratings of sentence intelligibility for 
the PD and the control group.  
Intrarater reliability for SIT ratings of PD and control group 
The results for intra-rater reliability showing the intraclass correlation coefficient 
(ICC) values and confidence intervals for speech intelligibility ratings for three judges 
are shown in APPENDIX Z. The ratings from Judge A were excluded in the statistical 
analysis due to missing data related to technical problems. Overall, a moderate to 
almost perfect level of intra-rater agreement was reached by the raters for 
transcription of sentence recordings, with judge B and Judge D achieving identical 
(almost perfect) levels of agreement with ICC’s of 0.968 each. 
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Summary results for question 3  
• For pwPD, an increase in the long-term variation of fundamental frequency 
was significantly associated with an increase in perceived severity of 
dysphonia.  For controls, an increase in the magnitude of frequency and 
amplitude tremor, and variation in frequency was significantly associated with 
an increase in dysphonia severity.  
• PwPD were rated as having a greater severity of dysphonia than controls 
however the difference between the groups was not statistically significant. 
• Inter-rater agreement showed moderate to moderately strong agreement 
between three raters for ratings of perceived dysphonia severity in pwPD and 
controls respectively. For intra-rater agreement, agreement was moderate to 
substantial across the three raters.  
• Acoustic tremor measures did not relate in any significant way to self-reported 
voice handicap in pwPD or in controls. 
• PwPD had a greater amount of voice handicap than controls and the 
difference was statistically significant.  
• For pwPD, acoustic tremor measures did not relate in any significant way to 
percentage correct speech intelligibility for sentences.  For controls there were 
no significant relationships between acoustic tremor measures and 
percentage correct speech intelligibility for sentences. 
• PwPD and controls had the same level of speech intelligibility at the sentence 
level. 
• Inter-rater reliability for sentence transcription was moderate for pwPD and 
controls. Intra-rater agreement was higher with moderate to almost perfect 
levels of agreement reached by two of the raters for pwPD and controls. 
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6.3.4 Question 4  
Question 4 relates to the nature and the degree of the relationship between acoustic 
voice tremor measures and specific disease variables. There are four parts to 
question 4 and the results will be presented separately. Part (A) explores the 
relationship between acoustic tremor measures and disease duration. Part (B) and 
part (C) explore the relationship with activities of daily living and motor symptom 
severity from the Unified Parkinson’s Disease Rating Scale (UPDRS), parts II and III 
respectively. Finally, part (D) looks at the relationship with PD phenotype. The main 
results relating to the specific research question are presented first, followed by 
supplementary findings where appropriate. The findings for question 4 are 
summarised at the end of the section.  
  
 
Question 6.3.4 (Part A) 
What is the nature of the relationship between acoustic voice tremor measures 
and disease duration? 
 
The main study findings are presented first, followed by supplementary findings. 
 
Spearman’s rho values from the correlational analysis of the acoustic voice tremor 
measures (Rftr, Ratr, Mftr, Matr, vFo, vAm) and disease duration are displayed in 
Table 6.24. The descriptive statistics for disease duration are outlined in Table 6.25. 
Table 6.24. Spearman’s correlation coefficient (rho) for Rftr, Ratr, Mftr, Matr, 
vFo, vAm, and disease duration  
 
 PD group (n=30) 
Acoustic Measures Abbreviations  Disease duration  
Rate frequency tremor Rftr (Hz) -0.160 (n=13) 
Rate amplitude tremor Ratr (Hz) 0.336  (n=16) 
Magnitude frequency tremor Mftr (%) 0.515** 
Magnitude amplitude tremor Matr (%) 0.418* 
Variation in frequency vFo (%) 0.408* 
Variation in amplitude vAm (%) 0.280 
*<0.05   **<0.01:  
Disease duration: years (n) since disease diagnosed 
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Table 6.25. Mean (SD), range, median and IQR values for disease duration 
(years) in PD group 
 
 PD group (n=30) 
 Disease duration  
Mean (SD) 5.23 (3.17) 
Range  1-12 
Median 5.00 
IQR 2.75-7.25 
 
Table 6.24 shows that there was a highly significant positive relationship between 
Mftr and disease duration, and that there was a significant positive relationship 
between Matr, vFo, and disease duration. Figure 6.10, Figure 6.11, and Figure 6.12 
show the relationship between Mftr, Matr, vFo, and disease duration respectively.  
 
 
Figure 6.10. Correlation between Mftr and disease duration 
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Figure 6.11. Correlation between Matr, and disease duration  
 
 
 
Figure 6.12. Correlation between vFo, and disease duration 
 
There is one outlier (PD 5) evident in the data for Mftr, Matr and vFo as shown in 
figures 4-1, 4-2, and 4-3. A review of the acoustic raw data for PD 5 shows wide 
variability of values across the three /a/ trials for Mftr, Matr, vFo and vAm 
(APPENDIX O). 
A further analysis was carried out with PD 5 data removed from the analysis to 
evaluate the effect of PD 5 on the correlational findings (Table 6.26). 
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Table 6.26. Spearman’s correlation coefficient (rho) for Rftr, Ratr, Mftr, Matr, 
vFo, vAm, and disease duration with outlier (PD5) removed from the analysis 
 
 PD group (n=29) 
Acoustic Measures Abbreviations  Disease duration  
Rate frequency tremor Rftr (Hz) -0.147(n=12) 
Rate amplitude tremor Ratr (Hz) 0.192  (n=15) 
Magnitude frequency tremor Mftr (%) 0.463* 
Magnitude amplitude tremor Matr (%) 0.355 
Variation in frequency vFo (%) 0.344 
Variation in amplitude vAm (%) 0.202 
*<0.05   **<0.01:  
Disease duration: years (n) since disease diagnosed 
 
Table 6.26 shows that when PD 5 data was removed from the analysis, the 
magnitude of frequency tremor was positively and significantly correlated with 
disease duration. However, the magnitude of amplitude tremor and variation in 
frequency did not show significant association with disease duration when PD 5 was 
excluded. Figure 6.13 displays the relationship between Mftr and disease duration, 
with PD 5 (outlier) excluded from the analysis. 
 
Figure 6.13. Correlation between Mftr and disease duration, with PD 5 removed 
from the analysis 
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A further analysis examining the relationship between acoustic tremor measures and 
age was carried out to determine if acoustic tremor measures related to age in any 
significant way. The findings are reported in supplementary results.  
Supplementary results 
Relationship between acoustic tremor measures and age (years)  
The results showing Spearman’s rho correlations for acoustic voice tremor measures 
and age are shown in Table 6.27. 
Table 6.27. Spearman’s correlation coefficient (rho) for Rftr, Ratr, Mftr, Matr, 
vFo, vAm, and age (years) for PD and control group 
 
 PD group  (n=30) Control group (n=28) 
Acoustic measures Age (years)  
Rftr (Hz) 0.008 (n=13) -0.401 (n=10) 
Ratr (Hz) -0.077 (n=16) 0.193 (n=17) 
Mftr (%) 0.233  0.509** 
Matr (%) 0.009 0.407* 
vFo (%) 0.186 0.528 ** 
vAm (%) 0.239 0.340 
*<0.05   **<0.01:  
 
The significant relationship between selected acoustic measures and disease 
duration was upheld when age was factored into the equation. Table 6.27 shows that 
for pwPD there was no significant relationship between any of the selected acoustic 
measures and chronological age. In contrast, for the control group there were 
significant positive relationships between Mftr, Matr vFo and age (Table 6.27). 
To ascertain the possible effect of outlier PD 5 on the findings in relation to acoustic 
measures and chronological age, the correlational analysis was repeated with PD 5 
data excluded from the analysis. Spearman’s rho analysis of the relationship 
between acoustic tremor measures and chronological age is shown in Table 6.28. 
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Table 6.28. Spearman’s correlation coefficient (rho) for Rftr, Ratr, Mftr, Matr, 
vFo, vAm, and age (years) for PD and control group, with PD 5 excluded 
 
 PD group  (n=29) Control group (n=28) 
Acoustic measures Age (years)  
Rftr (Hz) 0.014 (n=12) -0.401 (n=10) 
Ratr (Hz) -0.284 (n=15) 0.193 (n=17) 
Mftr (%) 0.1533  0.509** 
Matr (%) -0.094 0.407* 
vFo (%) 0.103 0.528 ** 
vAm (%) 0.160 0.340 
*<0.05   **<0.01:  
 
Table 6.28 shows that there were no significant relationships between any of the 
acoustic tremor measures and chronological age for pwPD, when the outlier PD 5 
was excluded from the analysis. 
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Question 6.3.4 (Part B) 
What is the nature of the relationship between acoustic voice tremor measures 
and activities of daily living?   
 
Table 6.29 presents the results of the Spearman Correlation Coefficient (rho) 
examination of the relationship between acoustic voice tremor measures (Rftr, Ratr, 
Mftr, Matr, vFo, vAm), and activities of daily living as measured on the Unified 
Parkinson’s Disease Rating Scale (UPDRS) part II. The descriptive statistics for 
UPDRS II are shown in Table 6.30. 
Table 6.29. Spearman’s correlation coefficient (rho) for Rftr, Ratr, Mftr, Matr, 
vFo, vAm, and UPDRS II  
 
 PD group (n=30) 
Acoustic Measures Abbreviations UPDRS II 
 
Rftr (Hz) Rftr (Hz) 0.283 (n=13) 
Ratr (Hz) Ratr (Hz) -0.425 (n=16) 
Mftr (%) Mftr (Hz) -0.009 
Matr (%) Matr (Hz) -0.018 
vFo (%) vFo (Hz) -0.149 
vAm (%) vAm (Hz) -0.126 
UPDRS II: Activities of Daily Living 
 
 
The results show that there were non-significant negative correlations between 
acoustic measures Ratr, Mftr, Matr vFo and vAM, and a non-significant positive 
correlation between Rftr, and activities of living when measured on the UPDRS II 
(Table 6.29). 
Descriptive statistics for UPDRS II 
The mean (SD), range, median, and IQR values for UPDRS II are shown in Table 
6.30. 
  
158 
 
Table 6.30. Mean (SD) range, median and IQR values for UPDRS II scores 
 
 PD group (n=30) 
 UPDRS II 
Mean (SD) 10.20 (3.85) 
Range 4-19 
Median 9.50 
IQR 7.00-13.25 
 
Supplementary results 
UPDRS II- group mean scores for 13 items  
The group mean scores and standard deviations for the individual items from the 
UPDRS II are displayed in Figure 6.14. 
 
 
Figure 6.14. Group mean scores and standard deviations for UPDRS II items 
 
Figure 6.14 shows that for this group of pwPD, tremor achieved the second highest 
severity rating, followed by speech. Handwriting achieved the highest severity rating.  
0.00
0.50
1.00
1.50
2.00
2.50
3.00 UPDRS II items 
159 
 
Relationship between acoustic tremor measures and UPDRS item 16 
A further analysis was carried out to determine the nature of the relationship 
between acoustic voice tremor measures and the self-report tremor item 16 from 
UPDRS II. Table 6.31 shows spearman’s rho values for examination of the 
relationship between acoustic measures (Rftr, Ratr, Mftr, Matr, vFo, vAm) and self –
report tremor item 16 from UPDRS II. 
 
Table 6.31. Spearman’s correlation co-efficient for Rftr, Ratr, Mftr, Matr, vFo, 
vAm and tremor item 16 from UPDRS II 
 
 PD group (n=30) 
Acoustic Measures Abbreviations UPDRS II 
Tremor (item 16) 
 
Rate frequency tremor Rftr (Hz) 0.303 (n=13) 
Rate amplitude tremor Ratr (Hz) -0.120 (n=16) 
Magnitude frequency 
tremor 
Mftr (Hz) 0.210 
Magnitude amplitude 
tremor 
Matr (Hz) 0.092 
Variation in frequency vFo (Hz) 0.007 
Variation in amplitude vAm (Hz) -0.185 
 
Table 6.31 shows that there were no significant correlations between the acoustic 
measures and the self-reported tremor item 16 from UPDRS II.  
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Question 6.3.4 (Part C). 
What is the nature and the degree of the relationship between acoustic voice 
tremor measures and PD motor symptom severity? 
 
The results for the research question are presented first, followed by the 
supplementary results. 
Table 6.32 presents results of the Spearman Correlation Coefficient (rho) 
examination of the relationship between acoustic tremor measures (Rftr, Ratr, Mftr, 
Matr, vFo, vAm) and motor symptom severity as measured on the motor part of the 
Unified Parkinson’s Disease Rating Scale (UPDRS) part III.  
The descriptive statistics for UPDRS III scores are shown in Table 6.33. 
Table 6.32. Spearman’s correlation coefficient (rho) values for Mftr, Matr, vFo, 
vAm and UPDRS III 
 
 PD group (n=30) 
 
Acoustic Measures Abbreviations  UPDRS III 
Rate frequency tremor Rftr (Hz) 0.168 (n=13) 
Rate amplitude tremor Ratr  (Hz) -0.529* (n=16) 
Magnitude frequency 
tremor 
Mftr 0.099 
Magnitude amplitude 
tremor 
Matr 0.299 
Variation in frequency vFo 0.110 
Variation in amplitude vAm 0.111 
Significant at 0.05 level: 
 
 
There was a significant negative correlation between the rate of amplitude tremor 
(Ratr Hz) and the severity of motor symptoms when measured on the UPDRS III. 
This means that an increase in motor symptom severity was associated with a lower 
rate of amplitude tremor. There were no other significant correlations, positive or 
negative for the acoustic tremor measures (Table 6.32). Figure 6.15 displays 
graphically the significant correlation between Ratr and UPDRS III. 
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Figure 6.15. Correlation between Ratr (Hz), and UPDRS III 
 
Descriptive statistics for UPDRS III 
The mean (SD), range, median and IQR values for UPDRS III are shown in Table 
6.33. 
Table 6.33. Mean (SD), range, median and interquartile (IQR) values for UPDRS 
III for pwPD  
 PD group (n=30) 
 UPDRS III 
Mean (SD)  25.00 (9.23) 
Range 8-41 
Median 24.50 
IQR 17.75-33.0 
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p≤ 0.05 
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Supplementary results  
 
UPDRS III –group mean scores for individual items 
The group mean scores and standard deviations for the individual items from the 
UPDRS III are displayed in Figure 6.16. 
 
 
 
Figure 6.16. PD group mean scores and standard deviations for individual 
items in UPDRS III  
 
Figure 6.16 highlights that body bradykinesia achieved the highest (most severe) 
rating and rest and action tremor scores were at the lower end of the score profile. 
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Relationship between acoustic measures and mean tremor score from UPDRS III 
The rho values from the examination of the relationship between acoustic voice 
tremor measures and the mean tremor score from UPDRS III are displayed inTable 
6.34. A mean tremor score was calculated from the scores of 5 tremor items in 
UPDRS III.  
Table 6.34. Spearman’s rho correlations for acoustic measures and mean 
tremor score from UPDRS III 
 PD group (n=30) 
 
Acoustic Measures Abbreviations  UPDRS III 
Mean tremor score 
 
Rate frequency tremor Rftr (Hz)  0.340(n=13) 
Rate amplitude tremor Ratr  (Hz)  -0.012 (n=16) 
Magnitude frequency 
tremor 
Mftr 0.008 
Magnitude amplitude 
tremor 
Matr 0.070 
Variation in frequency vFo -0.092 
Variation in amplitude vAm -0.215 
 
Table 6.34 shows that there were no significant correlations, positive or negative 
between acoustic tremor measures and the mean tremor scores from UPDRS III. 
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Relationship between disease severity (UPDRS II, UPDRS III) and disease duration   
To establish the nature of the relationship between disease severity as measured 
with UPDRS II and UPDRS III, and disease duration, spearman’s rho was 
calculated. Table 6.35 shows the correlational matrix for UPDRS II, UPDRS III and 
disease duration (years since diagnosis). 
 
Table 6.35. Spearman’s rho correlations for UPDRS II, UPDRS III and disease 
duration 
 
 PD group (n=30) 
 Disease duration 
UPDRS II 0.031 
UPDRS III 0.052 
 
Table 6.35 shows that disease severity was independent of disease duration for this 
group of PwPD with no significant associations between UPDRS II and disease 
duration, or between UPDRS III and disease duration. 
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Question 6.3.4 (Part D) 
What is the nature and degree of the relationship between acoustic voice 
tremor measures and PD phenotype? 
 
The phenotype frequency data is presented first, followed by differences between 
phenotypes on the basis of acoustic measures, and finally supplementary findings 
showing frequency data for rate of tremor based on phenotype. 
Phenotype data 
Table 6.36 shows the categorisation and frequency (n %) of pwPD on the basis of 
phenotype.  
Table 6.36. Frequencies [n (%)] of pwD with tremor dominant, PIGD and 
indeterminate PD phenotype 
 
PD phenotype [n (%)] PD (n=30) 
Tremor dominant 7 (23.3%) 
Postural Instability Gait 
Disorder (PIGD) 
21 (70%) 
Indeterminate 2 (6.7%) 
 
Differences between tremor-dominant, PIGD, and indeterminate phenotypes in relation to 
acoustic measures  
 
Table 6.37 presents the results for the analysis of variance (ANOVA) for rate of 
frequency tremor [Rftr (Hz)], rate of amplitude tremor [(Ratr (Hz)], magnitude of 
frequency tremor [Mftr (%)], magnitude of amplitude tremor [Matr (%)],variation in 
frequency [vFo (%)], and variation in amplitude [Vam (%)]  in relation to PD 
phenotypes [tremor-dominant, postural instability gait disorder (PIGD), 
indeterminate]. 
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Table 6.37. ANOVA for Rfrt, Ratr, Mftr, Matr, vFo & VAm, and PD phenotype 
(tremor-dominant, PIGD and indeterminate) 
 
PD group (n=30) 
 
Acoustic       
 Sum of 
Squares 
df Mean 
Square 
F Sig. 
 
 
Rftr      
Between Groups 1.572 2 0.786 0.099 0.907 
Within Groups 79.457 10 7.946   
Total 81.028 12    
 
Ratr 
     
Between Groups 1.384 2 0.692 0.120 0.888 
Within Groups 75.119 13 5.778   
Total 76.503 15    
 
Mftr 
     
Between Groups .115 2 .057 0.192 0.826 
 Within Groups 8.062 27 .299   
Total 8.177 29    
 
Matr 
     
Between Groups 5.070 2 2.535 0.822 0.450 
Within Groups 83.263 27 3.084   
Total 88.333 29    
 
vFo 
     
Between Groups 3.944 2 1.972 0.300 0.743 
Within Groups 177.209 27 6.563   
Total 181.154 29    
 
vAm 
     
Between Groups 19.742 2 9.871 0.830 0.447 
Within Groups 321.171 27 11.895   
Total 340.913 29    
 
ANOVA did not show a statistically significant difference in Rftr, Ratr Mftr, Matr, vFo, 
and vAm values for tremor-dominant, PIGD and indeterminate PD phenotypes 
(p>0.05) (Table 6.37). 
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A further analysis was carried out to look at differences between  tremor-dominant 
and PIGD phenotypes for (a) acoustic (b) auditory perceptual and (c) visual 
perceptual measures, omitting the ‘Indeterminate’phenotype  from the analysis due 
to small sample size (n=2).  Table 6.38 shows the mean (SD), median, range, and p 
values for all tremor measures on the basis of phenotype [tremor dominant; postural 
instability gait disorder (PIGD)]. 
Table 6.38 shows that for (a) acoustic tremor measures, mean values for Mftr, Matr, 
vFo and Vam were higher in the PIGD than in the tremor-dominant sub-group. 
However, the difference between the phenotypes was not statistically significant for 
any of the acoustic tremor measures. A further analysis was carried out with PD 5 
(outlier previously identified in figure 4-1 to 4-3) omitted from the analysis to 
ascertain if this would make a difference to the statistical findings. However, the 
difference between the groups with PD omitted from the analysis was not significant.  
In relation to (b) auditory perceptual measures, tremor dominant and PIGD had 
similar mean values for instability. For perceived tremor, tremor dominant PD  
showed a higher (greater severity) mean value than PIGD, however the difference 
was not statistically significant (Table 6.38). 
For (c) visual perceptual measures, mean values were higher (a greater amount of 
tremor behaviour in the vocal tract) in the tremor dominant than the PIGD phenotype. 
However similar to the other measures, statistical significance was not found (Table 
6.38). 
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Differences between tremor dominant and PIGD phenotypes in relation to (a) Acoustic (b) Auditory perceptual, (c) Visual perceptual 
measures 
 
Table 6.38. Mean (SD), median, range and p values for (a) acoustic (b) auditory perceptual (c) visual perceptual tremor 
measures based on phenotype [(tremor-dominant; postural instability gait disorder (PIGD)]  
 Tremor Dominant PIGD 
(a) Acoustic n Mean (SD) Median Range n Mean (SD) Median Range t z p 
Mftr 7  0.58 (0.21) 0.55 0.34-1.02 21 0.69 (0.62) 0.60 0.27- 3.29  -0.292 0.796 
Matr 7 2.25 (1.18) 1.73 1.28-4.01 21 2.43 (1.91) 2.01 0.76- 9.73  -0.239 0.836 
vFo 7 1.09 (0.35) 0.97 0.66-1.63 21 1.81 (2.96) 1.06 0.68- 14.65  -0.663 0.533 
vAm 7 6.41 (0.79) 6.48 4.97-7.56 21 8.23 (3.97) 7.48 3.40- 18.16  -0.822 0.435 
            
(b) Auditory-P            
Instability 4 27.00 (7.25) 25.50 20.00-32.00 20 27.85 (16.45) 24.00 4.00-63.00  -0.233 0.852 
Tremor 4 23.25 (6.70) 22.50 16.00-32.00 20 18.35 (12.51) 15.50 2.00-55.00  -0.115 0.273 
            
(c) Visual-P            
Palate /ah/ 7 1.61 (0.70) 1.50 1.00- 3.00 19 1.49 ((0.83) 1.50 0.00-3.00 0.328  0.746 
Tongue /ah/ 7 0.89 (0.93) 0.50  1.00-3.00 21 0.72 (0.55) 0.50 0.00-2.00  -0.299 0.796 
Larynx /ah/ 7 1.29 (0.58) 1.50 1.00- 2.00 21 0.90 (0.63) 0.75 0.00-2.00  -1.44 0.155 
Larynx /ee/ 7 0.71 (0.33) 0.75 0.00- 1.00 21 0.67 (0.50) 0.50 0.00-2.00 0.230  0.820 
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Supplementary results 
 
Frequency of detection and descriptive statistics for Rftr and Ratr in tremor-
dominant & PIGD phenotype 
 
The frequency of detection [(n)%], and the mean (SD), median values of rate of 
frequency (Rftr) and amplitude tremor (Ratr) in tremor dominant & PIGD 
phenotypes is shown in Table 6.39. 
Table 6.39. Frequency of detection [(n)%] and mean (SD), median values 
of Rftr and Ratr in tremor dominant and PIGD  phenotypes 
 
Acoustic Tremor dominant PIGD 
Rate of tremor n (%) Mean(SD) Median n (%) Mean(SD) Median 
 
Rftr  (Hz) 
 
2 (28.6%) 
 
4.50 (3.05) 
 
4.50 
 
10 (47.6%) 
 
4.49 (2.79) 
 
3.44 
Ratr (Hz) 3 (42.9%) 4.88 (0.97) 4.84 11(52.4%) 5.09 (2.70) 4.34 
 
Table 6.39 shows that frequency tremor (Rftr) was detected more frequently in 
the PIGD than the tremor-dominant phenotype. The rate of detection of 
amplitude tremor (Ratr) was closely matched in tremor dominant and PIGD 
groups. 
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Summary main results for question 4 
 
• The magnitude of frequency tremor is positively associated with an 
increase in disease duration, when duration is defined as the number of 
years since diagnosis 
• Acoustic voice tremor is not related in any way to the severity of PD 
disability (UPDRS II)  
• The rate of amplitude tremor (Ratr %) lowers as the severity of PD motor 
symptoms increase, when motor symptom severity is measured with the 
UPDRS.   
• There is no difference between people with tremor dominant PD sub-type 
and people with PIGD phenotype in relation to voice tremor measured 
acoustically.  
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Chapter 7. Discussion 
Introduction 
This is the first prospective study to be carried out on voice tremor in PD. This 
thesis set out to answer some fundamental questions about PD voice tremor. Is 
voice tremor a feature of PD? Is there a difference between pwPD on voice 
tremor measures and people without PD? How does voice tremor relate to 
pertinent voice and speech parameters, and disease variables? What are the 
characteristics of PD voice tremor?  
This study took a multi-dimensional approach to evaluation, to highlight the 
different ways tremor can be evaluated and the varied findings which thus 
ensue. This approach gives greater clarity to the plethora of descriptors in the 
literature. A greater understanding of terminology, coupled with greater 
precision in measuring key variables leads towards improved characterisation of 
this complex phenomenon.  
This is the first study to examine a number of different structures in the vocal 
tract using nasendoscopy, for the purpose of characterising ‘vocal tract tremor’ 
in PD. Based on this study findings, the term ‘vocal tract tremor’ is more apt 
than ‘laryngeal tremor’, when describing the source of auditory perceived PD 
tremor. This study moved beyond those studies that make claims about PD 
tremor in the absence of a matched comparator group, by including a 
neurologically healthy control group.  
In this chapter, general findings relating to the experimental group regarding 
gender, age and disability will be discussed first, followed by some background 
general issues. The findings from the four research questions and their 
component parts will be discussed in sections 7.1 to 7.4. Additional findings 
considered to be of importance to the broader PD field, and not covered in the 
research questions section are addressed in section 7.5. Clinical implications 
arising from the study, together with pointers towards further research are 
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described in section 7.6, and the final section 7.7 outlines the study 
conclusions. 
There were more males than females recruited into this study of thirty pwPD 
study, with a male to female ratio of 2.75:1. In comparison to other studies, the 
ratio of males to females in this study is both higher than the 1.5 male-to-female 
ratio reported by Midi et al.,131 and lower than the 3.4 and 3.1 reported by Perez 
et al.,107 and Goberman et al.,124 respectively.  
The age profile [(61 (10) 34-76 years)] of the pwPD in this study was very 
similar to D’Alatri et al.,210 (60 years), Stewart et al.,88 (59 years) and Perez et 
al’s.,107 study (65 years).  
The experimental group represented the milder end of the disease spectrum in 
relation to disability. The pwPD were independently mobile, excepting one 
participant who required a wheelchair to mobilise when he was off-medication. 
Disease duration was relatively short with almost 40% receiving their PD 
diagnosis within the previous three years.  
However whilst there are some important new findings from this study, there are 
several immediate issues against which background one has to view these 
results. The study findings indicate that voice tremor is associated with PD and 
with ageing. Comparing pwPD with neurologically healthy age-and-sex matched 
controls has highlighted the inherent challenges in identifying differences 
between the two groups. The fact that pwPD in the current study had short 
disease duration and a mild disease severity, contributed further to the 
challenge. However, the findings confirm that even though there are some 
similarities between pwPD and healthy controls, there are also some interesting 
differences which will be highlighted in sections 7.1-7.4. 
There is debate in the investigatory literature on motor aspects of PD as to 
whether one should assess in an ‘on’ or ‘off’ medication state, the argument for 
the latter being that one may arrive at insights closer to the true effects of PD 
independent of medication effects (section 2.5.3). Accordingly, this study 
addressed the possible confounding effects of medication on voice and speech 
results by assessing pwPD in a practically defined ‘off-medication’ state. 
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However a possible negative effect of this approach was that there was a study 
bias towards pwPD who firstly were prepared to forego dopaminergic 
medication and secondly those pwPD who could mobilise independently or with 
help to a hospital clinic when in an ‘off’ medication phase. As a result, the 
participants tended to be younger and have a milder disease severity than other 
PD studies. Further studies should evaluate patients ‘off’ medication perhaps in 
the pwPD own home, a step which is likely to result in the inclusion of patients 
with more severe symptoms. However it would not be possible to carry out the 
nasendoscopic examination outside a medical setting, therefore the study could 
not be replicated in an exact fashion 
Looking at voice tremor in the broader context of the disease is an important 
step towards greater understanding of the way in which speech/voice and limb 
symptomatology relate. The strong positive correlation between the magnitude 
of frequency tremor and disease duration, without the confounding effect of age 
points to a link between speech/voice system and the disease process. This is 
an important finding. However it would be important to test the relationship 
further, using auditory perceived tremor, and vocal tract tremor evaluation 
methods, in addition to acoustic measures as was used in the current study. 
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7.1 Research Question 1.  
Given that tremor represents one of the claimed cardinal features of PD, a 
fundamental and over-riding question of this study was whether voice tremor is 
a distinguishing feature of PD. A further question was if pwPD differ from age-
sex matched neurologically healthy controls when different instrumental and 
perceptual evaluation approaches are used. The findings in relation to acoustic, 
auditory perceptual and visual perceptual evaluation are discussed separately 
in the following three sections. 
(A)Acoustic tremor measures  
The current study represents the largest data set to report on acoustic voice 
tremor measures, in pwPD. Measures of the rate, periodicity and magnitude of 
frequency and amplitude tremor were selected as the key acoustic measures to 
differentiate pwPD from healthy controls. Variation in frequency and amplitude 
were selected as ancillary measures. In this section, I will discuss the findings 
for the key and ancillary acoustic tremor measures in the context of the 
literature, highlighting relevant issues relating to the methodology and study 
findings, before finally outlining the implications of the findings for further 
research. 
When periodic tremor is detected in the voice signal, the Motor Speech Profile 
(MSP)119 gives values for the rate, periodicity and magnitude of tremor. In the 
current study, frequency and amplitude tremor was detected by MSP in 
approximately 50% of pwPD. Amplitude tremor was detected in a slightly higher 
number of pwPD than frequency tremor (Table 6.7). Other studies have 
reported the presence of frequency and amplitude tremor in a small sample of 
pwPD116 88, on the basis of visual perception of tremor in a waveform. However 
this study goes further with a larger sample size and quantification of the 
acoustic tremor measures.  
 An important finding is that frequency and amplitude tremor was also detected 
in controls, and that amplitude tremor was detected in a similar number of 
pwPD and controls. The study findings therefore indicate that frequency and 
amplitude tremor is a feature of this group of pwPD, and of neurologically 
175 
 
healthy controls. Therefore measures detecting the presence of frequency 
and/or amplitude tremor may not be useful indices for differentiating between 
pwPD and controls. Boutsen et al.,184  also reported detection of frequency and 
amplitude tremor in their control group, using the same tremor protocol from 
MSP. However they reported lower rates of detection than the current study, 
and this is likely to be explained by the fact that control participants in the 
current study were older than those in Boutsen et al’s.,184 study. However in 
order to confirm this supposition, further studies would need to look at the effect 
of age on tremor measures in neurologically healthy controls. A further research 
development would be to look at the relationship between age and voice tremor 
in PD.  
The rate of tremor is one of the parameters used in the classification of tremors 
(section 3.2) with a 4-6 Hz tremor rate associated with rest tremor in PD180 
(section 3.4). In this study, the rate of frequency tremor did not differentiate 
pwPD from controls.  However, the rate of amplitude tremor did differentiate the 
groups. PwPD had a higher rate of amplitude tremor than controls (p value 
<0.05) (Table 6.7).The rate of voice tremor in the amplitude domain in this 
study, falls within the rest tremor frequency range associated with PD. 
Contrastively, Boutsen et al.,184 also using the voice and tremor protocol from 
MSP found that frequency tremor rate and not amplitude rate differentiated a 
group of patients with ataxic dysarthria from a healthy neurological group. The 
frequency tremor rate of their patients with ataxic dysarthria was lower at 3.65 
Hz than the frequency tremor rate of 4.39 Hz in pwPD in the present study. It 
appears therefore that the rate of amplitude tremor in the voice may be one 
useful diagnostic indicator in relation to PD voice symptomatology184. 
The measure of periodicity relates to the regularity of the detected tremor. The 
detected frequency and amplitude tremor was more periodic (closer to 100%) in 
pwPD than in controls.  Periodicity of frequency tremor varied much more in 
pwPD than in controls, with a larger standard deviation evident. This variability 
coupled with the small sample size may have resulted in the lack of statistical 
significance between the groups. The difference between the groups for 
periodicity of amplitude tremor approached significance.  
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When tremor is not detected, MSP gives values for the magnitude of non 
periodic (irregular) modulations (frequency and amplitude) present in the voice 
signal. In the current study, the magnitude of ‘non periodic’ frequency tremor 
(Mftr%) and amplitude tremor (Matr%) was numerically greater in pwPD than 
the neurologically healthy age-sex matched control group, however these 
parameters did not differentiate the groups. It is reasonable to expect that Matr 
would have differentiated the groups, considering the differentiating qualities of 
rate of amplitude tremor and the near significance of periodicity of amplitude 
tremor. One possible reason for the non significant finding may have been the 
higher variability (higher SD) in pwPD than the control group. Limb tremor in PD 
is highly variable, both within and between patients 235.  Considering participant 
PD5 for example, the values for Mftr % for the 1st 2nd and 3rd consecutive trials 
were 6.567, 0.977, and 2.337. These are large differences between consecutive 
trials. There were no methodological changes relating to equipment to explain 
the variability. To minimise the effect of tremor variability on tremor measures, 
using one trial as carried out by other authors184 210, instead of three as done in 
the present study may be indicated for further studies. An obvious disadvantage 
to this approach however, is that the variability of measures within patients is 
not evident. Recruiting a larger sample size and increasing the number of trials 
may help to offset the statistical issues arising from high variability between 
trials. 
Since no other study has compared pwPD and neurologically healthy controls 
on acoustic measures of frequency and amplitude tremor it is not possible to 
compare study findings directly with the literature. However, there were 
important similarities and differences between the present study findings and 
other studies in relation to the magnitude of frequency and frequency tremor in 
the PD group. The magnitude of frequency tremor (0.66%), (non periodic), for 
pwPD in the current study was very similar to D’Alatri et al’s 210 reported value 
(0.63%) in their study of twelve pwPD. In contrast the magnitude of amplitude 
tremor (2.49%) was lower in the present study than the value of 4.72% reported 
by D’Alatri et al.210 Both studies were similar with respect to acoustic analysis 
software analysis, mean age of participants, and data collection in an off-
medication state. However there were important differences also between the 
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studies which may explain the difference in findings. Firstly, D’Alatri et al’s 210 
reported mean values were based on one sustained /a/ trial, whereas the 
current study was based on the mean of three trials for each participant.  
Secondly, the pwPD had deep brain stimulation (DBS) carried out two to five 
years before the study evaluation was carried out. Finally, the participants in 
D’Alatri et al’s.,210 study had greater disease severity [higher scores on the 
Unified Parkinson’s Disease Rating Scale (UPDRS) motor scale].  DBS is 
generally carried out on patients at the severe end of the disease spectrum, 
who are no longer benefitting from dopaminergic medication, and have 
significant tremor and/or dyskinesias. The mean disease duration for the 
present study was much lower at 5.23 years (range 1-12) versus 16.04 (10-32 
years) in D’Alatri et al’s study.  It is conceivable that the magnitude of amplitude 
tremor would increase in tandem with greater disease severity and duration. 
This study has shown a significant positive relationship between magnitude of 
frequency tremor (Mftr%) and disease duration (Table 6.26). 
In contrast to the present study findings, Jiang et al.,173 reported that the 
‘magnitude of amplitude modulation’ differentiated their ‘pathological’ tremor 
group (n=10) from the normal control group.  However caution is required 
regarding interpretation of their findings in the context of the current study, for 
two reasons. Firstly, they had a heterogeneous study group, seven had PD and 
one had idiopathic tremor’, (understood by this author to be an ‘essential 
tremor’). Diagnostic information is not provided on the remaining two 
participants. Secondly, their method of quantifying the magnitude of amplitude 
tremor was different to the current study, and to D’Alatri et al’s.,210 study.  
Ancillary tremor measures 
Ancillary tremor measures of overall variation in frequency (vFo) and amplitude 
(vAm) were included in this study to broaden the scope of the analysis, and 
increase understanding of tremor measures. The findings show that pwPD had 
a greater amount of overall frequency variation (vFo) than controls, however the 
difference was not significant. An unexpected finding was the greater amount of 
vAm% in the control than the PD group (Table 6.9), albeit the difference was not 
significant. vAm (%) is a measure of the long-term variation in amplitude from 
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any variations in the amplitude of the voice (periodic modulations, non-periodic 
modulation, rising or falling amplitude)119. The findings from this study indicate 
that pwPD and age-sex matched controls have a similar amount of long-term 
frequency and amplitude variation. The study findings indicate that vFo and 
vAm do not differentiate pwPD from their matched controls, and suggest that 
pwPD and controls have similar levels of overall unsteadiness in the voice, 
using acoustic measurement.   
Control group values versus CSL control values 
An important ancillary finding in this study which has implications for clinicians 
and researchers using MSP is that the control group values for Mftr%, Matr % 
vFo% and vAm% were higher than the CSL published norms119.  These 
differences may be explained by a number of factors. Firstly, the participants 
were older in the current study than they were in the CSL sample. The mean 
(SD) age of the male and female combined group in this study was 60.11 (9.54) 
however, the mean (SD) age of the combined group published in the CSL 
manual was lower at 37.9 (11.3) years. Therefore age positively influences 
measures of frequency and amplitude modulation and overall variation. Thirdly, 
the CSL norms are based on speakers from the US, who may have lower levels 
of tremor and instability than speakers from Ireland. Thirdly, there were 
methodological differences which may explain the different findings for controls. 
In the current study, the mean value of three trials was used in the analysis and 
the middle 3 seconds was selected for analysis. For CSL norms, two trials were 
obtained but it is not reported if the mean value of the trials was used and/or if 
the middle three seconds was included119. D’Alatri et al.,210 used one trial from 
each participant after three training trials, however similar to the current study 
they selected the middle three seconds for analysis. Therefore, caution should 
be exercised when interpreting results generated from the MSP voice and 
tremor protocol for older patients. Clinicians will need to refer to norms gathered 
on subjects older than the CSL sample when interpreting their own patient’s 
tremor values. 
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Implications of findings and further research 
The findings in relation to acoustic measures of voice tremor and their role in 
differentiating pwPD from healthy controls underscores the challenge inherent 
in this task. The issue of ageing is a major confounder because of its effect on 
the neurologically healthy vocal tract and its relationship with PD. A necessary 
step towards greater clarity is that firstly there needs to be more research on the 
effect of ageing on voice tremor features in neurologically healthy controls, 
followed by the effect of age on voice tremor in PD. 
Measures of the magnitude of tremor in addition to overall variation in frequency 
and amplitude may not be useful for differentiating pwPD from healthy controls 
at least when disease severity is mild. To confirm or reject this hypothesis, 
further studies need to use these measures across a range of PD disease 
severity levels.   
The rate of amplitude tremor was the only acoustic measure that differentiated 
this group of pwPD from healthy controls. The clinical significance of this finding 
is not apparent from this study, especially since pwPD and controls did not differ 
significantly on auditory perceived tremor variables. However further insight into 
the implications of this finding may be obtained by looking at its relationship with 
visually perceived tremor in the vocal tract. 
The paucity of norms for acoustic tremor measures has been highlighted in this 
study.  Caution should be exercised when interpreting values for patients over 
the age of fifty years using the voice and tremor protocol from MSP. 
Researchers need to collate norms for neurologically healthy controls older than 
fifty, so that ‘pathological’ findings can be interpreted correctly. 
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 (B) Auditory perceptual tremor measures 
When listeners rated auditory perceived instability and tremor in pwPD and 
neurologically healthy controls, their ratings did not differentiate the groups on 
either instability or tremor. Instability (unsteadiness) was defined as “irregular 
fluctuations in pitch and/or loudness”. Tremor was defined as “rhythmic or 
nearly rhythmic fluctuations in pitch and/or loudness of the voice.” The issues 
relating to the findings for instability and tremor will be discussed separately in 
this section, followed by the supplementary study finding in relation to instability 
versus tremor, finishing with the implications of the findings for further research. 
Instability rating 
One reason for the lack of difference between the groups may have been the 
mild level of perceived instability in pwPD [(mean score of 27.27 (SD 14.92)] 
coupled with the mild level of instability in the healthy controls. The range of 
scores (4-63) across PD participants indicates that some patients had little or no 
perceptible voice instability and others had a significant degree. The low scores 
for instability may be explained by the fact that perceived instability and/or 
tremor was not a criterion for entry into the study. This requirement was 
important in order not to bias outcomes from the start and introduce the risk of 
circular argumentation. For example, two pwPD (PD 10, PD 21) achieved mean 
instability ratings of less than 10 /100 indicating little or no perceived voice 
instability. Of further relevance is that both of these pwPD had short disease 
duration (3 years and 1 year) respectively. In fact, over 60% of the group were 
diagnosed with PD in the last six years.  This study has shown that there is a 
positive relationship between the magnitude of frequency tremor and disease 
duration (Table 6.26). It may be the case therefore that there is a similar 
positive relationship between perceived instability and tremor, and disease 
duration. If this were found to be the case, including pwPD with longer disease 
duration may be associated with increased perceived instability and tremor. 
Further studies are needed to explore this supposition. 
The finding of mild instability in the neurologically healthy control group is 
worthy of comment especially since instability is associated with the ageing 
voice (section 2.5.1).The controls were mostly middle aged to elderly. None of 
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the controls had sought professional help in relation to their voice quality. 
Therefore one may conclude that the mild degree of voice instability did not 
impact on vocal function to a sufficient level to motivate them to seek 
professional help. Perhaps a mild degree of instability represents a ‘normal 
feature’ in the ageing voice.  
Tremor rating 
Similar issues relating to the instability findings apply to perceived tremor 
findings. Both pwPD and controls presented with a very mild degree of tremor.  
The individual ratings for pwPD show that six pwPD were rated with a mean 
score of ten or less indicating that tremor was barely perceptible. It is not 
possible from this work to say if tremor will be become more perceptible in time 
for this subgroup. However, this study has shown that the magnitude of 
frequency tremor increases in tandem with the number of years post diagnosis 
(Table 6.26).Therefore one would expect that perceived tremor would show a 
similar positive relationship. However, establishing the clinical utility of acoustic 
tremor measures (and acoustic measures in general) is an ongoing challenge. It 
may also be the case that voice tremor is never a feature for some pwPD in the 
same way that not all pwPD develop limb tremor (section 3.4). Longitudinal 
single case studies of pwPD using a multidimensional evaluation approach 
(similar to this study) would add to this study findings.  
Controls 
It appears from this study that pwPD with mild disease severity and 
neurologically healthy controls sound similar when rated on features of 
instability and tremor. Previous studies have not compared pwPD and 
neurologically healthy controls on auditory perceived tremor measures, 
therefore comparisons are not possible. However selected acoustic tremor 
measures have also shown similarities between pwPD and controls in this study 
(section 6.1.1).  
Instability versus tremor 
An important additional finding to the main research question was that instability 
on a sustained /a/ vowel was more of a feature than tremor for this group of 
pwPD (Table 6.11). This finding suggests one or both of the following 
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possibilities: this group of pwPD had in fact a greater amount of irregular than 
rhythmical fluctuations in their voice; the listeners found it easier to hear and 
rate the irregular fluctuations than the rhythmical ones leading to higher (more 
severe) ratings for instability. The poor inter-rater reliability suggests that the 
raters experienced more difficulty perceiving tremor than they did instability, 
thus lending support to the second possibility outlined above. 
The ratings for instability and tremor were found to be strongly and positively 
correlated in this group of pwPD. This is not surprising since both parameters 
pertain to fluctuations in the voice.  
 “Unsteadiness” (termed instability in this thesis) has been used by other 
authors to describe the speech and voice patterns of pwPD89 104.  The fact that 
experienced SLT’s considered pwPD to have a higher level of instability than 
tremor in their voice and were more reliable in their ratings between/within 
themselves, suggests perhaps the term ‘instability’ is a more appropriate 
descriptor  than ‘tremor’  to use when describing fluctuations in pitch and/or 
loudness in the PD voice.  
Implications of findings and further research 
Perceived instability and tremor evident in pwPD with mild disease severity, is 
also a feature of neurologically healthy controls. Therefore caution should be 
exercised when attributing auditory perceptual voice analysis findings in pwPD 
to the disease process. Further research is indicated to see if pwPD differ from 
controls on perceived tremor measures when pwPD have more severe disease 
symptomatology. 
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(B) Visual perceptual measures 
A key aspect of understanding and characterising PD voice tremor is identifying 
the anatomic sites in the vocal tract in which involuntary oscillatory movement 
occurs and the speech-related tasks which activate the tremor (4.3.2). Previous 
pronouncements on the topic have simply assumed that voice tremor must a 
priori be associated with laryngeal and/or vocal cord instability. There is though 
no a priori reason to assume this. The phonatory signal that forms the basis of 
acoustic and auditory perceptual analyses is open to influences from anywhere 
in the vocal tract. Visual analyses therefore represent important perspectives for 
understanding the source of perceived PD voice tremor.  
This is the first study to use nasendoscopy for the purpose of identifying tremor 
in the vocal tract in pwPD. The results of this study show some promising 
results with the identification and characterisation of tremor in the palate, tongue 
base and larynx, during rest breathing, voiceless /s/ sound and vowel tasks. A 
novel finding was the identification of tremor in the palate in pwPD. 
Nevertheless, there were some issues arising from interpretation of findings. 
This section will firstly address the issue of reliability findings to assist the 
clinical interpretation of the vocal tract tremor findings which follow. Issues 
around nasendoscopic examination will be highlighted before discussing the 
findings from the clinical examination of head and jaw tremor. The final part of 
the section highlights clinical implications from the findings and direction for 
further research. 
Inter-and intra-rater reliability 
In this study, four experienced SLT’s were required to make a judgement about 
the presence and severity of tremor behaviour, when viewing a silent video 
recording of a nasendoscopic examination of the vocal tract. The definition of 
tremor adopted for visual perceptual rating was that of an ‘involuntary, 
rhythmical or quasi-rhythmical oscillatory movement of a body part’.  
The raters showed poor to moderate inter-rater reliability when rating tremor 
severity in the PD group. This finding is not surprising considering that the 
raters were required to rate involuntary oscillatory movement from video 
recordings of silent nasendoscopic exams. Even though all the raters 
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considered they had experience in viewing endoscopic recordings, they would 
not have had extensive experience in rating involuntary movement. Visual 
perceptual judgements using ‘nasendoscopy’  have generally  shown poor 
reliability in the literature 236 237. Rating tremor behaviour in structures in the 
vocal tract is even more challenging, since the palate, tongue base, and larynx 
are dynamic and rarely steady structures.  
Reliability was poorer when rating tremor in the vocal tract in controls versus 
pwPD. The controls were rated with ‘less tremor’ in the vocal tract than pwPD 
therefore one might expect that the raters would show strong agreement 
regarding the fact that there was little or no involuntary movement evident. 
However raters may find it difficult to discern between ‘normal’ movement in 
structures and ‘subtle tremulous’ movement, thus leading to poorer agreement 
for the controls who have less involuntary movement. One issue therefore that 
arises for future work is the requirement for raters to have more training in 
interpreting and rating ‘normal’ movement of structures in the vocal tract. 
The raters rated 10% (PD & control) of the exams a second time (intra-rater). 
The wide range of percent exact agreement scores across the different tasks for 
pwPD highlights differences in reliability between tasks (APPENDIX W). For 
example, the raters are much more consistent in themselves when rating palatal 
tremor on a sustained /a/ vowel (88% agreement) than when rating tremor in 
the tongue base on a sustained /s/ (43%). The exact reason is unclear.However 
there are two possibilities. Firstly, the raters have more experience in general in 
evaluating the palate, (albeit intra- orally as part of an oro-motor exam), than the 
tongue base. Therefore one would expect that greater familiarity with the 
structure would improve reliability. Secondly, there was more tremor evident in 
the palate on a sustained /a/ vowel (mean 1.60, range 0-3) than there was in 
the tongue on a sustained /s/ (mean 0.81, range 0-3). Raters are more 
consistent in repeat ratings when structures are showing a greater amount of 
involuntary movement than when the movement is barely evident.  
When scores within one point were evaluated, agreement was 100% for all 
tasks excepting tongue /s/ (93%). Further analysis of agreement within raters 
for rating the presence and not the severity of tremor showed promising results 
185 
 
with 100% agreement reached for tremor in the palate (/s/, /a/) and tremor in the 
global larynx (vertical laryngeal tremor) on a sustained /a/ vowel. An increase in 
reliability as the specificity of the agreement is decreasing is not an unlikely 
finding. 
Tremor findings in the vocal tract 
This study differentiated pwPD from a neurologically health control group in 
relation to visually perceived tremor in the tongue, palate and larynx. The 
results clearly show that tremor goes beyond the larynx in PD. The term, ‘vocal 
tract tremor’ is therefore preferential (and more accurate) than the term ‘larynx 
tremor’ commonly used in the literature. This study went further than other 
studies by comparing pwPD with neurologically healthy controls using 
nasendoscopy, and by rating the severity and not just the presence of tremor. 
Even though the PD group were rated with a greater amount of tremor than the 
control group, the mean values were low across all tasks. The palate /a/ task 
achieved the highest rating overall (1.60) indicating mild/intermittent to 
moderate tremor severity on a scale of 0-3.  Effect size calculation however 
showed that the differences between the PD and control group were sizeable 
for a number of tasks (Table 6.13).The largest effect size (r =0.57) was 
achieved for tremor in the global larynx (vertical laryngeal tremor) on a 
sustained /a/ vowel. A previous study identified vertical laryngeal tremor in 55% 
of a group of 22 pwPD. However Perez et al.,107 did not include a control group 
and rated only presence of tremor unlike this study which also addressed 
tremor severity.   Vertical laryngeal tremor is emerging as an important source 
of tremor in pwPD and differentiates pwPD from controls. Further, raters gave it 
the same severity rating 75% of the time on repeat viewing which has important 
clinical implications, in terms of seeking variables that can be reliably identified 
and quantified. Vertical laryngeal tremor has also been reported in patients with 
essential tremor of the voice (ETV)200.Therefore it appears that there are 
similarities between pwPD and patients with ETV in relation to vocal tract 
tremor.  
Looking at individual pwPD profiles for overall vocal tract tremor, 97% (29/30) 
had some degree of tremor identified (Figure 6.9). This is higher than the 55% 
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reported by Perez et al.,107 in their PD study. The difference in prevalence may 
be explained by the focus on the palate and tongue in addition to the larynx, as 
was the case with the current study. The vocal tract tremor profile for this group 
of pwPD clearly shows that tremor is more evident in the palate than in the 
larynx or the tongue (Figure 6.8). This is the first study to document palatal 
tremor on a sustained /s/ (voiceless) sound and a sustained /a/ vowel in pwPD. 
Interestingly tremor in the palate on a sustained /a/ vowel achieved the highest 
rating relative to the other sites/tasks. PwPD have been reported to have 
weakening of pressure consonants and nasal imbalance. Palatal tremor 
identified in this study may contribute to articulatory and resonance imbalance, 
though further studies would need to explore this issue further. Tremor in the 
tongue regardless of speech related task achieved the lowest ratings (mean 
score less than 1), relative to the palate or the larynx. Hanson et al.,34 in their 
study of thirty two pwPD using a different examination approach considered that 
tremor mostly involved the ‘tongue and strap muscles’. Their findings appear to 
be inconsistent with the current study, which showed multiple sites. However 
since they did not attempt to quantify or characterise tremor it is difficult to relate 
their findings directly to the present study.  
An interesting and novel finding in the current study was that there was a 
greater amount of tremor behaviour identified in the larynx during a voiceless 
task [(larynx /s/; mean rating1.27)] than during sustained /a/ vowel (mean rating 
1.04) and /i/ (mean rating 0.68). The specific structure that the raters were 
asked to focus on in the larynx for sustained /s/ was the arytenoid cartilages. 
Perez  et al.,107 in their laryngeal study of  pwPD did not include a sustained /s/ 
task, but thought that it would be of interest to define a postural laryngeal task 
and examine tremor during the task107. During a sustained /s/, the arytenoids 
are ‘held’ in an open but slightly adducted position and therefore a sustained /s/ 
task with focus on the arytenoids cartilages could be considered a laryngeal 
‘postural’ task. The relationship between tremor identified on a sustained /s/ and 
auditory perceived tremor is not addressed in this work. Further studies could 
progress this question by evaluating auditory perceived tremor in a speaking 
task, and looking at the relationship with tremor identified visually during 
sustained voiceless sound /s/, and voiced sounds.  
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Controls 
Low levels of tremor were identified in the healthy neurological control group 
across the ten visual perceptual rating tasks. The mild rating of palatal tremor 
(/a/ in the control group is an interesting finding. Tremulousness has been 
associated with the ageing voice238 and instability and tremor were identified in 
controls in the current study. Perhaps palatal tremor is a source of perceived 
instability and/or tremor in neurologically healthy controls. Further research is 
required to explore this topic further. 
Nasendoscopy examination 
Nasendoscopy permits the observation and evaluation of tremor behaviour in 
the palate, tongue, larynx, and vocal cords, thereby contributing important 
information on possible sources of PD voice tremor. The findings from PD vocal 
tract tremor evaluation are important for a number of reasons: they increase 
understanding of potential sources of perceived tremor; they contribute to a 
classification approach to PD voice tremor; they broaden discussion around PD 
voice tremor by including tremor sites outside the larynx together with breathing 
and speech tasks.  
However, nasendoscopy is an invasive procedure, and is not routinely carried 
out on pwPD for voice analysis. In this study, all of the pwPD showed good 
tolerance of the nasendoscopic exam. The self-reported strong acceptability of 
the procedure coupled with a low level of reported discomfort in a minority of 
participants, and the valuable information obtained, implies that it is an 
acceptable procedure to use with pwPD for tremor analysis. Future studies 
should incorporate visual perceptual rating of vocal tract structures alongside 
routine auditory perceptual evaluation to improve understanding of 
pathophysiology of PD voice and speech disorders.  
Head and jaw tremor 
In this study the presence of head and jaw tremor was identified by this 
researcher prior to the nasendoscopic examination to give context to the voice 
tremor findings. Head tremor was identified in just two (6%) pwPD. This finding 
supports the literature which states that tremor rarely involves the head in PD6. 
The identified head tremor was considered subtle and mild in amplitude.  
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Conversely, jaw tremor was more prevalent than head tremor and was identified 
in eleven (35%) pwPD. The literature describes jaw tremor as being ‘relatively 
common’ in PD105,  however, no other study has quantified its prevalence in PD.  
It is not possible from this study to say if jaw tremor when present contributed 
any way to voice tremor identified acoustically, auditory perceptually or visually 
perceptually. Considering that jaw tremor is a feature of PD, further studies 
could incorporate jaw tremor evaluation, or control for it by using a bite block.  
Implications of findings and further research 
Focussing solely on the larynx gives an incomplete picture regarding possible 
sources of voice tremor in PD. Nasendoscopic examination, although invasive 
is well tolerated by pwPD and affords a view of tremor in laryngeal and 
extralaryngeal (outside larynx) sites. Therefore the term ‘vocal tract tremor’ is 
more meaningful when describing tremor behaviour in pwPD.  
The salience of vertical laryngeal tremor in the vocal tract tremor profile coupled 
with the high intra-rater agreement supports its clinical use. Studies looking at 
the effect of dopaminergic medication, deep brain stimulation (DBS), and voice 
therapy on voice tremor could include vertical laryngeal tremor as an outcome 
measure.  Note that vertical laryngeal tremor may be visually evident in a 
person’s neck. It would be informative to explore the relationship between 
visually perceived tremor in the neck and in the vocal tract, since the former is 
non invasive and thus more accessible to all clinicians. 
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7.2. Research Question 2  
Question 2 makes a logical progression from question 1, by examining acoustic 
tremor measures in the context of the more ‘clinical’ based measures. A major 
issue in the field of voice analysis relates to the clinical interpretation, and 
clinical utility of acoustic voice analysis (section 2.4.3).  An issue of greater 
immediacy for this study is that of determining the clinical correlates of acoustic 
voice tremor measures, from an auditory perceptual, and visual perceptual 
perspective. This work is necessary to determine if acoustic tremor measures 
have a role in the clinical evaluation of PD voice tremor. The key findings 
emerging from question 2 will be discussed first, to be followed by consideration 
of the broader implications of the findings for the field of acoustic analysis.   
The findings from this study showed that with an increase in the magnitude 
(extent) of frequency tremor (Mftr%), there was a greater amount of instability 
(unsteadiness) perceived in the voice. There was also a greater amount of 
tremor (rhythmic/quasi rhythmic fluctuations) perceived in the voice, with an 
increase in Mftr%. This finding suggests that what was perceived as ‘tremor’ or 
unsteadiness’ in the voice was related to modulations in the frequency of the 
voice, in this group of pwPD. 
Interestingly, but not altogether surprising, the overall variation in frequency 
(vFo %) was also associated with perceived instability and tremor in the voice. 
VFo is not strictly a measure of tremor. It is best to think of vFo as a generic 
measure of instability in the voice signal. It may reflect any of the following: 
rhythmic or quasi rhythmic oscillations (tremor), noncyclical or irregular 
oscillations (unsteadiness), or rising or falling fundamental frequency across the 
3-5 second recorded segment119. 
This study goes further when it makes a link beween the magnitude of 
frequency tremor (Mftr %) and variation in frequency (vFo), and visually 
perceived tremor in the vocal cords. This makes an important link between 
frequency tremor and tremor in the vocal cords. 
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From a clinical perspective, the researcher considered it very important to look 
at the relationship between what a listener perceives as tremor (rhythmic/nearly 
rhythmic fluctuations in pitch/loudness of the voice), and the possible source of 
that tremor in the vocal tract. The supplementary analysis findings were very 
revealing and novel, in that they showed that when tremor was perceived it was 
positively associated with vertical laryngeal tremor, and with tremor in the vocal 
cords. 
For controls, there were some similarities and some differences also, in the way 
that acoustic measures related to perceived instability and tremor, and to tremor 
in the vocal tract. The negative correlation between the rate of frequency tremor 
(Rftr Hz) and perceived tremor may be translated as, with an increase in the 
rate of tremor (more cycles per second), there is less perceived tremor in the 
voice. This is understandable since a faster tremor rate is harder to perceive. 
What is not clear though is why this relationship is evident in the control group 
and not the pwPD group.  The study findings in general are confirming that 
tremor is a feature of the ‘neurological’ voice and the ‘normal’ voice. The 
challenge is to identify the way in which tremor is realised in PD, and in 
neurologically healthy controls. 
From a methodological perspective, one might argue that a weakness of the 
study is the fact that the /a/ vowel on which the acoustic measures are based is 
not the same /a/ as which the auditory perceptual, and visual percpetual rating 
is based. This is a valid observation and therefore caution is required in the 
interpretation of the associations between the measures. However, it is also 
important to note that every effort was made by the researcher to minimise 
methodological variations by adhering to the following protocol: the same order 
of recording was followed for all pwPD and controls, i.e. audio-recordings were 
followed by acoustic recordings (maximum time interval of 5 minutes between 
audio and acoustic recording), followed by the nasendoscopic examination.    
The acoustic tremor measures from the Motor Speech Profile (MSP) have had 
limited application in the clinical field. The findings from this thesis contribute to 
that knowledge base.  
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7.3 Research Question 3 
This is the first study to evaluate PD voice tremor in the context of other 
pertinent voice and speech variables. The pupose of question 3 was to place 
PD voice tremor in the broader context of changes in voice quality, voice 
disability, and communication effectiveness, all of which are associated with 
PD. In the following sections, I will discuss the findings relating to the 
relationship between acoustic tremor measures and (a) severity of dysphonia 
(b) voice disability and (c) speech intelligibility. 
(A) Acoustic tremor measures and overall severity of dysphonia 
This is the first study to analyse PD voice tremor in the context of voice quality 
changes. Voice changes and PD are inextricably linked (section 2.3). The 
findings showed that for pwPD, acoustic tremor measures of rate (Rftr, Ratr) 
and magnitude of tremor (Mftr, Matr) did not relate to the perceived severity of 
dysphonia when dsyphonia was measured with the Consensus Auditory 
Perceptual Evaluation of voice (CAPE-V). However, a measure of overall 
instability, the overall variation in frequency (VFo %), did relate to severity of 
dysphonia. It is important to reiterate here that vFo is a measure of overall 
variation in frequency and may or may not reflect periodic tremor in the voice 
signal119.  
The positive relationship identified between vFo% and overall voice deviance 
(CAPE-V) cannot be considered unique to pwPD since a similar relationship 
was identified in the control group (Table 6.18). In addition, the positive 
relationship identified between magnitude of tremor (Mftr %) and auditory 
perceived voice deviance in the controls and not pwPD suggests that there may 
be differences between the groups in relation to tremor effects on voice quality. 
However, it is not possible to determine the nature of the difference based on 
the current study findings. 
The pwPD group were rated as having a mild degree of dysphonia severity 
when rated independently by three experienced SLT’s, using CAPE-V100. A mild 
severity rating is not surprising for a number of reasons. Participants were not 
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selected for the study on the basis of perceived dysphonia. As a group they had 
a relatively short disease duration and mild disease severity, which might 
suggest minimal dysphonia.  The study findings relating to overall severity of 
dysphonia are novel. Other studies have described voice changes in pwPD, but 
have focussed on prevalence and qualitative voice changes rather than 
determining an overall rating of voice deviance as happened in this study. One 
exception is the study carried out by Midi et al.131 who used the  overall grade 
(G) parameter from GRBAS99. The grade (G) parameter from GRBAS and the 
severity grade from CAPE-V have been shown to correlate positively101. There 
were a number of similarities between the current study and Midi et al’s131. Both 
pwPD groups were similar with respect to age and disease severity (mild), and 
both included a control group. However, disappointingly, it is not possible to 
compare the overall dysphonia severity CAPE-V findings with Midi et al’s131 (G) 
findings. Midi et al., 131 reported findings for overall grade of dysphonia (G) in 
graph format showing males to have a mean value of 6/10 and females a 
meanvalue of 3/10. Considering the GRBAS has a four point scale from 0-4, it is 
difficult to to interpret these scores. 
In this study the pwPD group were rated with an overall mild degree of 
dysphonia. The highest score obtained in this group of pwPD was 34 (range 0-
100). Severity of dysphonia was rated with the parameter ‘overall severity’, 
defined in CAPE-V as the ‘global integrated impression of voice deviance’. A 
mild dysphonia rating is not surprising for this pwPD group considering that 
dysphonia was not a criterion for entry into the study, coupled with the fact that 
the group were at the milder end of the disease severity continuum.  
A similar level of mild dysphonia was identified in the control group with a mean 
(SD) range value of 20.41(11.3). This finding may be explained by the fact that 
the majority of the control group were more than fifty years of age, with a mean 
age of 60 years. Changes in vocal tract structures are associated with ageing 
(section 2.5.1) and dysphonia in the aged population is relatively common142. It 
appears therefore that this group of pwPD with mild disease symptomatology 
and short disease duration were no different in terms of overall ‘dysphonia 
severity’ or ‘voice deviance’ when compared to a group of people without PD 
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who had a similar age profile. There is a need to look at pwPD across the whole 
time span of the disorder to truly appreciate voice changes and differences with 
healthy controls. 
It is difficult to compare present study findings directly with other studies, since 
perceptual based studies have concentrated more on ratings of distinct 
perceptual parameters, for example ‘hoarseness’89 than on an overall severity 
level of dysphonia (Table 2.1). Nevertheless, there is some similarity between 
the current study findings and Chenery et al’s89, with the finding that  even 
though hoarseness was present in 100% of their sample, it was ‘just noticed’  in 
80% (n=19) of their group. Further, the difference between their PD and control 
group for hoarseness ratings was not significant. The fact that in both studies 
the pwPD were at the milder end of the disease spectrum may be relevant.  
(B)Relationship between acoustic tremor measures and voice 
disability 
The purpose of question 3 (part B) was to explore the nature of the relationship 
between acoustic voice tremor measures and voice disability as measured on 
the Voice Handicap Index (VHI).The results show that the selected acoustic 
tremor measures were not predictive of the total VHI, or the VHI subscale 
scores, for pwPD (Table 6.20). An important finding to highlight is that this 
group of pwPD were found to have a significantly greater voice disability than 
an age and sex-matched control group (Table 6.21). 
The finding that there was no relationship identified between acoustic tremor 
measures, and voice disability is not surprising. It is difficult to relate objective 
acoustic measures to the self-perceived impact of a voice disorder which varies 
for each patient depending on their personality, social networks, family 
relationships and occupation129. Although a number of studies have used 
acoustic, and self-report measures132 71 131 129  in voice evaluation of pwPD, no 
previous study has explored the relationship between acoustic voice tremor and 
self-report measures. Wheeler et al.,129 looked at the relationship between 
acoustic measures (Fo, SDFo, jitter, shimmer) and the total and sub-scales of  
the VHI in a group of people (non PD) with mildly disordered voice quality, and 
also found that there was no significant relationship between acoustic and VHI 
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measures. The current findings highlight the non linear relationship that exists 
between disability and handicap81.  Acoustic tremor measures and self-report 
voice disability measures are not interchangeable therefore, based on the 
current results. 
 VHI total and subscale scores  
Self-perceived voice problems in pwPD have been reported in other studies, 
some of which have also used the Voice Handicap Index (VHI)132 71 131. The 
total VHI score for pwPD in the current study indicated a mild disability (Table 
6.21) and was similar to the values reported by Frost et al.71 Conversely, 
Carmichael et al.,132 in their study reported higher mean VHI scores [(mean 
39.99,(SD) 22.35)] than those in the current study which may be explained by 
the fact that their group had a greater disease severity profile (stages II to IV on 
the Hoehn & Yahr scale) than pwPD in the current study (Table 6.5). 
Gender differences were not the focus of the current study. However it is of 
general interest to clinicians working with PD that male pwPD reported greater 
levels of voice disability than female pwPD. Midi et al’s131 results show a similar 
trend with mean (SD) scores of 34.42 (3.45) for males and 15.5 (2.86) for 
females. There were more males (n=22) than females (n=8) in the present 
study and this differential may have complicated the findings. However, the 
mean age of the male and female pwPD groupwas very similar (60 years vs.62 
years) in the current study, therefore age difference cannot be seen as an 
influencing factor in the findings. In summary therefore, voice tremor when 
measured acoustically is not a predictor of increased voice disability in pwPD. 
Further studies should focus on different approaches to measuring tremor, in 
addition to other voice parameters for possible associations with voice disability. 
Gender differences in relation to voice disability in pwPD, is an area worthy of 
further exploration.  
 
(C). Relationship between acoustic voice tremor measures and 
speech intelligibility  
The final part of question 3 addresses the nature of the relationship between 
acoustic voice tremor measures and speech intelligibility for sentences, using 
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the Speech Intelligibility Test (SIT)156. In the current study, when the acoustic 
voice tremor scores were analysed with regard to associations with speech 
intelligibility, they were found not to relate in any significant way (Table 6.22). 
Previous studies have not addressed this specific question regarding voice 
tremor and speech intelligibility. However other studies have looked at other 
voice and speech variables with mixed findings reported. 
The fact that the pwPD group had a very mild reduction in speech intelligibility 
(94%) for sentences may be influential in the findings reported in this study 
(Table 6.23). It is important to reiterate here that the pwPD in this study were 
not recruited on the basis of any perceptible speech and/or voice difficulty. A 
number of the participants had no reduction in speech intelligibility. In fact a 
matched neurologically healthy control group were found to have the same 
mean % intelligibility score as the pwPD with no difference found between the 
groups. Acoustic voice tremor findings did not relate to speech intelligibility 
scores for the control group (Table 6.22)). 
An issue to consider is the fact that the sentences employed in SIT are not 
controlled for syntax or semantic cues to meaning 222. Therefore high scores on 
the SIT may reflect overall understandability rather than signal speech 
intelligibility. Therefore the intelligibility task used might be contributory to the 
negative findings regarding acoustic voice tremor and speech intelligibility.  
Testing speech intelligibility in pwPD in a dual task condition, for example with 
background noise, or with a group of listeners, may give a different more 
realistic intelligibility index. Another area worthy of consideration would be to 
use an all-voiced sentence task, which one would expect would increase tremor 
and possibly impact reduce speech intelligibility. Studies could also use auditory 
perceptual tremor measures with a sustained vowel and sentence task to test 
the relationship further. 
In this novel study, acoustic voice tremor measures did not contribute to 
sentence intelligibility scores, however further studies with a change in 
intelligibility task and/or a change in voice tremor measurement approach is 
indicated.  
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7.4 Research Question 4 
The aim of the final question was to establish the nature of the relationship 
between acoustic voice tremor measures, and four specific disease variables: 
(a) duration of disease; (b) activities of daily living (disability) (c) motor symptom 
severity, and (d) PD phenotype. Exploring the relationship between PD voice 
symptomatology and disease variables is warranted to enhance understanding 
of voice and disease pathophysiology, which contributes to diagnostics and 
treatment approaches. Voice tremor is uniquely placed to explore the 
relationships between voice dysfunction and disease variables by virtue of the 
fact that phonatory changes are salient in PD and limb tremor is a cardinal 
symptom of PD. The findings from the four sub-questions within question 4 are 
discussed under the relevant headings.  
  
(A) The relationship between acoustic voice tremor measures, and 
duration of PD disease?  
This preliminary work exploring voice tremor in the context of PD disease 
duration raises some interesting findings and questions.This study has 
demonstrated that there is a significant positive correlation between acoustic 
voice tremor and disease duration in a group of thirty pwPD. The magnitude of 
frequency (Mftr %) and amplitude tremor (Matr %) in the voice signal together 
with the overall variation in frequency (vFo %) were found to relate positively 
and significantly to disease duration (number of years post diagnosis). This 
relationship was upheld when age was controlled (Table 6.27).Therefore as the 
length of time from diagnosis increased there was a corresponding increase in 
the magnitude of tremor and the overall variation in frequency of the voice. The 
findings reported here would be strengthened if auditory perceptual and visual 
perceptual tremor measures were found to show a similar positive relationship 
with disease duration. 
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Mftr % in the voice signal had the strongest correlation with disease duration. 
This may be revealing of the pathophysiology of PD voice tremor. For example, 
the fact that Mftr % showed a stronger correlation with disease duration relative 
to Matr %, might suggest changes in the physiology of tremor over time 
reflected more in Mftr % than Matr %. Conversely, it may be the case that in fact 
the ‘magnitude’ of frequency tremor is a more sensitive indicator of disease 
duration.  This is a preliminary supposition based on a small sample of pwPD 
with a relatively short disease duration (mean 5.23 (3.17) (1-12 years). Further 
studies should replicate the methodology with a sample of pwPD who have had 
the disease for a longer period of time.  
There was one outlier (participant PD 5) in the acoustic measures data, evident 
in the correlation graphs for Mftr, Matr, vFo, and disease duration (Figure 6.10, 
Figure 6.11, Figure 6.12).The values for Mftr, Matr and vFo were significantly 
higher for PD 5 than were the values for the other participants. PD 5 was a 76 
year old female. She was the oldest participant in the group and had the longest 
disease duration (12 years) relative to the other participants. There was a wide 
range in values across the three trials for all the acoustic measures for this lady 
(APPENDIX O). The reason for the high variability across trials was not clear 
from re-analysis of the voice signals (3 trials) saved in the MSP data file. Limb 
tremor variability is a feature of PD (section 3.4) and voice tremor variability is 
also evident in acoustic voice tremor analysis shown in this study.  It is 
important to note that the participant with the greatest magnitude (%) of 
acoustic voice tremor and the greatest variability between trials was also the 
oldest pwPD. A possible drawback of this study is the ‘young’ age profile of the 
pwPD group [(61.40 (10.31) years].  It is necessary to include older (i.e. aged 
70 and over) participants in studies so that findings can be generalised to the 
clinical population239.  
Previous studies have not looked specifically at the relationship of acoustic or 
other voice tremor measures, and disease duration in pwPD.  However, other 
studies have looked at other speech and voice variables and disease duration, 
and report contrasting findings to the present study102 77 135.For example, 
Coates et al.,102and Miller et al.,77 found that speech intelligibility did not 
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correlate significantly with disease duration. Gamboa et al.,135 did not identify a 
relationship between self-report voice measures, a range of acoustic measures 
[fundamental frequency (Fo), jitter, shimmer, and harmonic-noise ratio (HNR)], 
‘phonetometric’ (dynamic range, s/z ratio, maximum phonational time), and 
disease duration. All aforementioned studies defined disease duration in 
relation to the number of years since diagnosis, similar to the present study. 
However, apart from the important fact that different speech and voice variables 
were studied across the studies, there were also differences in relation to 
dopaminergic medication schedules 102 77 135.For example, in the current study 
pwPD were tested ‘off medication’, whilst in other studies pwPD were ‘on 
medication’135, ‘off medication’77, and on different medication regimes within the 
same study102.  
To firmly establish the relationship between voice tremor and disease duration, 
it is necessary to broaden the scope of the work by looking at the relationship 
between other evaluation approaches (auditory perceptual, visual perceptual 
measures), and disease duration. Additionally, including pwPD older than 70 
years and with longer disease duration than the present study would be 
important methodologically. It would be informative also to establish if the same 
positive relationship between acoustic voice tremor and disease duration exists 
when pwPD are ‘on medication’.  
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(B) The relationship between acoustic voice tremor measures, and 
activities of daily living? 
The Unified Parkinson’s Disease Rating Scale (UPDRS) II is used widely, 
clinically and in PD studies to document the impact of the disease on the 
person’s activities of daily living. Understanding ways in which voice tremor 
relates to PD disability is important, particularly in the context of ameliorating 
symptoms and improving quality of life. Speech and voice studies do not 
generally report data on UPDRS II, therefore the findings here are novel and 
exploratory. 
Acoustic voice tremor was found not to relate positively or negatively to 
activities of daily living measured with UPDRS part II. Possible reasons for the 
lack of a relationship between the two measures, together with some interesting 
findings from adjunctive analysis of the UPDRS II scores is discussed as 
follows. 
The level of disability as measured with UPDRS II may have been too low for 
any meaningful relationships to emerge. Further studies encompassing pwPD 
with higher scores on UPDRS II may show different findings. Another reason 
may pertain to the way in which the different measurement tools are used. For 
example, computerised acoustic voice analysis was carried out at a discrete 
point in time. Conversely, global disability related to PD was measured on the 
basis of the pwPD self-perception of specific symptoms and activities (tremor, 
speech, handwriting etc.) over the preceding two week period. Item 5, which is 
the speech item in UPDRS II relates to pwPD self-perception of speech 
intelligibility only and not to voice tremor or other speech/voice variables. A final 
issue may relate to the fact that UPDRS II is a composite measure of pwPD 
self-reporting on different aspects of PD (walking, falling, tremor, handwriting 
etc) (APPENDIX A) and may not relate in any way to voice tremor. The 
researcher therefore tried to address this problem by looking specifically at the 
relationship between acoustic voice tremor measures and the self-report tremor 
item 16. However findings showed no significant relationship between acoustic 
voice tremor and self-report tremor measures (Table 6.31). It would be 
informative to broaden the scope of this question by including other voice 
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tremor measurement approaches (auditory perceptual, visual perceptual) in the 
analysis. In addition, looking at other voice variables, for example, hypophonia, 
dysphonia, speech intelligibility etc, to see how they relate to PD disability would 
also be valuable.  
It is worth highlighting an interesting ancillary finding that emerged from a 
supplementary analysis of the UPDRS II scores, based on group scores for the 
individual items (Figure 6.14). Across the 13 UPDRS II items, handwriting 
achieved the highest mean rating (most severe), followed by tremor and then 
speech. Therefore, although the overall disability was mild for this group of 
pwPD, their self-rating of tremor and speech was at the higher end of 
range.However acoustic voice tremor did not appear to contribute to their 
overall disability. 
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(C) Relationship between acoustic voice tremor measures and PD 
motor symptom severity 
The question of a relationship between voice tremor, motor symptoms, and limb 
tremor is not only interesting but also important because of the contribution the 
findings make to the motor/non motor debate. When the relationship between 
acoustic voice tremor and motor symptom severity (UPDRS III) were evaluated 
mixed findings emerged.  
Rate of amplitude tremor (Ratr Hz) 
As PD motor symptoms measured with the UPDRS III become more 
pronounced, there is a lowering of the rate of amplitude tremor (Ratr Hz) (Table 
6.32).  Neither the magnitude of tremor (frequency, amplitude) nor the overall 
variation of frequency or amplitude related in any way to UPDRS III scores. The 
findings suggest that as the disease process develops (increase in motor 
symptoms), the rate of tremor (amplitude) becomes slower. The rate of 
amplitude tremor [(mean 4.94(SD) 2.25 Hz)] differentiated pwPD from controls 
(Table 6.7) which strengthens the finding that Ratr and UPDRS are related at 
least in this group of pwPD. Pathological tremor is associated with a lower rate 
of tremor than normal ‘physiological tremor’ (section 4.1). One could speculate 
therefore, that the pathophysiology of voice tremor changes over the course of 
the disease leading to a lowering of the rate which translates into it being more 
noticeable clinically in more advanced stages of the disease.  
Magnitude of tremor (frequency & amplitude) 
It may be surprising that no relationship was found between the magnitude of 
frequency (Matr) or amplitude tremor (Matr) and the severity of motor 
symptoms, especially since Mftr and Matr were found to correlate positively with 
disease duration. One might expect a linear relationship between disease 
duration and motor symptom severity but supplementary analysis showed this 
not to be the case. Therefore although the rate of tremor (amplitude) was linked 
to motor symptom severity in this group of pwPD, the magnitude (frequency and 
amplitude) of tremor did not. It would be important to test this further with a 
group of pwPD who have greater disease severity than those pwPD in the 
current study. 
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Exploration of the relationship between acoustic voice tremor and limb tremor 
(UPDRS III tremor subscore) showed no significant associations for any of the 
acoustic measures (Table 6.34). Further analysis using auditory perceptual and 
visual perceptual measures would be helpful to support or refute the findings 
with acoustic tremor measures. 
The profile of the UPDRS III items based on group mean scores is revealing 
(Figure 6.16). It shows that item 31 ‘body bradykinesia’ achieved the highest 
(most severe) rating and the tremor items achieved some of the lowest scores.  
This finding reinforces the reports that PD tremor is highly variable. When pwPD 
self-rated limb tremor based on their observations over a two week period 
(UPDRS II), they rated limb tremor more severely than when the researcher 
rated limb tremor on the day of testing.  
Previous studies have not specifically or systematically looked at the 
relationship between acoustic voice tremor measures and motor symptom 
severity. However other studies have reported on relationships between other 
voice and speech measures and disease severity with different findings to the 
current study. Gamboa et al.,135 reported a higher incidence of ‘laryngeal’ 
tremor in 16 pwPD with a UPDRS total score greater than 24.3 (greater 
severity) when compared with 25 pwPD who had scores in the range of 0-24. 
There are a number of important differences between Gamboa et al’s.,135 study  
and the current one which makes interpretation difficult. For example, the 
authors135 combined the UPDRS subsection II and III to yield a total UPDRS 
score, whereas the current question relates to the UPDRS III sub- section only.  
Testing was carried out with pwPD in an ‘on-medication’ state contrasting with 
the present study with testing carried out ‘off medication’. In addition, there are 
also a number of methodological flaws in relation to the identification of 
‘laryngeal tremor’ (section 4.4) in Gamboa et al’s., study which makes it difficult 
to compare findings135.  
Goberman et al.,124 found a significant relationship between laryngeal instability 
measured with SDFo and the UPDRS III and concluded that as motor function 
became more impaired, laryngeal instability increased. Their pwPD group had a 
similar mean UPDRS II score to the current study, However, the authors 124 did 
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not include tremor measures, and the pwPD were ‘on medication’ therefore the 
studies cannot be compared directly. 
Extending the discussion from acoustic voice measurement to speech, Coates 
et al.,102 did not show a significant correlation between speech intelligibility 
measures and disease severity.  However, the authors cited a mean (SD) score 
of 1.4 SD (0.7) for the UPDRS motor subsection in their group of forty eight 
pwPD102. This score is difficult to interpret, considering the mean disease 
duration was 6.7 years. 
Implications and further research 
The novel and preliminary finding of a significant (negative) relationship 
between the rate of amplitude tremor and disease symptom severity is exciting 
since it suggests a tenuous relationship between voice tremor and PD 
pathophysiology. The fact that significant (positive) relationships were found 
between other tremor measures (Mftr, Matr), and disease duration adds further 
weight to the current question.  
This study finding of a positive association between selected voice tremor 
measures and PD disease contributes to the motor symptom/ non-motor 
speech debate. However, it must be stressed that current findings are 
preliminary and what is needed is for other studies to replicate these findings in 
pwPD with varying levels of disease severity and age groups.  
The lack of relationship between the magnitude of tremor measures (Matr, Mftr) 
and disease severity is somewhat surprising considering Mftr and Matr’s 
positive association with disease duration. However, the fact that there is not a 
linear relationship between disease duration and disease severity (APPENDIX 
C) might help to explain the disparity of findings for Mftr and Matr. It would be 
interesting to see if non-acoustic tremor measures (auditory and visual 
perceptual) were included in the analysis would different findings emerge in 
relation to Mftr and Matr measures. If auditory and/or visual perceptual tremor 
measures were found to correlate with motor symptom severity, one could 
question the appropriateness of Mftr and Matr as useful indices of acoustic 
voice tremor.  
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 (D) The relationship between acoustic voice tremor measures and 
PD phenotype? 
The final part of question 4 sought to establish the nature of the relationship 
between acoustic tremor measures and PD phenotype. The results show that 
none of the acoustic measures differentiated tremor-dominant PD from postural 
instability gait disorder (PIGD) (Table 6.37). The small sample size of pwPD 
with tremor-dominant PD (n=7) relative to PIGD (n=21), may have influenced 
the significance findings.  
It is important to note that Mftr%, Matr%, vFo%, and vAm% showed higher 
values in the PIGD group than the tremor dominant phenotype group. This 
finding suggests that pwPD who didn’t have tremor as the dominant aspect of 
their PD symptomatology had higher levels of tremor in the acoustic voice 
signal than pwPD who were tremor dominant.  However no definite conclusions 
can be made on this issue, since differences were non-significant between the 
groups.  
The small number of pwPD classified as tremor dominant relative to PIGD was 
a surprising finding for this author, expecting limb tremor to be a more 
prominent feature in the disease profile. However 30% of pwPD do not present 
with tremor limb180(section 3.4). 
Auditory perceptual and visual perceptual tremor measures in tremor dominant and 
PIGD phenotypes 
 
In addition to examining the relationship between acoustic tremor measures and 
tremor dominant and PIGD phenotypes, the analysis was extended to include 
perceptual and visual perceptual measures in the analysis. Neither auditory 
perceived instability and tremor, nor visually perceived tremor in the vocal tract 
differentiated the tremor dominant phenotype from the PIGD group. Therefore 
based on these study findings, pwPD with tremor dominant PD showed no 
difference to pwPD with a PIGD phenotype.  
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These study findings cannot be compared with other voice or speech studies 
since other studies have not addressed this question. In fact, in the PD literature 
in general, few clinical studies have incorporated PD sub-types65 despite calls 
for their inclusion. 
Clinical implications and further research 
Surprisingly, voice tremor does not appear to be more of a feature of pwPD who 
fall into the tremor dominant category than pwPD of the postural instability gait 
disorder type (PIGD).   
Speech and voice studies should incorporate data on pwPD phenotype to gain 
understanding of the how PD and speech-voice pathophysiology interact. 
  
206 
 
7.5 Additional study findings 
An important finding from the study which does not come under the research 
question discussion section pertains to the Hospital Anxiety and Depression 
Scale (HADS) results.  
Anxiety and depression 
Anxiety and depression is associated with PD (section 1.4) and anxiety and/or 
depression may impact in general on speech and/or voice function (section 
2.5.2). A known psychological disorder requiring treatment was one of the 
exclusion criteria for the study. The researcher considered it prudent also to 
obtain a baseline measure of the emotional status of pwPD, and used the 
Hospital Anxiety & Depression Scale (HADS) for that purpose (section 5.5.7). 
However no effort was made to relate the voice tremor findings to the HADS 
findings. 
The study findings of significant differences between pwPD and controls in 
relation to anxiety and depression underscores findings in the literature 
reporting increased levels in pwPD 49 50 43 51 54. Anxiety symptoms were more 
prominent than depression in this group of pwPD, with 23% (n=5) scoring 
outside the normal range (0-7) for anxiety, versus 12.5% (n=1) for depression. 
Of note is the fact that more male than female pwPD, scored outside the normal 
range for anxiety. The prevalence of reported anxiety based on HADS scoring 
was unexpectedly high (23%) in this group of pwPD, relative to the controls 
(3.7%). The effect of anxiety on voice tremor or other speech and voice findings 
cannot be ascertained from his study since it was not a study focus. However, 
an important point to highlight in this regard is that heightened anxiety did not 
prevent any of the pwPD having the nasendoscopy examination.  
The prevalence of depression (12.5%) in the pwPD group is lower than other 
prevalence levels reported (section 1.4). It is probable that depression is a more 
overt condition than increased anxiety, with patients more likely to be referreed 
to mental health specialists and/or receiving treatment than is the case for 
anxiety. Four (11%) of patients were excluded from the study in relation to a 
known depression condition. However, none of the pwPD group had been 
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diagnosed with an anxiety related disorder and none were receiving 
professional help for anxiety. 
PD speech and voice studies should not only control for anxiety levels in pwPD, 
but also look for evidence of a relationship between anxiety levels and speech 
and voice syptomatology. In addition, exploration of gender differences in 
anxiety levels in the context of communication disability in pwPD is warranted 
based on the current study findings.  
7.6 Summary clinical Implications & further research 
Based on the current study findings: 
• Voice tremor analysis benefits from a multi-dimensional approach. 
• Voice tremor is associated with PD and with ‘normal voice’. 
• PwPD with a mild disease severity and neurologically healthy controls 
may sound similar in relation to overall voice instability. 
• The instability in the PD voice is probably related to tremor in the palate 
and tremor in the global larynx (vertical laryngeal tremor). 
• There is a need to collect acoustic data on neurologically healthy controls 
(over 50 years) for comparison with pwPD data. 
• More direction is needed regarding the optimum number of trials that 
should be used in acoustic voice analysis. 
• Acoustic measurement detects tremor in the voice. 
• The rate of amplitude tremor tremor appears to be a useful acoustic 
measure for differentiating pwPD from controls.  
• Vocal tract tremor is a better descriptor than ‘laryngeal tremor’ to 
describe the source of PD voice tremor. 
• Nasendoscopy is an acceptable procedure for use in voice analysis for 
pwPD. 
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• There are links between voice tremor and disease duration, and disease 
severity, but not between voice tremor and limb tremor. 
Research ideas generated from the study are as follows: 
The field of motor speech disorders would benefit from studies of the 
neurologically healthy person (over 50 years), for comparison with PD 
and other neurological disorders. 
Speech-voice PD studies should include patients who have had the 
disease over a wide range of years (disease duration) and with varying 
levels of disease severity. 
Gender differences in speech and voice symptomatology in pwPD should 
be explored further. 
For the broader field, greater cognisance should be given to increased 
anxiety levels in pwPD. 
Exploring contributory factors to increased voice disability in male versus 
female pwPD would guide treatment goals. 
 
7.7. Conclusions 
In this study I set out to determine if voice tremor was a feature of PD when 
pwPD were compared with neurologically healthy controls, and to determine 
ways in which voice tremor related to pertinent voice and speech variables and 
disease variables. I recruited thirty pwPd and twenty eight controls.I attempted 
to differentiate between the two groups by using a number of instrumental and 
perceptual analyses of voice tremor. The main findings of my work were: voice 
tremor is a feature of pwPD with mild disease severity and of neurologically 
healthy controls; voice tremor can be detected acoustically, and the rate of 
amplitude tremor appears to be a useful measure for differentiating pwPD from 
controls; tremor in the vertical laryngeal dimension and tremor in the palate are 
the main anatomic sources of voice tremor in pwPD; selected (acoustic) voice 
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tremor measures relate to duration of PD disease and disease severity; pwPD 
have significantly greater voice disability than controls. 
These results have progressed our understanding of voice tremor in the 
following ways: voice tremor is a feature of pwPD however it is also a feature of 
people without PD. The rate of amplitude tremor may be an important acoustic 
tremor measure for identifying tremor particularly in pwPD with short disese 
duration. Selected acoustic tremor measures showed some association with 
disease variables. The main anatomic source of voice tremor in pwPD is the 
palate and the global larynx (vertical laryngeal dimension). There are a number 
of clear research priorities as a consequence of my work. These are to: study 
voice tremor in pwPD over a wider age span and duration of disease; determine 
acoustic norms for neurologically healthy controls over 50 years; explore gender 
differences in speech and voice symptoms in pwPD.  
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APPENDIX A: Unified Parkinsons Disease Rating Scale II   
(Activities of Daily Living) 
5. Speech: 
 
0 = Normal 
1 = Mildly affected. No difficulty being understood 
2 = Moderately affected. Sometimes asked to repeat statements.  
3 = Severely affected. Frequently asked to repeat statements.  
4 = Unintelligible most of the time.  
  
6.Salivation: 
 
0 = Normal. 
1 = Slight but definite excess of saliva in mouth; may have nighttime drooling. 
2 = Moderately excessive saliva; may have minimal drooling. 
3 = Marked excess of saliva with some drooling. 
4 = Marked drooling, requires constant tissue or handkerchief.  
  
7.Swallowing: 
 
0= Normal. 
1= Rare choking. 
2= Occasional choking. 
3= Requires soft food. 
4= Requires NG tube or gastrotomy feeding.  
  
8. Handwriting:  
0= Normal 
1= Slightly slow or small 
2= Moderately slow or small; all words are legible 
3= Severely affected; not all words are legible 
4= The majority of words are not legibl 
 
9. Cutting food and handling utensils:  
0= Normal 
1= Somewhat slow and clumsy, but no help needed 
2= Can cut most foods, although clumsy and slow; some help needed  
3= Food must be cut by someone, but can still feed slowly 
4= Needs to be fed 
  
212 
 
10.Dressing: 
 
0= Normal 
1= Somewhat slow, but no help needed 
2= Occasional assistance with buttoning, getting arms in sleeves  
3= Considerable help required, but can do some things alone  
4 =Helpless 
 
11.Hygiene: 
0 = Normal. 
1 =Somewhat slow, but no help needed. 
2=Needs help to shower or bathe; or very slow in hygienic care. 
3= Requires assistance for washing, brushing teeth, combing hair, going to 
bathroom. 
4 =Foley catheter or other mechanical aids. 
 
12. Turning in bed and adjusting bedclothes: 
0 =Normal. 
I =Somewhat slow and clumsy, but no help needed. 
2 =Can turn alone or adjust sheets, but with great difficulty. 
3 =Can initiate, but not turn or adjust sheets alone. 
4 =Helpless. 
  
13. Falling. (unrelated to freezing): 
0 =None. 
1 =Rare falling. 
2 =Occasionally falls, less than once per day. 
3 =Falls an average of once daily. 
4 =Falls more than once daily. 
  
14. Freezing when walking: 
0 =None. 
1 =Rare freezing when walking; may have start-hesitation. 
2 =Occasional freezing when walking. 
3= Frequent freezing. Occasionally falls from freezing.  
4 =Frequent falls from freezing. 
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15. Walking: 
0 = Normal. 
I =Mild difficulty. May not swing arms or may tend to drag leg.  
2= Moderate difficulty, but requires little or no assistance.  
3=Severe disturbance of walking, requiring assistance.  
4=Cannot walk at all, even with assistance. 
  
16. Tremor: 
0 =Absent. 
1 =Slight and infrequently present. 
2 =Moderate; bothersome to patient. 
3 =Severe; interferes with many activities. 
4 =Marked; interferes with most activities. 
  
17. Sensory complaints related to parkinsonism: 
0=  None. 
I =  Occasionally has numbness, tingling, or mild aching. 
2 = Frequently has numbness, tingling, or aching; not distressing. 
3 = Frequent painful sensations. 
4 = Excruciating pain. 
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APPENDIX B: Unified Parkinsons Disease Rating Scale III 
(Motor Examination)  
18. Speech: 
0= Normal. 
1=Slight loss of expression, diction and/ or volume. 
2= Monotone, slurred but understandable; moderately impaired.  
3= Marked impairment, difficult to understand. 
4 =Unintelligible. 
  
19. Facial expression: 
0 =Normal. 
1 =Minimal hypomimia, could be normal "Poker Face". 
2= Slight but definitely abnormal diminution of facial expression.  
3= Moderate hypomimia; lips parted some of the time. 
4=Masked or fixed facies with severe or complete loss of facial expression; lips 
parted 1/4 inch or more. 
  
20. Tremor at rest: 
0 =Absent. 
1 =Slight and infrequently present. 
2 =Mild in amplitude and persistent. Or moderate in amplitude, but only 
intermittently present. 
3 = Moderate in amplitude and present most of the time. 
4= Marked in amplitude and present most of the time. 
  
21. Action or postural tremor of hands: 
0 =Absent. 
1 =Slight; present with action. 
2 =Moderate in amplitude, present with action. 
3 =Moderate in amplitude with posture holding as well as action. 
4 =Marked in amplitude; interferes with feeding. 
 
22. Rigidity: (Judged on passive movement of major joints with patient relaxed 
in sitting position. Cogwheeling to be ignored.) 
0 =Absent. 
1 =Slight or detectable only when activated by mirror or other movements.  
2= Mild to moderate. 
3 =Marked, but full range of motion easily achieved. 
4 =Severe, range of motion achieved with difficulty. 
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23. Finger taps: (Patient taps thumb with index finger in rapid succession with 
widest amplitude possible, each hand separately.) 
0= Normal. 
I = Mild slowing and/or reduction in amplitude. 
2= Moderately impaired. Definite and early fatiguing. May have occasional 
arrests in movement. 
3 =Severely impaired. Frequent hesitation in initiating movements or arrests in 
ongoing movement. 
4 =Can barely perform the task. 
  
24. Hand movements: (Patient opens and closes hands in rapid succession 
with widest amplitude possible, each hand separately.) 
0 =Normal. 
1= Mild slowing and/or reduction in amplitude. 
2= Moderately impaired. Definite and early fatiguing. May have occasional 
arrests in movement. 
3 =Severely impaired. Frequent hesitation in initiating movements or arrests in 
ongoing movement. 
4 =Can barely perform the task. 
  
25. Rapid alternating movements of hands: (Pronation-supination 
movements of hands, vertically or horizontally, with as large an amplitude as 
possible, both hands simultaneously.) 
0 =Normal. 
I =Mild slowing and/or reduction in amplitude. 
2= Moderately impaired. Definite and early fatiguing. May have occasional 
arrests in movement. 
3 =Severely impaired. Frequent hesitation in initiating movements or arrests in 
ongoing movement. 
4 =Can barely perform the task. 
 
26. Leg agility: (Patient taps heel on ground in rapid succession, picking up 
entire leg. Amplitude should be about 3 inches.) 
0 = Normal. 
1= Mild slowing and/or reduction in amplitude. 
2=Moderately impaired. Definite and early fatiguing. May have occasional 
arrests in movement. 
3 =Severely impaired. Frequent hesitation in initiating movements or arrests in 
ongoing movement. 
4 =Can barely perform the task. 
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27. Arising from chair: (Patient attempts to arise from a straight-back wood or 
metal chair with arms folded across chest.) 
0 =Normal. 
I = Slow; or may need more than one attempt. 
2 =Pushes self up from arms of seat. 
3 =Tends to fall back and may have to try more than one time, but can get up 
without help. 
4 =Unable to arise without help. 
  
28. Posture: 
0 =Normal erect. 
1 = Not quite erect, slightly stooped posture; could be normal for older person. 
2=Moderately stooped posture, definitely abnormal; can be slightly leaning to 
one side. 
3 =Severely stooped posture with kyphosis; can be moderately leaning to one 
side. 
4 =Marked flexion with extreme abnormality of posture. 
 
29 Gait: 
0= Normal. 
1= Walks slowly, may shuffle with short steps. but no festination or propulsion. 
2= Walks with difficulty, but requires little or no assistance; may have some 
festination, short     steps, or propulsion. 
3 = Severe disturbance of gait, requiring assistance. 
4=Cannot walk at all, even with assistance. 
 30. Postural stability:(Response to sudden posterior displacement produced 
by pull on shoulders while patient erect with eyes open and feet slightly apart. 
Patient is prepared) 
0=Normal. 
1= Retropulsion, but recovers unaided. 
2=Absence of postural response; would fall if not caught by examiner. 3=Very 
unstable, tends to lose balance spontaneously. 
4= Unable to stand without assistance. 
 31. Body bradykinesia and hypokinesia: (Combining slowness, hesitancy, 
decreased armswing, small amplitude, and poverty of movement in general.) 
 
0 =None. 
1= Minimal slowness, giving movement a deliberate character; could be normal 
for some persons. Possibly reduced amplitude. 
2= Mild degree of slowness and poverty of movement which is definitely 
abnormal. Alternatively, some reduced amplitude. 
3 =Moderate slowness, poverty or small amplitude of movement. 
4 =Marked slowness, poverty or small amplitude of movement. 
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APPENDIX C: Table Spearman’s (rho) correlation of disease duration, 
UPDRS II, and UPDRS III 
 
 
 
UPDRS II UPDRS III 
 
Disease duration* 
 
 
0.031 
 
0.052 
*Years since onset of disease 
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APPENDIX D: Hoehn & Hahr Staging 
Stage 0 No sign of disease 
Stage 1 Unilateral disease 
Stage 2 Bilateral disease without impairment of 
balance 
Stage 3 Mild to moderate bilateral disease; some 
postural instability; physically independent 
Stage 4 Severe disability; still able to walk or stand 
unassisted 
Stage 5 Wheelchair bound or bedridden unless 
unaided 
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APPENDIX E: Patient Data Screening Form- Eligibility Criteria 
Inclusion criteria: 
Patient must have a diagnosis of Idiopathic Parkinson’s Disease (PD), given by 
Consultant Neurologist, fulfilling the criteria of the UK Parkinson’s Disease 
Society Brain Bank. 
Name _______________________ Date___________________ 
DOB______________Age:_______________________ 
Year PD diagnosed________________ Number years since onset_______ 
PD Medications: 
_______________________________________________________ 
Other Meds:________________________________________________ 
Exclusion criteria: 
1. Does patient have a neurological condition in addition to PD?  Yes / No 
2. Has patient had neurosurgery including DBS?   Yes / No 
3. Has patient been a smoker in the past 5 years?   Yes / No 
4. Does patient have a history of: 
a. Laryngeal malignancy?      Yes / No 
b. Surgery/Trauma to the Head/Neck region?  Yes / No 
c. Radiotherapy and/or Chemotherapy to H/N?  Yes / No 
5. Does patient have a history of alcohol or chemical abuse?  Yes / No 
6. Does patient have a history of hyperthyroidism?  Yes / No 
7. Is patient taking any of the following medications? 
a. Mood stabilizers (lithium carbonate, solian, seroquel)  Yes / No 
b. Bronchodilators (theophylline, Alupent)   Yes / No 
c. Anticonvulsants (valproic acid, Depakote)  Yes / No 
     d.   Immuno-suppresSants     Yes / No 
220 
 
8. Does patient have speech/voice problems unrelated to PD? Yes / No 
 
9. Does patient have a hearing problem that affects his/her  
ability to hear speech at a conversational level?  Yes / No 
10. Has patient had voice treatment including LSVT in the    
previous year?       Yes / No 
11. Does patient suffer from dyskinesias in the Off-Medication   
state that would preclude carrying out a fibreoptic examination of the 
vocal tract?           
       Yes / No 
 
12. Is patient immobile in an Off-Medication state to the extent that he/she 
would be unable to attend the SLT OPD clinic for study assessments?
  
       Yes / No 
13. Is patient a non-english speaker?      
       Yes / No 
 
If patient satisfies the above criteria, i.e negative response to all 
questions, then proceed to carrying out the MMSE 
MMSE score        ___________ 
(≤23/30 indicative of cognitive impairment)    
 
14. Does patient have a cognitive impairment as assessed by the MMSE? 
Yes / No 
If patient has a cognitive impairment (score of ≤23/30) then he/she is 
excluded from further involvement in the study 
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APPENDIX F: Consensus Auditory Perceptual Evaluation of Voice  
(CAPE-V) task protocol 
Task 1: Sustained vowels 
 “The first task is to say the sound /a/. Hold it as steady as you can in your 
typical voice, until I ask you to stop” (The examiner gives a model of the task). 
The participant performs this task x 3 times for five seconds. “Next, say the 
sound /i/.Hold it as steady as you can, in your typical voice, until I ask you to 
stop”. The participant performs this task x 3 times for five seconds. 
Task 2: Sentences 
The following sentences will be presented, one at a time to the participant on 
flash cards. The examiner says to the participant. “Please read the following 
sentences, as if you were speaking to somebody in real conversation”. If the 
participant has difficulty reading, the examiner will ask the participant to repeat 
the sentence after the examiner. 
a) The blue spot is on the key again 
b) How hard did he hit him 
c) We were away a year ago 
d) We eat eggs every Easter 
e) My mama makes lemon muffins 
f) Peter will keep at the peak 
Task 3: Spontaneous Speech 
I want you to speak for 30 seconds on the topic of ‘your early childhood, 
where you lived and the place you grew up’. 
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APPENDIX G: Flexible Endoscopic Vocal Tract Examination (VTE) 
protocol  
 
Flexible Endoscopic Vocal Tract Examination protocol (VTE) 
Anatomic Site ‘Activating’ condition Instructions  
Soft Palate At rest breathing ‘I want you to breathe normally’ 
 Sustained /s/ ‘I want you to make a long S 
sound like this–SSSSSSSSSSS 
for 5 seconds’ 
 Sustained /a/   ‘In a voice that feels comfortable 
in pitch & loudness, I want you to 
make a long /a/ sound like 
‘AHAHAHAHAHAH for 5 sec’s’ 
 Tongue Base  At rest breathing  ‘I want you to breathe normally’  
 
 Sustained /s/    
‘I want you to make a long S 
sound like this–SSSSSSSSSSS’ 
for 5 seconds’ 
 Sustained /a/ ‘In a voice that feels comfortable 
in pitch & loudness, I want you to 
make a long /a/ sound like 
AHAHAHAHAHAH for 5 sec’s’  
Larynx/ 
Pharynx    
At rest breathing ‘I want you to breathe normally’ 
 
Sustained /s/ ‘I want you to make a long S 
sound like this–SSSSSSSSSSS 
for 5 seconds’  
 
Sustained /a/  ‘In a voice that feels comfortable 
in pitch & loudness, I want you to 
make a long /a/ sound like 
AHAHAHAHAHAH for 5 sec’s’   
 
Sustained /i/  ‘In a voice that feels comfortable 
in pitch & loudness, I want you to 
make a long /i/ sound like eeeeee’ 
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APPENDIX H: Voice Handicap Index (VHI)  
Instructions: These are statements that many people have used to describe their voices and the effects of their voices on their lives. 
Check the response that indicates how frequently you have the same experience.   
  Never Almost 
Never 
Sometimes Almost 
Always 
Always 
F1 My voice makes it difficult for people to hear me      
P2 I run out of air when I talk      
F3 People have difficulty understanding me in a noisy room      
P4 The sound of my voice varies throughout the day      
F5 My family has difficulty hearing me when I call them throughout the house      
F6 I use the phone less often than I would like      
E7 I’m tense when talking with others because of my voice       
F8 I tend to avoid groups of people because of my voice      
E9 People seem irritated with my voice      
P10 People ask: “What’s wrong with your voice?”      
F11 I speak with friends, neighbours or relatives less often because of my voice      
F12 People ask me to repeat myself when speaking face-to-face      
P13 My voice sounds creaky and dry      
P14 I feel as though I have to strain to produce voice       
E15 I find other people don’t understand my voice problem      
F16 My voice difficulties restrict my personal and social life      
P17 The clarity of my voice is unpredictable      
P18 I try to change my voice to sound different      
F19 I feel left out of conversations because of my voice      
P20 I use a great deal of effort to speak      
P21 My voice is worse in the evening      
F22 My voice problem causes me to lose income      
E23 My voice problem upsets me      
E24 I am less out-going because of my voice problem      
E25 My voice problem makes me feel handicapped      
P26 My voice “gives out” on me in the middle of speaking      
E27 I feel annoyed when people ask me to repeat      
E28 I feel embarrassed when people ask me to repeat      
E29 My voice makes me feel incompetent      
E30 I’m ashamed of my voice problem      
 
224 
 
 
APPENDIX I: Voice and tremor parameters from the Motor Speech Profile (MSP) of 
Computerised Speech Laboratory (CSL) 119 
1. Fo (Fundamental Frequency) /Hz/  
This is the average Fo of the client during the sustained /ah/ 
2. To (Average Pitch Period)/ms/ 
This is the average value of all extracted using the pitch period values 
3. Fhi (Highest Fundamental Frequency)/Hz/ 
This is the greatest of all extracted period-to-period fundamental frequency values.  
4. Flo (Lowest Fundamental Frequency) /Hz/ 
This is the lowest of all extracted period-to-period fundamental frequency values 
5. STD (Standard deviation of Fo) /Hz/ 
This is the standard deviation of all extracted using the period-to-period fundamental 
frequency values. 
6. Rate of frequency tremor (Rftr) measured in Hz  
The frequency of the most intensive low-frequency Fo-modulation component in the 
specified Fo-tremor analysis range 
7. Rate of amplitude tremor (Ratr) measured in Hz  
The frequency of the most intensive low-frequency Fo-modulating component, in the 
specified amplitude-tremor analysis range 
8. Periodicity of the frequency tremor [Pftr (%)] 
If rate of tremor is very consistent, then it is a periodic tremor 
9. Periodicity of the amplitude tremor [Patr(%]) 
If rate of tremor is very consistent, then it is a periodic tremor 
10. Magnitude of frequency tremor (Mftr), measured in % 
The magnitude or extent of frequency tremor, can be from periodic or non-periodic 
modulation  
11. Magnitude of amplitude tremor (Matr), measured in % 
The magnitude or the extent of amplitude tremor which can be from periodic or from non- 
periodic modulation 
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12. Coefficient of variations in the Fundamental Frequency (vFo), measured in % 
vFo is the long-term variation in fundamental frequency (Fo) from any variations in the Fo of the 
voice. Fo variations include periodic modulations, non-periodic modulations, and rising or falling Fo 
across the recorded segment.  
13. Coefficient of variations in the amplitude (vAm) measured in % 
vAm is the long-term variation in amplitude from any variations in the amplitudes of the voice. 
Amplitude variations include periodic modulations, non-periodic modulations, and rising or falling 
amplitude.  
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APPENDIX J: Consensus Auditory Perceptual Evaluation of Voice (CAPE-V) Rating Protocol 
Instructions to raters 
This experiment is about rating voice quality and tremor features using the protocol of the 
Consensus Auditory Perception Evaluation of Voice, referred to as CAPE-V. I have made some 
minor modifications to the CAPE-V rating form for the purposes of this study. 
There are 61 voice samples, each sample averages 1-1.5 minutes in length approximately. The 
only information that you will have is the gender which is stated on the rating sheet. All recordings 
follow the same format, you will hear the vowel /a/ sustained for 3-5 seconds 3 times, followed by a 
sustained vowel /i/, and then 6 short sentences from the CAPE-V. 
Rating forms 
In your folder you have 61 rating forms for the experiment and 4 extra forms for the practice 
session. You will note at the top of the sheet that there are two tasks: sustained vowels; sentence 
production (6 short sentences).  
Parameters  
There are 5 parameters to rate. 
1. Overall severity: global, integrated impression of voice deviance 
2. Roughness: perceived irregularity in the voicing source (voice is not smooth) 
3. Breathiness: audible air escape in the voice 
4. Instability: irregular fluctuations in pitch and/or loudness, also termed unsteadiness 
5. Tremor: (sustained /a/) rhythmic or nearly rhythmic fluctuations in pitch and/or loudness of 
the voice 
I will play each recording twice and then will repeat the sustained /a/ for you to focus specifically 
on the tremor aspects.  
You should base your rating of the overall severity, roughness and breathiness on the sustained 
vowels and sentences, combining your ratings of each task to give one rating for each 
parameter. You will all hear the voice sample at the same time through the MAC and speakers, 
but will fill in the rating form independently, meaning without discussion between you.  
How to rate a parameter 
Each parameter is rated by placing a tick on the 100mm visual analogue scale. Your judgment 
may be assisted by referring to general regions indicated below each scale: “MI refers to “mildly 
deviant”; “MO” refers to moderately deviant; “SE” refers to severely deviant. The regions indicate 
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gradations in severity, rather than discrete points. You may notice that they are not placed in equal 
intervals because our perception of sound is usually not linear. You can place a tick mark at any 
location along the line. 
Practice session 
We will now have some practice with rating voices not related to the study and to help to familiarise 
you with the form. When rating parameters: overall severity, roughness, and breathiness, include 
the vowels and the sentences in your final rating.  For the instability and tremor parameters, I want 
you to rate them on the basis of the sustained /a/ vowel.  
 After the 4 practice samples have been rated by you, we will discuss any issues that you might 
have before moving on to the study samples. 
Study Samples 
The next rating sheet should say ID 01 M. You will hear the sustained vowels, 6 sentences twice 
followed by the sustained /a/ once again to help with the tremor ratings. Remember that you rate 
the tremor feature only on the basis of a sustained /a/. 
We will take a break after the first 20 samples. 
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APPENDIX K: Consensus Auditory-Perceptual Evaluation of Voice (CAPE- V) rating form 
(Modified Version) 
 
Rater _________________  ID ____________________ 
The following parameters of voice quality will be rated upon completion of the following tasks: 
1. Sustained vowels, /a/ and /i/ for 3-5 seconds duration each 
2. Sentence production: 
  
a. The blue spot is on 
the key again. 
b. How hard did he hit 
him? 
c. We were away a 
year ago 
a. We eat eggs every 
Easter. 
b. My mama makes 
lemon muffins. 
c. Peter will keep at the 
peak. 
 
 
Legend:  MI = Mildly Deviant; MO= Moderately Deviant;  
SE= Severely Deviant 
  
   
Overall Severity  ______________________________________________  
 MI MO SE 
Roughness  ______________________________________________  
 MI MO SE 
Breathiness  ______________________________________________  
 MI MO SE 
Sustained /a/ 
Instability  ______________________________________________  
 MI MO SE 
Tremor   ______________________________________________  
 MI MO SE 
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APPENDIX L: Vocal Tract Tremor Rating Form  
Reviewer Number ________________  
 
Video:            Start  ___________     Finish: _____________ 
Circle the number 
Unable to rate 
(UR) 
Poor View 
(PV) 
 
(Place tick) 
Palate     
Palate Breathe 0 1 2 3  
Palate ‘SSSS’ 0 1 2 3  
Palate ‘AHAHAH’ 0 1 2 3  
Base of Tongue (TB) 
TB Breathe 0 1 2 3  
TB ‘SSSS’ 0 
 
1 2 3  
TB ‘AHAHAH’ 0 1 2 3  
Larynx (Lx) 
Lx Breathe 
(Arytenoid 
movement) 
0 1 2 3  
Lx /S/ 
(Arytenoid 
movement) 
0 1 2 3  
Lx ‘AHAHAH’ 
(global laryngeal 
tremor) 
0 1 2 3  
Lx ‘eeee’ 
(vocal cords) 
(arytenoids) 
 
0 1 2 3  
Tremulous Movement Rating Legend: 
0=  absent  
1=  mild/intermittent tremulous movement 
2 = moderate tremulous movement 
3=  severe tremulous movement 
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APPENDIX M: PD group-raw data for demographical, MMSE, HADS, & disease variables 
Table. PD group: demographical, YSO, MMSE, HADS, H&Y, UPDRS II, III, mean tremor, PIGD score & phenotype  
PD Gender Age Age onset YSO MMSE HADS 
Anxiety 
HADS 
Depr 
H&Y UPDRS  
II 
UPDRS 
 III 
Mean tremor  PIGD  
score 
Phenotype 
PD 1 M 69 62 7 29 2 6 2 14 25 0.25 0.80 PIGD 
PD 2 M 55 46 9 29 0 3 2 15 31 0.88 0.80 Indet 
PD 3 M 71 67 4 28 4 5 2 10 19 0.25 0.60 PIGD 
PD 4 M 60 57 3 29 0 1 2 13 16 0.38 0.25 Tremor 
PD 5 F 76 64 12 27 4 5 2 7 21 0.13 0.60 PIGD 
PD 6 M 47 45 2 30 4 7 2 10 25 0.75 0.80 PIGD 
PD 7 M 69 59 10 29 4 3 2 12 33 1.50 0.60 Tremor 
PD 9 M 34 32 2 26 14 7 3 14 27 0.63 0.60 Indet 
PD 10 F 58 55 3 29 8 18 1 7 11 0.50 0.60 PIGD 
PD 11 F 60 55 5 29 1 1 1 16 19 0.00 0.60 PIGD 
PD 12 M 71 67 4 30 7 6 2 9 16 0.38 0.40 PIGD 
PD 13 M 54 52 2 29 11 6 2 11 21 1.25 0.20 Tremor 
PD 14 M 60 55 5 29 6 2 2 7 28 1.13 0.20 Tremor 
PD 15 M 54 46 8 29 7 5 3 17 38 0.50 1.00 PIGD 
PD 16 F 76 65 11 28 3 2 2 12 18 0.13 1.20 PIGD 
PD 17 M 73 66 7 30 1 1 1 9 17 0.63 0.20 Tremor 
PD 18 F 49 44 5 30 7 0 1 7 8 0.75 0.20 Tremor 
PD 20 M 44 41 3 30 7 3 2 8 24 0.25 0.40 PIGD 
PD 21 F 57 56 1 30 0 3 1 4 13 0.25 0.40 PIGD 
PD 22 M 76 70 6 29 0 2 3 13 31 0.50 0.80 PIGD 
PD 23 M 70 67 3 29 5 6 3 9 37 0.25 0.80 PIGD 
PD 24 F 62 56 6 30 3 1 1 7 13 0.25 0.40 PIGD 
PD 25 M 51 48 3 28 3 2 3 10 33 0.75 0.80 PIGD 
PD 26 M 67 66 1 29 2 4 3 8 41 0.25 0.80 PIGD 
PD 27 M 65 63 2 30 4 4 2 8 24 0.50 0.80 PIGD 
PD 28 F 63 52 11 29 6 4 2 4 22 0.00 0.80 PIGD 
PD 29 M 71 66 5 28 3 4 2 7 26 1.13 0.60 Tremor 
PD 30 M 67 65 2 29 8 3 3 19 34 0.50 1.80 PIGD 
PD 31 M 58 51 7 27 9 5 3 14 41 0.88 0.60 PIGD 
PD 32 M 55 47 8 28 1 0 3 5 38 0.25 1.40 PIGD 
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APPENDIX N: Control group-raw data for demographical, MMSE, HADS, and VHI data    
Table.  Control group: demographical, MMSE, HADS and VHI scores (*missing data) 
 ID Gender Age MMSE HADS Anx HADS 
Depr 
VHI 
Total 
VHI 
Funct 
VHI 
Phys 
VHI Emot 
1 C 2 M 71 29 2 2 4 3 0 1 
2 C 3 M 63 30 2 3 6 4 2 0 
3 C 4 M 54 28 0 0 0 0 0 0 
4 C 5 M 57 30 0 0 7 4 3 0 
5 C 8 M 74 29 4 2 1 1 0 0 
6 C 9 F 73 29 3 2 1 1 0 0 
7 C 10 M 36 28 2 0 3 2 1 0 
8 C 11 M 45 29 7 3 3 1 2 0 
9 C 12 M 51 30 4 1 0 0 0 0 
10 C 13 M 53 28 3 2 1 1 0 0 
11 C 14 F 69 30 0 2 24 4 10 10 
12 C 15 F 70 29 2 1 18 9 7 2 
13 C 16 M 45 30 0 0 0 0 0 0 
15 C 18 F 56 30 5 1 3 2 1 0 
16 C 19 M 67 28 7 7 4 4 0 0 
17 C 20 M 53 28 8 5 15 8 2 5 
18 C 21 F 52 30 3 3 0 0 0 0 
19 C 22 M 61 29 1 1 0 0 0 0 
20 C 23 M 69 28 0 0 0 0 0 0 
21 C 24 F 60 30 4 1 0 0 0 0 
22 C 25 M 64 29 0 0 7 4 3 0 
23 C 26 F 56 30 2 0 0 0 0 0 
24 C 27 M 73 25 * * * * * * 
25 C28 F 56 29 1 0 0 0 0 0 
26 C29 M 64 29 2 1 1 0 1 0 
27 C30 M 67 28 2 1 1 1 0 0 
28 C31 M 66 28 5 3 7 5 2 0 
29 C32 M 58 29 2 0 2 0 2 0 
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APPENDIX O: PD group - Individual trial and mean trial values for acoustic measures from Motor Speech Profile (MSP)  
 
  PD group Fo Hz STD F0 vFo% vAm% Rftr Hz Pftr % Mftr% Ratr Hz Patr % Matr % 
1 PD 1 M 118.119 1.228 1.039 6.465     0.562     1.579 
    116.532 1.003 0.861 8.727     0.651 2.703 35.353 2.447 
  PD 1 Mean 117.326 1.116 0.950 7.596     0.607 2.703 35.353 2.013 
                        
2 PD 2 M 119.270 1.441 1.209 8.579 1.835 24.591 0.682 4.545 33.085 3.982 
    119.476 1.358 1.137 10.777 4.545 25.707 0.705 4.651 34.412 5.732 
  PD 2 Mean 119.373 1.400 1.173 9.678 3.190 25.149 0.694 4.598 33.749 4.857 
3 PD 3 M 131.267 2.606 1.985 19.46     0.818     1.772 
    129.014 2.572 1.993 5.377 2.500 19.849 0.67     1.931 
  PD 3 Mean 130.141 2.589 1.989 12.419 2.500 19.849 0.744     1.852 
4 PD 4 M 120.021 0.77 0.641 8.391     0.337     1.754 
    120.493 0.878 0.729 5.103     0.302     1.427 
    120.853 0.759 0.628 5.968     0.388     2.196 
  PD 4 Mean 120.456 0.802 0.666 6.487     0.342     1.792 
5 PD 5 F 147.224 52.148 35.421 17.479 2.247 12.706 6.567 10.526 34.977 9.906 
    111.739 2.399 2.147 15.064     0.977 9.524 46.928 8.151 
    243.701 15.593 6.398 21.954 4.255 20.897 2.337     11.154 
  PD 5 Mean 167.555 23.380 14.655 18.166 3.251 16.802 3.294 10.025 40.953 9.737 
6 PD 6 M 201.832 1.222 0.606 8.849     0.249     1.621 
    207.914 4.628 2.226 10.237     0.333     1.378 
    210.148 0.709 0.337 4.837     0.252     1.024 
  PD 6 Mean 206.631 2.186 1.056 7.974     0.278     1.341 
7 PD 7 M 167.278 2.263 1.353 5.424     0.503     1.223 
    163.860 1.365 0.834 6.129     0.657     1.658 
    163.206 1.200 0.735 9.226     0.502     1.629 
  PD 7 Mean 164.781 1.609 0.974 6.926     0.554     1.503 
8 PD 9 M 120.649 0.735 0.609 9.725     0.400     3.405 
    121.27 0.514 0.424 9.027     0.315 5.128 53.762 3.852 
    121.356 0.436 0.36 5.537     0.245 2.469 37.933 2.233 
  PD 9 Mean 121.092 0.562 0.464 8.096     0.320 3.799 45.848 3.163 
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  PD group Fo Hz STD F0 vFo% vAm% Rftr Hz Pftr % Mftr% Ratr Hz Patr % Matr % 
9 PD 10 F 175.117 1.207 0.689 7.513     0.445     1.807 
    179.093 1.464 0.817 6.090     0.408     1.326 
    196.872 1.070 0.543 6.730     0.402     1.291 
  PD 10 Mean 183.694 1.247 0.683 6.778     0.418     1.475 
10 PD 11 F 175.225 1.229 0.701 5.410     0.343     0.594 
    180.314 1.690 0.937 8.283     0.294     0.882 
    188.358 1.779 0.945 2.842     0.332     0.815 
  PD 11 Mean 181.299 1.566 0.861 5.512     0.323     0.764 
11 PD 12 M 121.048 0.878 0.725 3.198     0.334     1.059 
    122.223 0.944 0.772 3.816     0.353     1.346 
    122.556 0.700 0.571 3.186     0.242     1.108 
  PD 12 Mean 121.942 0.841 0.689 3.400     0.310     1.171 
12 PD 13 M 159.071 1.229 0.773 6.387     0.492     1.116 
    166.939 1.292 0.774 4.699     0.498     1.168 
    162.273 1.421 0.876 8.495     0.550     1.556 
  PD 13 Mean 162.761 1.314 0.808 6.527     0.513     1.280 
13 PD 14 M 148.313 2.087 1.407 4.800     0.567 4.651 47.087 3.708 
    144.405 2.156 1.493 7.446     0.872 5.000 28.773 5.441 
    142.271 1.584 1.114 5.991     0.511 4.878 25.315 2.894 
  PD 14 Mean 144.996 1.942 1.338 6.079     0.650 4.843 33.725 4.014 
14 PD 15 M 136.536 3.073 2.251 6.402     0.869 2.564 31.408 2.716 
    128.554 2.066 1.607 3.550 2.174 30.515 0.810 2.500 30.099 1.693 
    130.362 2.387 1.831 5.623 3.226 22.198 0.830 4.545 59.996 1.733 
  PD 15 Mean 131.817 2.509 1.896 5.192 2.700 26.357 0.836 3.203 40.501 2.047 
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  PD group Fo Hz STD F0 vFo% vAm% Rftr Hz Pftr % Mftr% Ratr Hz Patr % Matr % 
15 PD 16 F 183.137 3.030 1.655 10.020 2.632 12.545 0.825     5.007 
    177.395 1.854 1.045 13.934 2.105 26.466 0.670 10.000 53.802 5.950 
    196.187 2.644 1.348 10.732     0.599 10.000 57.811 4.231 
  PD 16 Mean 185.573 2.509 1.349 11.562 2.3685 19.5055 0.698 10.000 55.8065 5.063 
16 PD 17 M 123.279 1.629 1.321 5.634     0.551     1.617 
    123.028 1.463 1.189 3.917     0.588     1.479 
    124.878 2.008 1.608 5.320 6.667 52.942 0.713     1.509 
  PD 17 Mean 123.728 1.700 1.373 4.957 6.667 52.942 0.617     1.535 
17 PD 18 F 184.317 2.218 1.203 3.812 2.105 16.502 0.682 5.882 34.067 1.472 
    179.641 4.179 2.327 4.603 2.597 35.796 1.710     2.016 
    180.412 2.463 1.365 10.694     0.677     1.723 
  PD 18 Mean 181.457 2.953 1.632 6.370 2.351 26.149 1.023 5.882 34.067 1.737 
18 PD 20 M 123.278 0.753 0.611 5.306     0.399     2.099 
    126.368 1.649 1.305 6.820 3.636 51.334 0.603 5.128 53.194 3.245 
  PD 20 Mean 124.823 1.201 0.958 6.063 3.636 51.334 0.501 5.128 53.194 2.672 
19 PD 21 F 152.269 1.054 0.692 3.999     0.355 4.348 34.659 1.505 
    159.335 1.277 0.801 4.880     0.447     1.186 
    164.057 1.084 0.661 4.469     0.288     0.934 
  PD 21 Mean 158.554 1.138 0.718 4.449     0.363 4.348 34.659 1.208 
20 PD 22 M 143.561 1.493 1.040 4.756 4.167 28.439 0.764 3.333 55.835 2.207 
    145.265 1.583 1.090 10.664 8.696 17.153 0.652     1.858 
  PD 22 Mean 144.413 1.538 1.065 7.710 6.432 22.796 0.708 3.333 55.835 2.033 
21 PD 23 M 149.354 1.739 1.164 6.892     0.442     0.779 
    151.047 1.332 0.882 9.478     0.337     0.934 
    156.130 1.261 0.808 6.090     0.316     1.399 
  PD 23 Mean 152.177 1.444 0.951 7.487     0.365     1.037 
22 PD 24 F 178.042 1.974 1.106 8.583     0.678     2.374 
    181.025 3.449 1.906 5.337     0.700     1.664 
    196.972 2.007 1.019 4.761     0.553     1.333 
  PD 24 Mean 185.346 2.477 1.344 6.227     0.644     1.790 
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  PD group Fo Hz STD F0 vFo% vAm% Rftr Hz Pftr % Mftr% Ratr Hz Patr % Matr % 
23 PD 25M 107.077 2.190 2.045 2.045 10.000 71.015 0.702     3.485 
    104.533 1.956 1.871 7.274 10.526 65.155 0.690 6.667 52.413 3.290 
    105.427 1.623 1.540 6.589     0.669     2.882 
  PD 25 Mean 105.679 1.923 1.819 5.303 10.263 68.085 0.687 6.667 52.413 3.219 
24 PD 26 M 120.293 1.561 1.297 7.112     0.580     1.817 
    120.057 1.489 1.240 8.008 1.980 23.928 0.621     1.455 
    119.023 1.000 0.840 7.511     0.362 2.532 55.132 1.818 
  PD 26 Mean 119.791 1.350 1.126 7.544 1.980 23.928 0.521 2.532 55.132 1.697 
25 PD 27 M 122.819 1.394 1.135 6.959     0.701     2.061 
    120.786 2.600 2.152 9.315 4.348 14.258 1.188     2.249 
    121.780 2.247 1.845 13.401 3.226 41.162 0.905     2.825 
  PD 27 Mean 121.795 2.080 1.711 9.892 3.787 27.710 0.931     2.378 
26 PD28 F 163.818 1.894 1.156 19.627     0.716     1.716 
    166.269 2.091 1.258 16.540     0.590     2.602 
  PD 28 Mean 165.044 1.993 1.207 18.084     0.653     2.159 
27 PD 29 M 86.749 0.716 0.825 8.299     0.466 4.167 50.186 4.298 
    87.579 0.700 0.799 7.768     0.451 3.704 60.765 4.554 
    87.137 0.842 0.966 6.624     0.364     2.959 
  PD 29 Mean 87.155 0.753 0.863 7.564     0.427 3.936 55.476 3.937 
28 PD 30 M 121.729 1.269 1.042 6.875 8.000 12.261 0.670 2.439 26.765 2.388 
    130.379 1.423 1.091 6.159     0.542     1.442 
    129.636 1.049 0.809 4.179     0.583 4.762 35.831 2.127 
  PD 30 Mean 127.248 1.247 0.981 5.738 8.000 12.261 0.598 3.601 31.298 1.986 
29 PD 31 M 118.983 1.301 1.094 5.825     0.697 4.545 61.955 1.937 
    118.883 0.965 0.812 6.345     0.672 4.545 64.466 2.730 
  PD 31 Mean 118.933 1.133 0.953 6.085     0.685 4.545 63.211 2.334 
30 PD 32 M 120.979 1.474 1.219 8.837     0.586     2.691 
    121.515 1.099 0.905 9.156     0.491     3.219 
    120.954 1.369 1.132 11.578     0.516     3.387 
  PD 32 mean 121.149 1.314 1.085 9.857     0.531     3.099 
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APPENDIX P:  Control group: Individual trial and mean trial values for acoustic measures from Motor Speech Profile (MSP)  
  CONTROLS Fo Hz STD F0 vFo% vAm% Rftr Hz Pftr % Mftr% Ratr Hz Patr % Matr % 
1 C02 M 102.530 1.168 1.139 5.886     0.493     2.107 
    115.246 1.221 1.060 10.061     0.393     1.568 
    115.410 1.208 1.046 11.024     0.545     1.809 
  C 02 Mean 111.062 1.199 1.082 8.990     0.477     1.828 
2 C03 M 97.151 0.852 0.877 7.360     0.486 2.941 53.594 2.084 
    97.051 0.939 0.967 4.691     0.487 2.353 24.436 2.128 
  C 03 Mean 97.101 0.896 0.922 6.026     0.487 2.647 39.015 2.106 
3 C04 M 118.470 1.024 0.864 4.527     0.336     1.977 
    121.032 1.047 0.865 5.028     0.432     2.699 
    123.363 1.339 1.086 8.767     0.409 2.353 38.036 2.493 
  C04 Mean 120.955 1.137 0.938 6.107     0.392 2.353 38.036 2.390 
4 C05 M 131.116 1.506 1.149 9.846     0.588 2.410 46.556 2.470 
    125.910 1.657 1.316 11.034 3.030 22.329 0.840 2.899 34.025 5.570 
    127.513 1.666 1.307 10.367 2.041 17.672 0.646 2.439 17.388 3.708 
  C 05 Mean 128.180 1.610 1.257 10.416 2.536 20.001 0.691 2.583 32.656 3.916 
5 C08 M 122.753 1.013 0.825 9.572     0.438     2.112 
    123.232 0.947 0.769 8.548     0.464     1.599 
    123.271 2.048 1.661 9.743     0.774     2.520 
  C08 Mean 123.085 1.336 1.085 9.288     0.559     2.077 
6 C 09 F 186.100 3.097 1.664 12.285     0.589     3.163 
    188.788 6.652 3.523 13.122     1.159     6.860 
    89.706 2.485 2.770 13.563 2.817 25.085 0.931 2.899 39.321 4.671 
  C09 Mean 154.865 4.078 2.652 12.990 2.817 25.085 0.893 2.899 39.321 4.898 
7 C10 M 118.964 0.721 0.606 5.597     0.249     1.489 
    119.145 0.674 0.566 5.392     0.208 2.247 32.911 1.576 
    118.591 0.781 0.658 7.440     0.208     1.580 
  C 10 Mean 118.900 0.725 0.610 6.143     0.222 2.247 32.911 1.548 
8 C11 M 107.664 0.508 0.472 5.764     0.309     1.462 
    97.944 0.628 0.641 3.806     0.399     1.186 
    97.651 0.699 0.716 4.571     0.492     1.314 
  C11 Mean 101.086 0.612 0.610 4.714     0.400     1.321 
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  CONTROLS Fo Hz STD F0 vFo% vAm% Rftr Hz Pftr % Mftr% Ratr Hz Patr % Matr % 
9 C12 M 120.236 1.753 1.458 10.023 2.817 28.726 0.786     1.236 
    121.484 2.536 2.088 7.498 2.703 36.871 1.146 3.030 60.001 2.435 
    123.241 2.121 1.721 8.254 3.226 11.078 0.696     1.838 
  C 12 Mean 121.654 2.137 1.756 8.592 2.915 25.558 0.876 3.030 60.001 1.836 
10 C13 M 145.600 0.864 0.593 7.705     0.298     1.064 
    145.517 1.069 0.735 11.849     0.420     1.591 
    150.408 1.326 0.881 8.092     0.383     1.207 
  C 13 Mean 147.175 1.086 0.736 9.215     0.367     1.287 
11 C14 F 166.929 2.174 1.303 7.693     0.488     1.870 
    160.494 1.567 0.976 4.218     0.646 2.02 11.875 1.827 
    164.404 1.649 1.003 6.965 2.632 16.792 0.711     1.203 
  C 14 Mean 163.942 1.797 1.094 6.292 2.632 16.792 0.615  2.02  11.875 1.633 
12 C 15 F 214.897 4.742 2.206 17.886 2.703 41.490 0.990     2.755 
    222.563 2.295 1.031 20.936     0.574     1.746 
  C 15 Mean 218.730 3.519 1.619 19.411 2.703 41.490 0.782     2.251 
13 C16 M 120.306 0.675 0.561 3.382     0.331 6.667 35.799 1.644 
    118.972 0.769 0.647 6.019     0.331     1.340 
    121.050 1.335 1.103 10.131     0.465 2.273 33.029 2.175 
  C 16 Mean 120.109 0.926 0.770 6.511     0.376 4.470 34.414 1.720 
14 C 18 F 242.441 1.584 0.653 15.506     0.322     1.614 
    250.331 1.803 0.720 7.795     0.526     1.959 
    237.754 1.441 0.606 9.490     0.367     1.316 
  C 18 Mean  243.509 1.609 0.660 10.930     0.405     1.630 
15 C19 M 119.782 0.933 0.779 11.529     0.499     1.864 
  C 19 Mean 119.782 0.933 0.779 11.529     0.499     1.864 
16 C20 M 122.042 0.916 0.751 9.214     0.295     1.889 
    121.539 0.710 0.584 11.756     0.337     2.915 
    124.210 0.595 0.479 7.528     0.272     1.621 
  C 20 Mean 122.597 0.740 0.605 9.499     0.301     2.142 
17 C21 F 177.105 1.978 1.117 4.575 2.041 10.710 0.772     1.431 
    170.734 1.434 0.840 3.749     0.539     1.390 
    175.608 1.990 1.133 5.809 4.762 32.212 0.698 1.852 19.821 1.926 
  C21 Mean 174.482 1.801 1.030 4.711 3.402 21.461 0.670 1.852 19.821 1.582 
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  CONTROLS Fo Hz STD F0 vFo% vAm% Rftr Hz Pftr % Mftr% Ratr Hz Patr % Matr % 
18 C22 M 117.766 0.960 0.815 7.797     0.450     1.535 
    117.452 0.935 0.796 10.495     0.358     1.451 
  C 22 Mean 117.609 0.948 0.806 9.146     0.404     1.493 
19 C23 M 116.312 0.898 0.772 4.649     0.516     1.997 
    117.478 0.947 0.806 8.272     0.306     1.970 
    116.277 0.613 0.527 4.758     0.318 3.077 19.338 1.692 
  C23 Mean 116.689 0.819 0.702 5.893     0.380 3.077 19.338 1.886 
20 C 24 F 152.288 0.555 0.364 8.893     0.185     1.071 
    161.130 1.372 0.851 9.444     0.362 2.667 53.751 1.537 
    163.467 1.302 0.796 4.573     0.311     1.083 
  C 24 Mean 158.962 1.076 0.670 7.637     0.286 2.667 53.751 1.230 
21 C25 M 102.977 1.617 1.570 6.292     0.559 2.941 58.639 1.965 
    101.195 1.227 1.212 4.331 11.111 40.324 0.686     1.684 
    106.139 1.397 1.316 4.214 2.273 26.603 0.692     1.984 
  C 25 Mean 103.437 1.414 1.366 4.946 6.692 33.464 0.646  2.941  58.639 1.878 
22 C 26 F 149.904 0.977 0.652 5.815     0.240 1.942 26.011 2.137 
    149.494 0.915 0.612 6.813     0.261 3.390 34.009 2.627 
    150.002 3.119 2.080 10.392     0.481     2.429 
  C 26 Mean 149.800 1.670 1.115 7.673     0.327 2.666 30.010 2.398 
23 CM 27 189.887 3.994 2.103 8.166     0.912     2.352 
    187.002 4.188 2.240 9.727     0.985 3.774 43.694 2.441 
    193.440 3.033 1.568 6.661 2.273 18.942 0.724     1.693 
  C 27 Mean 190.110 3.738 1.970 8.185 2.273 18.942 0.874 3.774   2.162 
24 C 28 F 196.541 0.839 0.427 5.056     0.174     1.224 
    201.394 0.903 0.448 7.611     0.188     1.051 
    211.985 1.283 0.605 4.760     0.270     1.184 
  C 28 Mean 203.307 1.008 0.493 5.809     0.211     1.153 
25 CM 29 122.599 1.206 0.983 8.648     0.585     1.486 
    121.295 1.052 0.867 5.014     0.439     2.141 
    119.588 1.042 0.872 5.702     0.607 3.636 48.716 2.852 
  C 29 Mean 121.161 1.100 0.907 6.455     0.544 3.636 48.716 2.160 
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  CONTROLS Fo Hz STD F0 vFo% vAm% Rftr Hz Pftr % Mftr% Ratr Hz Patr % Matr % 
26 CM 30 120.608 2.126 1.763 9.285 2.299 14.185 0.741     3.388 
    121.342 1.566 1.291 9.444     0.394 2.151 38.449 3.133 
    119.616 1.743 1.457 7.444     0.596 2.000 39.230 2.248 
  C 30 Mean 120.522 1.812 1.504 8.724 2.299 14.185 0.577 2.076 38.840 2.923 
27 CM 31 117.371 1.128 0.961 6.898     0.414 4.545 55.021 1.713 
    117.725 0.892 0.757 8.613     0.494 2.500 45.133 2.150 
    118.015 1.441 1.221 5.588 2.105 23.771 0.763 4.651 31.537 2.283 
  C 31 Mean 117.704 1.154 0.980 7.033 2.105 23.771 0.557 3.899 43.897 2.049 
28 CM 32 120.500 1.035 0.859 6.652     0.484 2.353 52.253 2.318 
    119.592 0.899 0.751 9.378     0.372 2.778 37.470 2.518 
    118.530 1.287 1.086 9.150     0.539     2.100 
  C 32 Mean 119.541 1.074 0.899 8.393     0.465 2.566 44.862 2.312 
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APPENDIX Q: Intraclass correlation coefficient (ICC) & 95% confidence intervals (CI) for 
inter-rater reliability for auditory perceived instability and tremor (CAPE-V), for PD & 
control group 
 
 Instability  Tremor  
 PD group 
(n=26) 
 
Control 
(n=27) 
PD group 
(n=27) 
Control 
(n=27) 
ICC 0.780 0.717 0.306 0.481 
95% CI  0.628-0.885 0.541-0.847 0.065-0.560 0.249-0.692 
ICC: two way mixed-effects model (consistency definition) based on a single rater 
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APPENDIX R: Intraclass correlation coefficient (ICC) and confidence intervals (CI’s) for 
intra-rater reliability for auditory perceived tremor and instability (PD and controls 
combined) 
 
 Instability 
(n=6) 
 Tremor 
(n=6) 
  
 Intraclass 
correlation 
coefficient * 
95% 
confidence 
interval 
Intraclass 
correlation 
coefficient * 
95% 
confidence 
interval 
 
Rater A 0.439 -0.472- 0.897 0.031 -0.741- 0.768  
Rater B -0.017 -0.762- 0.747 0.652 -0.202- 0.943  
Rater C 0.846 0.253- 0.977 0.607 -0.272- 0.934  
ICC: two way mixed-effects model (consistency definition) based on a single rater 
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APPENDIX S: Auditory perceived instability (CAPE-V), individual and mean ratings 
(Raters A, B, C) for PD group 
 
 Instability Ratings 
n PD group Rater A Rater B Rater C  Mean 
1 01 49 39 60 49 
2 02 34 14 49 32 
 03 * * * * 
 04 * * * * 
3 05 63 57 68 63 
4 06 19 13 13 15 
5 09 13 3 20 12 
6 10 9 2 2 4 
7 11 31 13 51 32 
8 12 13 6 25 15 
9 13 38 5 17 20 
10 15 28 11 34 24 
11 16 31 24 61 39 
12 17 26 19 35 27 
13 18 41 25 44 37 
14 20 14 7 28 16 
15 21 3 12 10 8 
16 22 11 5 31 16 
17 23 12 24 31 22 
18 24 34 37 46 39 
21 25 18 11 44 24 
22 26 29 20 38 29 
23 27 19 11 13 14 
24 28 54 54 60 56 
25 29 22 12 37 24 
26 30 28 13 46 29 
27 31 11 3 30 15 
28 32 51 38 55 48 
*Missing data 
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APPENDIX S: Auditory perceived instability (CAPE-V), individual and mean ratings 
(Raters A,B,C) for Control group  
 
 Instability Ratings 
n Controls Rater A Rater B Rater C Mean 
1 02 40 36 43 40 
2 03 20 14 32 22 
3 04 25 25 38 29 
4 05 30 12 50 31 
5 08 39 27 37 34 
6 09 37 37 32 35 
7 10 22 4 10 12 
8 11 12 12 24 16 
9 12 23 13 33 23 
10 13 15 5 17 12 
11 14 24 37 37 33 
12 15 15 15 14 15 
13 16 43 24 37 35 
14 18 10 5 2 6 
15 19 23 12 28 21 
16 20 14 14 22 17 
17 21 10 4 27 14 
18 23 9 11 21 14 
19 24 0 4 11 5 
20 25 12 28 47 29 
21 26 35 25 39 33 
22 27 41 56 70 56 
23 28 20 4 19 14 
24 29 13 4 5 7 
25 30 40 39 57 45 
26 31 16 11 47 25 
27 32 40 29 37 35 
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APPENDIX T: Auditory perceived tremor (CAPE-V), individual and mean ratings  
(Raters A,B,C) for PD group 
 
 
Auditory perceived tremor ratings (CAPE-V) for PD group 
n  PD group Rater A Rater B Rater C Mean 
1 PD01 5 11 58 25 
2 PD02 4 3 43 17 
3 PD03 * * *  
4 PD04 * * *  
5 PD05 61 38 66 55 
6 PD06 4 13 0 6 
7 PD09 10 4 0 5 
8 PD10 7 3 8 6 
9 PD11 34 4 3 14 
10 PD12 14 4 25 14 
11 PD13 39 5 19 21 
12 PD15 28 11 34 24 
13 PD16 34 11 7 17 
14 PD17 26 10 35 24 
15 PD18 41 12 43 32 
16 PD20 12 5 29 15 
17 PD21 2 5 0 2 
18 PD22 12 4 0 5 
19 PD23 10 1 0 4 
20 PD24 35 12 2 16 
21 PD25 18 10 43 24 
22 PD26 29 6 39 25 
23 PD27 8 11 21 13 
24 PD28 0 12 56 23 
25 PD29 18 7 23 16 
26 PD30 26 13 45 28 
27 PD31 11 4 30 15 
28 PD32 48 4 55 36 
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APPENDIX U: Auditory perceived tremor (CAPE-V) individual and mean ratings  
(raters A,B,C), for control group 
 
Auditory perceived tremor ratings (CAPE-V) for control 
group 
n Controls Rater A Rater B Rater C Mean 
1 02 40 14 40 31 
2 03 21 14 31 22 
3 04 7 13 38 19 
4 05 29 12 50 30 
5 08 55 4 26 28 
6 09 24 13 24 20 
7 10 16 3 0 6 
8 11 11 3 24 13 
9 12 13 5 0 6 
10 13 13 5 0 6 
11 14 18 7 14 13 
12 15 15 5 0 7 
13 16 44 9 37 30 
14 18 9 3 1 4 
15 19 14 12 28 18 
16 20 13 9 0 7 
17 21 9 3 23 12 
18 23 9 3 20 11 
19 24 0 4 9 4 
20 25 11 8 46 22 
21 26 35 4 25 21 
22 27 40 35 70 48 
23 28 20 5 0 8 
24 29 10 4 0 5 
25 30 39 40 52 44 
26 31 16 12 46 25 
27 32 42 9 32 28 
 
 
  
246 
 
APPENDIX V: Intraclass correlation coefficient (ICC) (single measures) and 95% 
confidence intervals (CI) for inter-rater reliability (four raters), for tremor severity in ten 
vocal tract conditions, for PD and control group 
 
 
 
ICC 95% CI  ICC 95% CI 
 PD n=27  Control n=22  
Palate breathe 0.754 0.614-0.864 0.315 0.107-0.564 
 n=29  n=24  
Palate /s/ 0.631 0.462-0.780  0.491 0.287-0.696  
 n =25  n=23  
Palate /a/ 0.686 0.518-0.827 0.577 0.377-0.762  
 n=28  n=22  
Tongue breathe 0.672 0.509-0.810 0.461 0.246-0.683  
 n=28  n=23  
Tongue /s/ 0.524 0.338-0.707 0.211 0.023-0.460 
 n=27  n=22  
Tongue /a/ 0.574 0.390-0.746 0.071 -0.87-0.315 
 n=28  n=22  
Larynx breathe 0.676 0.515-0.813 0.260 0.060-0.514 
 n=27  n=23  
Larynx /s/ 0.758 0.619-0.866 0.360 0.153-0.597 
 n=30  n=25  
Larynx /a/ 0.454 0.270-0.646 0.155 -0.14-0.391 
 n=30  n=24  
Larynx /i/ 0.225 0.056-0.439 0.244 0.054-0.487 
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APPENDIX W: Intra-rater agreement for vocal tract tremor ratings (scale 0-3) [(exact, 
and within 1 point agreement (%)], for PD and control group 
 
Intra-rater agreement % 
 
 PD group (n=4) Control group(n=2) 
 Exact agreement  Within 1 point    Exact agreement Within 1 point  
Palate breathe 75 100 38 100 
Palate /s/ 63 100 50 100 
Palate /a/ 88 100 50 87 
Tongue breathe 94 100 75 100 
Tongue /s/ 43 93 50 100 
Tongue /a/ 56 100 50 100 
Larynx breathe 69 100 75 100 
Larynx /s/ 67 100 75 100 
Larynx /a/ 75 100 63 100 
Larynx /i/ 62 100 75 100 
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APPENDIX X: Intra-rater % agreement (4 raters) for vocal tract tremor ratings  
for presence & absence of tremor, for PD and control group 
 
 % Agreement 
 Tremor 
present/absent 
Tremor 
present/absent 
 PD (n=4) %  Control (n=2) 
Palate breathe 87.5 50 
Palate /s/ 100 62.5 
Palate /a/ 100 87.5 
T/B Breathe 93.75 75 
T/B /s/ 75 50 
T/B /a/ 75 50 
Larynx Breathe 87.5 75 
Larynx /s/ 93.75 75 
Larynx /a/ 100 62.5 
Larynx /i/ 62.5 75 
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APPENDIX Y: Intraclass Correlation Coefficient (ICC) values for inter-rater reliability 
ratings (4 raters) of speech intelligibility, for PD and control group 
 
 Speech IntelligibilityTest  
 PD (n=21) Control (ln=24) 
Intra class correlation 
coefficient * 
0.523 0.539 
Confidence Intervals  0.307-0.733 0.338-0.731 
*ICC two way mixed-effects model using a consistency definition for single measures 
  
250 
 
 
APPENDIX Z: Intraclass Correlation Coefficient (ICC) values for intra-rater reliability 
ratings (4 raters) of speech intelligibility, for PD and control group 
 
 Intraclass 
correlation 
coefficient  
95% confidence 
interval 
 
  Lower limit Uppper limit 
Judge A * * * 
Judge B 0.968 0.729 0.997 
Judge C 0.599 -0.589 0.968 
Judge D 0.968 0.730 0.997 
Judge B,C,D 0.784 0.428 0.982 
ICC: two-way random effects model, consistency definition  
 
* Judge A not included for reliability since there was data missing for 3 out of 5 participants  
(PD1, PD 11, PD22, C2, C26) 
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 APPENDIX AA: Intraclass correlation coefficients (ICC’s) and confidence intervals 
(CI’s) for inter-rater reliability of dysphonia severity rating (CAPE-V), for PD and control 
group 
 
 CAPE-V  Dysphonia Severity 
 PD group 
(n=26) 
Control group 
  (n=27) 
   
ICC  0.564 0.726 
 CI  0.339-0.753 0.554-0.852 
Two-way mixed effects model (single measures) using consistency definition 
 
APPENDIX BB: Intraclass correlation coefficients (ICC’s) and confidence intervals (CI’s) 
for intra-rater reliability of dysphonia severity rating (CAPE-V), for PD and control group 
 
 
 Severity of Dysphonia (CAPE-V)  (n=6) 
 Intraclass 
correlation 
coefficient * 
95% confidence 
interval 
  Lower limit 
Rater A 0.418 -0.491-0.891 
Rater B 0.777 0.056-0.966 
Rater C 0.735 -0.043-0.958 
Two-way mixed effects model (single measures) using consistency definition 
  
 
APPENDIX CC: PwPD self-report of experience, pain and anxiety during nasendoscopy
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Glossary  
 
Accelerometry: 
Means of measuring the motion of body segments through the use of small devices called 
accelerometers, which respond to the frequency and amplitude of movement. 
Acoustic analysis: 
Acoustic analysis is the process of extracting and quantifying precisely defined and salient 
features of the speech signal (e.g. intensity, duration, frequency) through objective 
instrumental means as opposed to subjective perceptual means.  
Amplitude:  
A property referring to the height of a (sound) wave. The bigger the wave, the more intense 
the sound pressure level, and the louder we perceive the signal to be. 
Auditory-perceptual (perceptual): 
Relates to rating sound with the naked ear (as opposed to using instrumentation)  
Basal Ganglia (BG):  
A set of nuclei situated subcortically in the brain and which act as a concerted unit. The BG 
comprises the striatum (caudate, putamen, nucleus accumbens), the sub-thalamic nucleus 
(STN), globus pallidus (internal and external segments, ventral pallidum), and substantia nigra 
(pars compacta, pars reticulate) 
Bowing: 
Bowing of the vocal cords refers to an effect of the physical changes associated with atrophy 
of the vocal cords which leads to loss of elasticity resulting in a bowed shape as opposed to 
parallel closure/vibratory pattern to the vocal cords. 
Co-efficient of variation (COV): 
Here, COV is a perturbation measure (frequency and amplitude), referred to as long-term (as 
opposed to cycle to cycle) and relies on a calculation over the entire set of cycles chosen for 
analysis. The COV for a sequence of numbers is the standard deviation divided by the mean 
times 100. COV would be large if periods or amplitude were to vary slowly around the mean, 
over the duration of the analysis (usually 100 consecutive cycles after vocal initiation). 
Relatively high values of COV for frequency may suggest uncontrolled low-frequency 
neuromuscular fluctuations of the cricothyroid or thyroarytenoid muscles or of the air pressure. 
Similarly high values of COV for amplitude may suggest relatively low-frequency (slow) neuro-
muscular fluctuations in the thyroarytenoid muscles or sub-glottal air pressure fluctuations, 
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both of which may change the amplitude of glottal flow and the waveshape. The COV 
amplitude may be high if the laryngeal sound source is normal but the supra laryngeal vocal 
tract fluctuates. 
Deep Brain Stimulation (DBS): 
DBS involves the implantation of permanent electrodes into the brain and providing electrical 
stimulation. 
 
Digitizing tablet: 
A digitizing (graphic tablet) is a computer input device that allows one to hand draw images 
and graphics, and objectively quantify the amplitude and frequency of tremor. 
Electroglottography:  
Electroglottography 134 also referred to as laryngography is a non-invasive technique used to 
examine configuration of the glottis related to its opening and closing, using a high frequency 
electric signal (2-5 MHz typically) passed between two electrodes positioned at two different 
locations on the neck. As the vocal fold tissues make contact, the conductance increases, 
which is interpreted as glottal closing. Conversely, decrease in the conductance is interpreted 
as glottal opening. The speed quotient (contact  index) measured by the EGG  is the ratio of 
the durational difference between the contact closing and the contact opening phases, divided 
by the duration of the contact phase, and is intended to measure the symmetry of the EGG 
contact phase. 
Electromyography (EMG) 
EMG is a technique for evaluating and recording the electrical activity produced by skeletal 
muscles and is performed using an instrument called an electromyograph. An 
electromyography detects the electrical potential generated by muscles cells, when these cells 
are electrically or neurologically activated. 
Fluctuation: (refer to Perturbation) 
 
FEV1: 
Forced Expiratory Volume is the volume of air exhaled during the 1st second of a forced 
expiratory manoeuvre starting from the level of total lung capacity. 
 
Flutter: 
Flutter is a rapid vocal tremor of 7-10 hertz which is associated with the dysarthria of 
amyotrophic lateral sclerosis (ALS.) It is difficult to detect in conversational speech, and is 
usually measured acoustically. 
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Formant frequency  
The second formant frequency (F2) slope is a measure of the rate of tongue movement from a 
consonant into a vowel and is measured by comparing the second formant (F2) value at the 
initiation of voicing (0msec) to the F2 value 50 msec into the vowel. 
 
Freezing of gait: 
Freezing of gait (FOG) described as a sudden and transient difficulty that can occur at the 
beginning or during the performance of rhythmic and repetitive movements. FOG has been 
positively associated with deterioration of speech and disease duration.  
Fundamental frequency (Fo): 
Fo is a measure of the rate at which the vocal cords open and close (vibrate) during 
phonation. One opening and closing movement is termed a cycle. Fo is measured in cycles 
per second (hertz), usually abbreviated as Hz.  
Fundamental frequency variation (SDFo): 
SD Fo is calculated as the square root of the variance around the mean Fo. 
Global laryngeal tremor: 
Here refers to tremor in the vertical dimension of the larynx as a unit, relative to the 
surrounding aero-digestive tract. 193 
Harmonics-to-noise ratio (HNR): 
HNR reflects the relationship between the amount of periodic energy and noise in the voice 
signal per unit time. 
Jitter: 
An acoustic measure of ‘perturbation’ or variability of frequency between adjacent cycles  
(opening and closing movement of the vocal cords).  It refers to the short-term (cycle-to-cycle) 
perturbation in the fundamental frequency of the voice and is therefore an evaluation of small 
cycle-to-cycle change in frequency. Typically, periods range from 1-10 ms and jitter deals with 
temporal changes down to a few microseconds. Since jitter involves changes that occur over 
adjacent cycles, the measure reflects short-term or high-frequency fluctuations. 
Jitter is calculated as follows: For a sequence of N consecutive cycles, jitter is obtained by 
averaging the absolute values of adjacent-cycle frequency differences, dividing by the mean 
frequency for the N cycles and multiplying by 100.  
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Laryngoscopy (indirect, rigid, fiberoptic): 
Indirect laryngoscopy: the examiner holds the tongue forward out of the mouth, the larynx is 
examined with a laryngeal mirror placed at the faucal arches, and the patient phonates and /i/ 
sound which elevates the larynx and permits visualization. The forward tongue position 
interferes with the normal physiological configuration of the larynx. This exam cannot be 
recorded and has been superseded by rigid laryngoscopy and fiberoptic endoscopy.  
Rigid laryngoscopy: a rigid scope with a 70 or 90 degree angle lens at the distal end, 
introduced into the mouth and placed at the faucal arches, tongue is held forward and patient 
phonates /i/ sound (similar to indirect laryngoscopy. A camera can be attached to the scope 
which permits recording and playback of the procedure. Frequently strobe lighting is used with 
this technique which permits viewing of vocal cord vibration. 
Fiberoptic laryngoscopy: also referred to as ‘nasendoscopy’, since the flexible fiberoptic scope 
is introduced into the larynx through the nasal cavity, permitting visualization of the 
nasopharynx, oropharynx and and laryngopharynx. A camera can be attached to the scope 
which permits recording and play backof the procedure. Strobe lighting may also be applied to 
examine vocal cord vibration. 
Modulation: 
The term modulation is used to quantify the systematic change of a cyclic parameter (usually 
the frequency or amplitude) of a periodic signal. 
 
Nasendoscopy: (refer to Laryngoscopy) 
 
Noise-to-harmonic ratio (NHR): 
NHR is an average ratio of energy of the inharmonic components in the range of 1500 Hz to 
4500 Hz to the harmonic components energy in the range of 70 Hz to 4500 Hz. It is a general 
evaluation of the noise presence in the analysed signal (e.g amplitude and frequency 
variations, turbulence noise, subharmonic components,and voice breaks)138. 
Perturbation: 
Perturbation represents a minor disturbance or a temporary change, from an expected 
behaviour. Perturbations do not alter the qualitative appearance/sound of a visual or temporal 
pattern. They are small irregularities that for the most part are overlooked. Perturbation 
analysis is based on the premise that small fluctuations in frequency, amplitude and wave 
shape are always present in a voice signal, reflecting the internal “noises” of the human body.  
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Whereas a perturbed system usually returns to normal, (it is attracted to a stable state), a 
fluctuating system is somewhat out of control. A fluctuation suggests a more severe deviation 
from a pattern. It reflects an inherent instability in the system.  ‘Vocal tremor’ or ‘vibrato’ may 
be described as a fluctuation in fundamental frequency and amplitude. It is more than a 
perturbation since there is no ultimate stabilization of fundamental frequency or intensity 
toward some constant value. The tremor or vibrato is a pattern itself, rather than a small 
deviation from a pattern. 114 
Phonatory instability: 
Phonatory instability relates to fluctuations in frequency and amplitude measures and has 
been described as short-term or long-term. Short-term phonatory instability refers to cycle-to 
cycle variations in frequency and amplitude. Measures include jitter and shimmer. Long-term 
phonatory instability refers to variations in frequency and amplitude that occur more slowly 
than the ‘quasi-periodic’ glottal vibration.  
Physiological tremor: (refer to Tremor) 
 
Pitch: 
Pitch is the perceptual correlate of fundamental frequency. The inherent pitch of a voice is 
positively related to the size of the larynx and its structures (hence in general male voices are 
lower than female), but also to the anterior-posterior tension within the vocal cords. 
Positron Emission Tomography (PET): 
Positron Emission Tomography or PET as it is commonly called uses a special type of camera 
and a tracer (radioactive chemical) to look at organs in the body. The tracer usually is a spcial 
form of glucose which collects in cells that use a lot of energy. 
Prosody: 
Prosody is the rhythm, stress, and intonation of speech. It may reflect various features of the 
speaker or the utterance: the emotional state of the speaker; the form of the utterance 
(statement, question, or command); the presence of irony or sarcasm; emphasis, contrast and 
focus; or other elements of language that may not be encoded by grammar or choice of 
vocabulary.  
Reliability: 
Reliability refers to the likelihood that two individual raters will produce the same rating for a 
given speech or voice sample. 
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Shimmer: 
Shimmer is a measure of the variability of amplitude between adjacent cycles, termed short-
term (cycle-to-cycle) variability. 
Soft Phonation Index (SPI) 
An acoustic measure from the Multi-Dimensional Voice Programme (MDVP) from the 
Computerised Speech Laboratory (CSL), SPI is an average ratio of the lower frequency 
harmonic energy (1600Hz-4500Hz) harmonic energy. Increased SPI may be an indication of 
incomplete or loosely adducted vocal folds138. 
Spectogram: 
Here a visual signal display of an acoustic signal from a voice sample. 
Spectography: 
Here the process of acquiring/displaying a graphic image of frequency and amplitude as a 
function of time from an acoustic signal.  
Tremor: 
Tremor is a low-frequency rhythmic involuntary fluctuation in amplitude or frequency or both. 
Supraglottic tremor: tremor in the structures above (supra) the vocal folds (glottis), including 
the epiglottis, ventricular folds, aryepiglottic folds and supraglottic portion of the arytenoids. 
Physiological tremor: normal physiological tremor that has an irregular rapid rate that ranges 
from 8 to 12 Hz.  
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